Pathway-Specific Signaling and its Impact on Fertility:  A Focus on the Kisspeptin Receptor, Kiss1r by Ahow, Maryse R.
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
12-1-2014 12:00 AM 
Pathway-Specific Signaling and its Impact on Fertility: A Focus on 
the Kisspeptin Receptor, Kiss1r 
Maryse R. Ahow 
The University of Western Ontario 
Supervisor 
Dr. Andy Babwah 
The University of Western Ontario 
Graduate Program in Physiology 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Maryse R. Ahow 2014 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Molecular and Cellular Neuroscience Commons 
Recommended Citation 
Ahow, Maryse R., "Pathway-Specific Signaling and its Impact on Fertility: A Focus on the Kisspeptin 
Receptor, Kiss1r" (2014). Electronic Thesis and Dissertation Repository. 2537. 
https://ir.lib.uwo.ca/etd/2537 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
PATHWAY-SPECIFIC SIGNALING AND ITS IMPACT ON FERTILITY: 
A FOCUS ON THE KISSPEPTIN RECEPTOR, Kiss1r 
(Thesis format: Monograph) 
 
 
by 
 
 
Maryse R. Ahow 
 
 
Graduate Program in Physiology 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of  
Doctor of Philosophy 
 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
© Maryse R. Ahow, 2014  
 
 ii 
 
Abstract 
Hypothalamic gonadotropin-releasing hormone (GnRH) is the master regulator of the 
neuroendocrine reproductive (HPG) axis and its secretion is regulated by various afferent 
inputs to the GnRH neuron. Activation of some Gαq/11-coupled receptors leads to GnRH 
neuronal membrane depolarization and GnRH secretion. The most potent trigger of GnRH 
secretion is kisspeptin (KISS1), the ligand for the Gαq/11-coupled receptor, KISS1R. The 
critical role for the KISS/KISS1R system in reproduction is revealed in patients bearing 
KISS1R mutations causing reproductive axis dysfunction. Furthermore mice carrying 
targeted KISS1R deletion phenocopy human patients in being infertile and 
hypogonadotropic.  While studies have shown that Kiss1r signaling is essential for attaining 
and maintaining fertility the underlying mechanisms have not been fully elucidated. Our 
overall goal of this study was to reveal novel signaling mechanisms downstream of Kiss1r 
that regulate GnRH secretion and fertility. We recently demonstrated that in addition to 
Gαq/11, Kiss1r also signals to ERK1/2 via the β-arrestin pathway. Here we investigated the 
role of this β-arrestin signaling in Kiss1r-dependent Gnrh secretion. Using mice lacking β-
arrestin, we determined that Kiss1r triggers significant Gnrh secretion via the β-arrestin 
pathway. Thus, mice use both the Kiss1r-coupled Gαq/11 and β-arrestin cascades to regulate 
Gnrh secretion and thereby, fertility. In addition to β-arrestins, Kiss1r potentially uses other 
Gαq/11-independent signaling pathways to regulate fertility. To test whether these pathways 
are sufficient to attain and maintain fertility we created Gnrh neuronal-specific Gαq/11 
knockout mice and characterized their reproductive development and capacity to trigger Gnrh 
secretion following KISS1 administration. While these mice were hypogonadotropic and had 
delayed pubertal onset they retained partial fertility and ability to trigger Gnrh secretion in 
response to KISS1 stimulation confirming that Kiss1r-Gαq/11-independent signaling is 
sufficient for attaining and maintaining fertility. Overall, we show that Kiss1r signals via both 
Gαq/11-dependent and -independent mechanisms to regulate Gnrh secretion and fertility. We 
also demonstrated that one of these Gαq/11-independent pathways is mediated by β-arrestins 
in mice. Based on these novel findings, the potential now exists to develop new molecular 
strategies to treat infertility in humans. 
Keywords:  KISS1R, IHH, L148S, β-arrestin, Gαq/11, GnRH, LH, FSH, HPG axis  
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Chapter 1: Literature Review 
1.1 The reproductive axis 
The three tiered reproductive axis consists of coordinated hormonal signals relayed 
between the hypothalamus, pituitary and gonads (HPG axis) (Fig. 1.1). Hypothalamic 
gonadotropin-releasing hormone (GnRH)  is established as the master control of the HPG 
axis and in the mammalian brain there are fewer than 1500 GnRH neurons which are not 
organized in distinct nuclei but scattered throughout the medial septum, preoptic area and 
basal hypothalamus (Wray 2002, Silverman et al. 1994, Wu et al. 1995). Regardless of 
location most GnRH neurons project their axons into the median eminence. The median 
eminence is one of seven areas in the brain devoid of a blood-brain-barrier (BBB). When 
stimulated, GnRH is released in a pulsatile fashion into a fenestrated capillary bed called 
the primary plexus. This primary plexus which is nearer the hypothalamus is connected to 
a secondary plexus nearer the anterior pituitary; by a hypophysial portal vein.  Once in 
the secondary plexus, GnRH diffuses out of the blood and activates GnRH receptors on 
gonadotropes in the anterior pituitary resulting in the synthesis and release of 
gonadotropins; luteinizing hormone (LH) and follicle stimulating hormone (FSH) into 
systemic circulation (Fig. 1.1) (Wray 2002). 
1.2 Gonadotropin Hormone Releasing (GnRH) Neurons  
In the early 1970’s hypothalamic GnRH was established as the prime regulator of the 
reproductive hormonal cascade in vertebrates, including mammals (McCann et al. 2002, 
Schally et al. 1971, Baba et al. 1971). Mammals have two forms of this 10 amino acid 
neuropeptide GnRH-1 and GnRH-2. The GnRH receptor (GnRHR) is expressed on the 
plasma membrane of gonadotropin releasing cells in the anterior pituitary. It is a seven-
transmembrane spanning receptor (7TMR) but unlike most other receptors in this 
category, it lacks a carboxy tail which prevents rapid desensitization and internalization. 
While the GnRH-2 agonist modulates sexual behaviour, GnRH-1, (Glu-His-Trp-Ser-Tyr-
Gly-Leu-Arg-Pro-Gly) activates GnRH-R1 on anterior pituitary gonadotropes and 
triggers gonadotropin secretion and is thus central regulator of the reproductive axis 
(Millar 2005). GnRHR couples to and signals via several G proteins in a cell-type 
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dependent manner (Armstrong et al. 2009). In the gonadotrope it primarily signals via 
Gαq/11 and activation by GnRH leads to the PIP2 hydrolysis, InsP3 formation, protein 
kinase C (PKC) activation and ERK1/2 phosphorylation (Kaiser et al. 1995). GnRHR 
expression on pituitary gonadotropes is dependent on pulsatile GnRH stimulation. 
However, continuous GnRH exposure leads to non-β-arrestin mediated desensitization of 
the receptor, which is utilized in some clinical treatments (Kaiser et al. 1995, Nathwani et 
al. 2000, An et al. 2005). Pulsatile GnRH stimulates gonadotropes in an amplitude and 
frequency-dependent manner. The primary targets for LH and FSH are the gonads where 
they initiate sexual maturation and gametogenesis. FSH stimulates spermatogenic tissues 
of testes and granulosa cells of the ovarian follicle to enhance the maturation of the sperm 
and egg. LH stimulates the Leydig cells of the testis to produce testosterone (T) and 
thecal cells of the ovaries to produce estrogen (E2) and progesterone (P4). In addition to 
their roles in the development of secondary sexual characteristics, these gonadal steroid 
hormones feed back on both the hypothalamus and anterior pituitary to regulate GnRH 
and LH secretion (Pinila et al. 2012, d’Anglemont de Tassigney et al. 2010).   
GnRH neurons in the hypothalamus receive a variety of stimulatory and inhibitory inputs 
but among these, kisspeptin (KISS1) is the most potent positive trigger of GnRH release. 
Kisspeptin neurons lie upstream of hypothalamic GnRH neurons, specifically in the 
arcuate nucleus (ARC) and anteroventricular periventricular nucleus (AVPV) in rodents 
and the infundibular nucleus in primates. While testosterone in males inhibits GnRH and 
LH secretion by negative feedback on Kiss1 neurons in the ARC, E2 and P4 in females 
can stimulate Kiss1 neurons in the AVPV while inhibiting the Kiss1 neurons of the ARC. 
This differential regulation is dependent on the stage of the ovarian cycle. Some other 
afferent inputs that regulate GnRH secretion are leptin, Neurokinin B (NKB), glutamate, 
norepinepherine, N-methyl-D-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA). Inhibitory inputs include: RF-related peptides (RFRP), 
gamma-aminobutyric acid (GABA) and Dynorphin.  
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Figure 1.1: Graphic representation of the hypothalamic-pituitary gonadal (HPG) 
axis.  
(1) Kisspeptin neurons in the ARC and AVPV of the hypothalamus secrete KISS-1 which 
activates KISS1R (2) on the membrane of hypothalamic GnRH neurons. Intracellular 
signaling cascade downstream of KISS1R results in the pulsatile secretion of GnRH to 
the ME (3). In the anterior pituitary GnRH activates GnRH-R expressed on gonadotropes 
(4) leading to the pulsatile secretion of gonadotropins, LH and FSH into systemic 
circulation (5). LH and FSH act on the gonads to promote gametogenisis and gonadal 
steroid hormone production; E2, T and P4. These hormones feedback (positively and 
negatively) on the hypothalamus and pituitary to regulate GnRH, LH and FSH release 
(6). AVPV, anteroventral periventricular nucleus; ARC, arcuate nucleus; ME, median 
eminence. Adapted from Pinilla et al. 2012 and d’Anglemont de Tassigny et al. 2010. 
 
 
4 
 
GnRH expressing neurons are unique since they originate outside the CNS. During 
embryonic development GnRH secreting neurons originate from the epithelium cells of 
the olfactory placode (~ E10.5 in the mouse). (Bless et al. 2004, Limonta et al. 2003, 
Wray 2002, Schwanzel-Fukuda et al. 1989, Wray et al. 1989, Jasoni et al., 2009) Prior to 
birth, these neurons co-migrate along the vomeronasal axons with the olfactory neurons 
across the cribiform plate (Fig. 1.2) (Wireman et al. 2011). The olfactory neurons migrate 
to the olfactory bulb and the GnRH neurons migrate to the anterior hypothalamus (~ 
E18.5 in the mouse) (Wray, 2002, Jasoni et al. 2009, Tobet et al. 2003). 
 
 
Figure 1.2: Graphic representation of GnRH neuronal migration during 
development. 
Nascent GnRH neurons (green) in the OE co-migrate with olfactory neurons (red) along 
vomeronasal axons. GnRH neurons migrate towards the anterior hypothalamus and 
olfactory neurons towards the OB. OE, olfactory epithelium, VNO, vomeronasal organ, 
OB, olfactory bulb. Adapted from Suarez et al. 2012 and Cariboni et al. 2011. 
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Disruption in GnRH neuronal migration during development results in a 
hypogonadotropic condition called Kallmann syndrome (Seminara 1998). This syndrome 
is characterized by delayed puberty and anosmia due to a defect in the developmental co-
migration if the GnRH and olfactory neurons. In humans and primates, GnRH pulse 
frequency and amplitude increase embryonically as the hypothalamus and hypophyseal 
portal system develop.  Placental steroids provide negative feedback and thereby lower 
fetal gonadotropin levels. When this negative feedback is removed at birth GnRH, LH 
and FSH secretion increase in the neonates and remain elevated for 1-2 years in girls and 
6 months in boys (Grumbach et al. 2005). Through an unknown mechanism, thought to 
involve GABA and NPY, GnRH neurons subsequently enter a quiescent stage 
characterized by low LH pulse amplitude and frequency for the rest of childhood then 
gradually reawakens in puberty (Plant 2008, Weisz et al. 1980, Ehlers et al. 2013, 
Waldhauser et al. 1981 and Blogowska et al. 2003). 
GnRH neurons vary slightly in anatomical location depending on species. It is unknown 
if these differences significantly affect their physiological function but should be kept in 
mind when comparing GnRH activity between species. In rodents, GnRH neurons are 
mainly located in the preoptic region (POA), scattered from the medial septum to the 
band of Broca.  In humans, most of the GnRH neurons are located in the infundibular 
nucleus (referred to as arcuate nucleus in other species) with very few in the POA. In 
monkeys, GnRH neurons are mainly found scattered lateral to the ARC in a region called 
the mediobasal hypothalamus (MBH). In sheep, GnRH neurons are found in both the 
POA and ARC (Herbison et al. 2006, Ramaswamy et al. 2008, Hrabovszky et al. 2010, 
Goodman et al. 2007, Lehman et al. 1986, Schwanzel-Fukuda et al. 1989, Ohkura et al. 
2009).  
GnRH pulses occur every 30 minutes in rodents and every 1.5 hours in humans (Knobil 
1992, 1980, Belchetz et al. 1978, Moenter et al. 1991). Since GnRH release is mirrored in 
LH pulsatility, for small animal models where direct measurement of GnRH secretion is 
difficult, serum LH is an acceptable surrogate marker for GnRH secretion (Fig. 1.3) 
(Messager et al. 2005, Christian and Moenter, 2010). 
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Figure 1.3: GnRH secretion is directly reflected by gonadotropin (LH) release. 
(A) Measurement of circulating levels of LH and GnRH in an individual ewe 
demonstrating a preovulatory surge. (B) Measurement of cerebrospinal GnRH (filled 
squares) and serum LH (open circles) in an individual ewe after i.c.v. administration of 
50 nmol kisspeptin. GnRH pulses closely mirror LH pulses and since GnRH secretion 
cannot be readily measured in other species such as mice and small rodents, LH 
pulsatility is used as a surrogate for GnRH. Adapted from Messager et al. 2005, Christian 
and Moenter, 2010. 
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1.2.1 Biological systems for studying GnRH neurons 
Since GnRH neurons are few in number and scattered throughout the mediobasal 
hypothalamus they present a technical challenge to obtain and purify for direct analysis 
of the intracellular mechanisms regulating synthesis and secretion of GnRH. This 
challenge has been somewhat overcome by the development of immortalized GnRH 
neuronal cell cultures.  (Krsmanovic et al. 1999, Wray 2002, Silverman et al. 1994, Wu et 
al. 1995, Mayer et al. 2009, Mellon et al. 1990, Liposits et al. 1991). Various strategies to 
create these cellular models have been employed including; GnRH-neuronal directed 
tumoregenisis in the hypothalamus and olfactory placode, lentiviral modification of 
dissociated hypothalamic cells and lastly conditional activation of a GnRH-neuronal 
specific oncogene (Mellon et al. 1990, Radovick et al. 1991, Salvi et al. 2006, Wolfe et 
al. 2008, Belsham et al. 2004, Mayer et al. 2009). To date however the GT1-7 line 
created by Mellon et al. 1990 remains the most well characterized and widely used 
immortalized GnRH neuronal cell line in the literature (used in over 300 publications) 
(Liposits et al. 1991, Mayer et al. 2009, Belsham et al. 2004). This line has been shown to 
express low endogenous levels of KISS1R and respond to kisspeptin treatment by 
increases in GnRH mRNA and secretion and in serum free media (no cell division) 
exhibit classical neuronal phenotype with long extended neurites and many interneuronal 
connections (Mellon et al. 1990, Nunemaker et al. 2001, Novaira et al. 2009). Also, 
compared to other lines, GT1-7s represent post-migratory, adult GnRH neurons since the 
line was created by targeted tumorigenesis in the anterior hypothalamus of adult mice. 
GT1-7s also express estrogen receptors (ERα and ERβ) (Hu et al. 2008 and Krsmanovic 
et al. 2009). The creation of the GT1-7 line allowed for the investigation at the molecular 
level in the GnRH neuron however, while GT1-7s are convenient models for GnRH 
neurons they remain experimentally challenging line to manipulate requiring lipid based 
transfection techniques and have a relatively slow doubling rate of 3-4 days which can be 
even slower when under antibiotic selection during the creation of stables for example 
(Mellon et al. 1990).  
While immortalized cultures of GnRH neurons like the GT1-7s are convenient tools they 
do have some limitations. Firstly, they are transformed cells and might not fully represent 
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a primary culture of GnRH neurons since the continuous expression of the Simian virus 
40 tumor antigen (SV40-TAg) sometimes interferes with regular cell function (Weiner et 
al. 1991). Secondly, determining how afferent inputs to the GnRH neuron are regulated is 
not possible in a clonal cell line. For example estradiol feedback regulates 
KISS1secretion and this in turn affects GnRH secretion, investigating this chain of events 
would not be possible in a line made purely of immortalized and dissociated GnRH 
neurons. Lastly, it has been shown that there are sub-populations of GnRH neurons which 
may serve different functions and secrete GnRH in response to different stimuli. 
However as a clonal line, where the entire population represents a single GnRH neuron, 
these differences in responses would not be observed (Kimura et al. 1998). To overcome 
these experimental limitations, the GnRH-GFP mouse was created where the gene for the 
green fluorescent protein reporter (GFP) is inserted downstream of the mGnRH promoter 
(Suter et al. 2000). Because the GFP signal made it easy to locate the scattered GnRH 
neurons in the hypothalamus this transgenic mouse was used in a wide variety of studies 
including, electrophysiological analysis of GnRH neuronal pulsatility (Suter et al. 2000), 
immunoflourescent analysis of protein expression in GnRH neurons directly in brain 
slices and assessment of changes in gene expression by single cell qPCR on GnRH 
neurons (Xu et al. 2008). 
Another useful tool was the creation of GnRH-Cre transgenic mice which allowed in vivo 
investigation of the functional role of various genes expressed in the GnRH neuron by 
creating mice with GnRH-neuronal specific genetic ablation of the gene of interest (Yoon 
et al. 2005, Wintermantel et al. 2006 and Skynner et al. 1999, Kawakowsky et al. 2012, 
Parkash et al. 2012, Schmid et al. 2013). These mice have been well established and 
characterized showing more than 97% efficiency of Cre-dependent recombination in 
GnRH neurons. This is very important since studies have shown that even as little as 10% 
of the total GnRH neuron population, is sufficient to drive reproductive function of the 
HPG axis (Mayer and Bhoem, 2011).  
1.2.2 Regulation of GnRH secretion 
Throughout adulthood a complex and dynamic system of GnRH pulses and surges 
maintains reproductive function. The nature and mechanisms behind the GnRH pulse 
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generator as well as the trigger for the onset of puberty is still not fully understood 
(Dungan et al. 2006 Oakley 2009). In postpubertal men, testosterone formation by the 
leydig cells is continuous. When levels become high enough they negatively feedback 
and inhibit the hypothalamus and anterior pituitary (Fig. 1.1) resulting in lower and more 
infrequent GnRH and LH pulses (Jackson et al. 1991, Steiner et al. 1982, Kelch et al. 
1985). In post-pubertal women, the result of feedback regulation by gonadal steroids 
depends on the phase of menstrual cycle. In the luteal phase of the menstrual cycle, 
estrogen and progesterone produced by the corpora lutea negatively feedback and 
suppress GnRH and LH secretion. The resulting lower GnRH pulse frequency promotes 
preferential FSH secretion over LH secretion which leads to stimulation of follicular 
development for the next menstrual cycle (Marshall et al. 1993 and 2001). Prior to 
ovulation, during the follicular phase, the frequency of the GnRH pulses increases but the 
amplitude remains relatively low. There is a switch in response to estrogen from negative 
to positive feedback causing the increased GnRH pulse frequency that drives the 
preovulatory LH surge late in the follicular phase prompting ovulation. While our 
understanding of the exact mechanisms underlying the switch from positive to negative 
E2 feedback on the hypothalamus during the menstrual cycle remains incomplete, it is 
clear that estrogen plays an important role in regulating GnRH secretion (Simerly et al. 
1998, Cooke et al. 1998). 
It is important to note that while some animals like rats and mice have estrous cycles, 
primates and humans have menstrual cycles. The overall events are similar but there are 
some significant differences between these cycles. In mice the estrous cycle is 
approximately 5 days compared to the 28 day menstrual cycle in women. Also, in the 
menstrual cycle the endometrium is shed in the absence of conception whereas it is 
absorbed in estrous cycles. Unlike primates, mice are spontaneous ovulators where 
ovulation is induced by copulation or male pheromones. While the overall hormonal 
milieu remains the same between these two types of cycles, the timing is slightly 
different. In mice estrogen, progesterone and LH surges overlap prior to ovulation 
compared to women where the estrogen surge slightly precedes the LH surge and 
ovulation (Staley et al. 2005).   
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In addition to gonadal steroid feedback many excitatory and inhibitory factors influence 
GnRH neuronal activity which allows these neurons to integrate external and internal 
cues in the dynamic control of the reproductive axis. In addition to secreting into the 
median eminence, GnRH neurons also transmit signals to other neurons involved in 
odour and pheromone processing, sexual behaviour, appetite and defensive behaviour 
(Dumalska et al. 2008, Merchenthaler et al. 1984, Jennes et al. 1991, Boehm et al. 2005, 
Yoon et al. 2005). GnRH neuron activity and secretion are stimulated by excitatory 
afferent inputs from AMPA, NMDA, glutamate (via mGluR), and GABA (post-puberty) 
while inhibitory inputs such as endorphins, corticotropin-releasing hormone (CRH) and 
neuropeptide Y (NPY) suppress it (Terasawa and Fernandez 2001, Plant 2001, Seminara 
and Kaiser 2005, Han et al. 2005, Howlett et al. 1986, McShane et al. 1992). Other 
molecules such as dopamine and norepinepherine are thought to act as neuromodulators 
which fine-tune GnRH pulsatility (Dumalska et al. 2008). Although numerous regulators 
of GnRH release have since been identified the exact mechanisms underlying pulsatile 
GnRH secretion are still not fully understood. What is clear however is that a dynamic 
balance between excitatory and inhibitory signals together regulate GnRH pulses (d’ 
Anglemont de Tassigney 2010, Pinilla et al. 2012). In 2003 a novel neuropeptide called 
Kisspeptin (KISS1) was discovered to be the most potent positive trigger for GnRH 
secretion and was critical for the timely onset of puberty (Seminara et al. 2003, de Roux 
et al. 2003, Pinilla et al. 2012, Popa et al. 2008).  
1.3 Kisspeptin and the Kisspeptin receptor 
Kisspeptin was initially described as a metastasis suppressor (Lee et al. 1996) and 
ongoing studies continue to investigate its role in the pathology of various cancers 
(Harms et al. 2003). In 2001, several independent groups identified KISS-1 as the ligand 
for the orphan receptor GPR54, now called the kisspeptin receptor (KISS1R) (Kotani et 
al. 2001, Ohtaki et al. 2001 and Muir et al. 2001, Kirby et al. 2010).  
In humans, the KISS1 gene located on the long arm of chromosome 1 (1q32) encodes a 
145 amino acid precursor protein which is cleaved into smaller peptides collectively 
referred to as kisspeptins (West et al. 1998). These kisspeptins belong to the superfamily 
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of RF-amide related peptides (RFRP) due to a shared carboxy terminus containing an 
Arg-Phe-NH2 motif (Fig. 1.4) (Roa et al., 2008, Pinilla et al. 2012). 
Early studies describe KISS1 as a potent metastasis suppressor in C8161, a human 
melanoma cell line (Lee et al., 1996, Lee and Welch 1997). It was soon shown that the 54 
amino acid kisspeptin peptide, KP-54, undergoes subsequent cleavage and results in the 
formation of kisspeptin 14, 13 and 10 corresponding to the number of amino acids they 
contain (Fig. 1.4). KP-54 -14 -13 -10 are all biologically active, share the same carboxy 
terminus and bind KISS1R. (Kotani et al. 2001, Ohtaki et al. 2001) KP-10 has been 
shown to have the greatest receptor affinity but is rapidly degraded in serum, while KP-
54 has a lower receptor binding affinity but is more stable in serum (Thompson et al., 
2006, Mikkelsen et al. 2009, Asami et al. 2013, Matsui et al. 2013). A recent study 
demonstrated that a specific proprotein convertase called furin is essential for post-
translational processing of KP-54 into the smaller peptides (Harihar et al. 2014).  
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Figure 1.4: Graphic representation of the formation of kisspeptins from the cleavage 
of a 145 amino acid precursor encoded by the Kiss1 gene. 
The prepro-kisspeptin is enzymatically cleaved to 54 amino acid kisspeptin fragment 
(KP-54, also called metastin). Subsequent proteolytic cleavage yields KP-14, KP-13 and 
KP-10 all of which share the 10 amino acid sequence of Kp-10 which is shown to be 
enough to activate KISS1R. (Adapted from Pinilla et al. 2012 and Roa et al. 2008). 
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KISS1R is a Gαq/11-coupled (Class A) GPCR and activation by kisspeptin stimulates 
phospholipase C (PLCβ) catalysed hydrolysis of phosphatidylinositol 4,5-bisphosphate 
(PIP2) to the InsP3 and DAG. InsP3 activates its receptor on the endoplasmic reticulum 
(ER) resulting in the efflux of ER Ca
2+
 into the cytosol (Fig. 1.5).  PLCβ mediated 
hydrolysis of PIP2, intracellular Ca
2+ 
mobilization and InsP3 accumulation are therefore 
key readouts for KISS1R signaling via Gαq/11. Studies showed that pertussis toxin had no 
effect on InsP3 turnover or Ca
2+ 
mobilization which together confirm that KISS1R is 
coupled to Gαq/11. They also showed that kisspeptin did not change cAMP levels 
indicating that it does not couple to Gs or Gi. Kisspeptin stimulation also resulted in 
arachidonic acid release, ERK1/2 and p38 MAP kinase phosphorylation (Lee et al. 1999, 
Wacker et al. 2008, Muir et al. 2001, Liu et al. 2008 and Constantin et al. 2009). ERK1/2 
phosphorylation is an important result of KISS1R action since it has been shown to 
regulate GnRH secretion (Castellano et al. 2006). In vitro work in the Babwah laboratory 
demonstrated that β-arrestin mediates Kp-dependent ERK1/2 phosphorylation using WT 
KISS1R and β-arrestin deficient MEFs (Pampillo et al. 2009, Szereszewski et al. 2010). 
In this dissertation we confirmed that KISS1R signals in a β-arrestin-dependent manner 
to ERK1/2 using a KISS1R mutant, L148S and β-arrestin deficient MEFs and further 
demonstrated that a functional result of this β-arrestin- dependent cascade is GnRH 
secretion. 
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Figure 1.5: Schematic diagram for intracellular KISS1R signaling combining 
known and proposed mechanisms. 
Kisspeptin (1) couples KISS1R to Gαq/11 (2) and results in the cleavage of PLCβ 
catalysed hydrolysis of PIP2 into second messengers, InsP3 and DAG (3). InsP3 binds its 
receptor and causes release of Ca
2+
 from ER stores (4) DAG and Ca
2+ 
together activate 
the PKC enzyme (5) needed to potentiate the Gαq/11–dependent KISS1R cascade. In the 
continued presence of kisspeptin, GRK2 and possibly β-arrestin proteins mediate 
homologous desensitization of KISS1R (6) and internalization (6-7). Internalized 
KISS1R may then be either degraded or recycled to the plasma membrane (8) (Ferguson 
2001, Shenoy et al. 2003, Kotani et al. 2001, Pampillo et al. 2009, Bianco et al. 2011, 
Wacker et al. 2008). 
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Two landmark studies in 2003 highlighted the critical role of kisspeptin and KISS1R in 
the re-awakening of the HPG axis for the timely onset of puberty (de Roux et al. 2003 
and Seminara et al. 2003). These studies examined genetic profiles of patients diagnosed 
with idiopathic hypogonadotropic hypogonadism (IHH), a syndrome characterized by an 
underactive HPG axis leading to delayed pubertal onset, low levels of serum 
gonadotropins and sex steroids and isolated infertility. Patients diagonosed with IHH in 
these studies were found to also bear homozygous deletions in the KISS1R gene. Further 
evidence that confirmed the importance of KISS1R as a regulator of fertility came from 
genetically engineered mice completely lacking the KISS1R gene (Lapatto et al. 2007, 
d’Anglemont de Tassigny et al. 2007, Dungan et al. 2012). These mice recapitulated the 
infertile hypogonadotropic hypogonadism (HH) phenotype of the human patients. Taken 
together, these results show that both mice and humans with non-functional KISS1R 
leads to impeded pubertal onset resulting in infertility in adults combined with low serum 
gonadotropin and sex steroids as well as abnormal gonadal development.  
1.3.1 Kiss1/Kiss1R system directly potentiates GnRH secretion  
Regardless of species, route of administration, estrous cycle phase and type of kisspeptin 
agonist used, application of kisspeptin was demonstrated to be a potent trigger of 
gonadotropin secretion in vivo. Continuous as well as bolus administration of kisspeptin 
resulted in significant increases in serum gonadotropins in humans (Dhillo et al. 2005 and 
2007), monkeys (Plant et al. 2006, Shahab et al. 2005) ruminants (sheep and goats) 
(Messager et al. 2005, Hashizume et al. 2010) rodents (Gottsch et al. 2004, Irwig et al. 
2004, Messager 2005, Matsui et al. 2004, Navarro et al. 2005) and horses (Magee et al. 
2009 and Decourt et al. 2014). Kisspeptin regulation of gonadotropin secretion was 
shown to be upstream of the GnRH neuron since pre-treatment with GnRH antagonists 
(acyline and antide) result in elimination of the kisspeptin-triggered rise in serum LH and 
FSH. (Irwig et al. 2004, Plant et al. 2006, Shahab et al. 2005, Gottsch et al. 2004 and 
Rosewier et al. 2009) Also, kisspeptin treatment of hypothalamic explants stimulates 
GnRH secretion ex vivo (Thompson et al. 2004 and Tovar et al. 2006). Additionally, 
kisspeptin treatment increases c-Fos activity (marker of neuronal activity) and GnRH 
transcription in GnRH neurons (Matsui et al. 2004, Irwig et al. 2004, Han et al. 2005, 
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Novaira et al. 2009 and Oakley, 2009). Three layers of evidence demonstrate that 
kisspeptin action is not just upstream of GnRH secretion but directly on the GnRH 
neurons. Firstly, Kiss1 neurons are not just found in close association with GnRH 
neurons but also make direct contact with GnRH cell bodies and axons on the internal 
side of the median eminence (ME) in rodents, (Roseweir et al. 2009, Clarkson et al. 2006, 
Smith et al. 2008, Inoue 2008, Decourt et al. 2008 (horse) Magee et al. 2009 (horse), 
Pompolo et al. 2006 (sheep) Hrabovsky et al. 2010 (humans)) Secondly, Kiss1R is 
expressed in the majority of GnRH neurons in many species (Han et al. 2005, Messager 
et al. 2005 and Irwig et al. 2004, Herbison et al. 2010, Smith et al. 2011). Finally, KISS1 
can depolarize and increase firing rates of GnRH neurons in vitro in the presence of 
tetrodotoxin (TTX) and treatment with kisspeptin antagonist (peptide 234) suppresses 
GnRH neuron firing, pulsatility and secretion. (Liu et al. 2008, Zhang et al. 2008, Han et 
al. 2005, Pielekla-Fortuna et al. 2008, Quaynor et al. 2007, Dumalska et al. 2008, 
Rosewier et al. 2009, Millar 2010) 
1.3.2 Kisspeptin neuron subpopulations 
With their close spatial associations, it is not surprising that both GnRH neurons and 
Kiss1 neurons are localized mainly to the infundibular nucleus (InF) in humans (ARC in 
other species) with a second dense population in the rostral preoptic area (Rometo et al. 
2007 and Hrabovszky et al., 2010). While the Kiss1 population in the ARC seems to be 
standard across species, there seems to be a wide variation in the rostral preoptic 
population (Clarkson et al. 2006, Pompolo et al. 2006, Ramaswamy et al. 2008; Clarkson 
et al. 2009, Hrabovszky et al.2010). Rodents for example, have a well-defined nucleus of 
Kiss1 neurons in the anteroventral periventricular nucleus (AVPV) and the 
periventricular nucleus PeN (Gottsch et al. 2004, Smith et al. 2005 and 2006, Clarkson et 
al. 2006 and 2009) but humans, sheep, goats have a more scattered kisspeptin neuron 
distribution in the preoptic area and in the monkey it seems to be completely absent 
(Pompolo et al. 2006, Ramaswamy et al. 2008, Oakley 2009, Hrabovszky et al. 2010). 
These anatomically separate populations of Kiss1 neurons also play functionally distinct 
roles in regulation of the HPG axis (Millar 2010). It is well established that gonadal sex 
steroids (E2, T, P4) regulate the HPG axis by negative and positive feedback on the 
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hypothalamus and the pituitary (Karsch et al. 1987, Shaw et al. 2010).However, GnRH 
neurons do not express significant levels of estrogen receptors (ERα) or androgen 
receptors (AR). Recent studies show that kisspeptin neurons express high levels of sex 
steroid receptors (ERα, PR and AR) and mediate the feedback of gonadal steroids on 
GnRH secretion (Lehman and Karsch 1993, Navarro et al. 2004, Estrada et al. 2006; 
Franceschiniet al. 2006, Smith et al. 2005, Adachi et al. 2007, Cheng et al. 2010, Smith et 
al. 2007). GnRH neurons do express ERβ but this receptor is not involved in steroid 
feedback (Herbison and Pape 2001, Smith 2005, Bateman et al. 2008) It is now 
established that kisspeptin neurons in the ARC mediate negative steroid feedback and 
those in the AVPV mediate positive feedback (Smith et al. 2005, Clarkson et al. 2006, 
Adachi et al. 2007). In sheep, humans and monkeys there is less distinct anatomical 
separation of the two kisspeptin neuronal populations but it remains entirely possible for 
two distinct types of kisspeptin neurons to both be localized in the ARC/InF (Rometo et 
al. 2007, Estrada et al. 2006; Pompolo et al. 2006, Ramaswamy et al. 2008 and Oakley 
2009). 
Evidence for Kiss1 neurons in ARC mediating negative steroid feedback comes from 
studies using gonadectomised animals (rodents, sheep, monkeys) to show that in the 
absence of gonadal steroid feedback Kiss1 mRNA expression in the ARC increases and 
this result is reversed with estrogen or testosterone replacement (Irwig et al. 2004, Oakley 
2009 and Lehman et al. 2010, Smith et al. 2005, Pompolo et al. 2006). Due to the absence 
of negative steroid feedback, castrates normally experience a post-castration LH surge 
(McPherson 1982). The administration of a kisspeptin antagonist (peptide 234) in these 
animals prevents this surge, indicating that increased Kiss1 mRNA expression in the 
ARC is translated to increased KISS1 secretion resulting in the post-castration LH surge 
(Roseweir et al. 2009). Further evidence for this is that ovariectomized Kiss1r
-/-
 mice 
show increased Kiss1 mRNA expression in the ARC but fail to show the expected LH 
surge (Dungan et al. 2007). Taken together, these findings demonstrate that gonadal 
steroids inhibit kisspeptin neurons in the ARC and reduce their stimulatory input for 
GnRH/LH release Skorupskaite et al. 2014. 
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Kiss1 neurons in ARC also mediate negative steroid feedback over the estrus cycle in 
rodents. Kiss1 mRNA is low during proestrus when estrogen levels are high and high 
during diestrus when estrogen levels are low (Adachi et al. 2007, Smith et al. 2006). 
Menopause is another period when estrogen levels are low due to decreased ovarian 
follicles, and in both humans and monkeys Kiss1 mRNA and LH secretion are increased 
(Kim et al. 2009, Rance et al. 2008 and Rometo et al. 2007). 
1.3.2.1 KNDy neurons in the ARC 
While kisspeptin is the most potent trigger for GnRH secretion, it is not the only 
regulator. This is suggested by the sustained low gonadotropin levels and Gnrh pulses in  
Kiss1r 
-/-
 mice and variable hypogonadal phenotype with some degree of estrous cyclicity 
in Kiss1
-/-
 mice (Seminara et al. 2003, Colledge 2009, Lapatto et al. 2007, Navarro et al. 
2009). Also, in a separate Kiss1r
-/-
 mouse, ovariectomy followed by estradiol treatment 
resulted in a Gnrh/LH surge and Fos activity in Gnrh neurons (Dungan et al. 2007). 
Kisspeptin neurons in the ARC also express the neuropeptides neurokinin B (NKB) and 
dynorphin (Dyn) which have been shown to regulate Gnrh secretion (Cheng et al. 2010, 
Goodman et al. 2007, Wakabayashi et al. 2010, Hrabovszky et al. 2010, Topalaglu et al. 
2009). Because almost all Kiss1 neurons in the ARC co-express NKB and Dyn they were 
called KNDy neurons (Goodman et al. 2007 
Similar to Kiss1, NKB has been shown to mediate negative steroid feedback on the 
hypothalamus (Rance et al. 1991 and 1994). Ovariectomized monkeys showed an 
increase in NKB mRNA expression in the InF (ARC) which like Kiss1, is reduced with 
estrogen replacement (Abel et al. 1999, Sandoval-Guzman et al. 2004). Humans bearing 
NKB or NKB receptor mutations displayed IHH symptoms similar to those caused by 
KISS1R mutations (Guran et al. 2009 and Topalaglu et al. 2009). NKB effect on 
gonadotropins seems to vary depending on species and hormonal status. NKB (senktide) 
stimulates LH release in ruminants that have been ovariectomized but treated with E2 and 
P4, anestrous ewes, and females in the follicular phase of the estrus cycle ( NKB also 
stimulates LH secretion in juvenile male monkeys and intact male and female mice. LH 
response decreases when NKB is administered to sheep in the luteal phase or 
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ovariectomized mice treated with E2. The exact understanding of NKB regulation on 
GnRH secretion is incomplete but it is clear from patients with NKB or NKBR mutations 
that it does play a critical role in HPG axis function (Wakabayashi et al. 2010, Navarro et 
al. 2011, Sandoval-Guzman et al. 2004, Kinsey-Jones et al. 2012).  
Dynorphin activates the kappa opioid receptor (KOR) and mediates the inhibitory 
progesterone feedback on GnRH pulsatility. Dyn or KOR antagonists result in increased 
LH levels and OVX sheep and postmenopausal women show decreased Dyn expression 
in the ARC and this result is not reversible with E2 administration. Taken together these 
results indicate that progesterone and dynorphin inhibit GnRH pulsatility and LH 
secretion (Foradori et al. 2006, Goodman et al. 2004 and 2007). Overall, gonadal steroids 
negatively regulate GnRH secretion by acting on the kisspeptin neurons in the ARC 
(KNDy neurons). Here they suppress kisspeptin and NKB (GnRH stimulators) and 
promote dynorphin (GnRH inhibitor).  
1.3.2.2 Kisspeptin neurons in the AVPV 
Kisspeptin neurons in the preoptic area/AVPV do not express NKB or dynorphin but do 
co-express tyroxine hydroxylase and mediate E2 positive feedback on GnRH neurons 
(Simerly et al.1989, Smith et al. 2005 and 2006). Evidence for Kiss1 neurons in AVPV 
mediating positive steroid feedback comes from studies using gonadectomised animals 
(rodents, sheep, monkeys) to show that in the absence of gonadal steroid feedback Kiss1 
mRNA expression in the AVPV decreases. This result is reversed with estrogen or 
testosterone replacement (Dungan et al. 2007, Smith et al. 2005; Pompolo et al. 2006). 
During the pre-ovulatory LH surge in the late follicular phase when E2 levels are at their 
highest, Kiss1 neurons in the AVPV are activated and direct delivery of kisspeptin 
antagonist to this area suppresses the surge (Kinoshita et al. 2005, Pineda et al. 2010, 
Adachi et al. 2007, Smith et al. 2006, Clarkson et al. 2008, Teresawa 1980, Wintermantel 
et al. 2006). In mice during proestrus, when E2 is the highest, Kiss1 mRNA in the AVPV 
is also at the highest expression level (Smith et al. 2006). In rodents, ERα expressing 
neurons make direct contact with GnRH neurons and due to their localization these are 
thought to be Kiss1 neurons in the AVPV (Teresawa 1980, Wintermantel et al. 2006).  
Ovariectomized mice treated with E2 and P4 are still able to induce GnRH neuron 
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activation (using Fos as a marker of neuronal activation) and corresponding LH surge. 
However, Kiss1r 
-/-
 mice treated in the same manner show no LH surge and no GnRH 
neuron activation demonstrating a role for Kiss1/Kiss1R mediating E2/P4 positive steroid 
feedback on GnRH neurons (Clarkson et al. 2008).  
While humans and sheep do not have a distinctly separate Kiss1 neuronal population in 
the AVPV, studies have still demonstrated that Kiss1/Kiss1R signaling in the ARC/InF 
mediates positive steroid feedback on GnRH neurons. In humans, a study in assisted 
reproductive therapies utilised KP-54 to generate a LH surge which resulted in successful 
ovulation and live term birth (Abbara et al. 2013). Healthy women treated with KP-54 
twice daily resulted in an advanced pre-ovulatory LH surge during their menstrual cycle 
(Jayasena et al. 2013).  In sheep, kisspeptin treatment advances the pre-ovulatory LH 
surge which is ablated or reduced by administration of Kiss1 antagonists. (Kinoshita et al. 
2005, Caraty et al. 2007, Clarkson et al. 2008, Pineda et al. 2010) Also, since sheep like 
humans do not have anatomically separate Kiss1 populations, it is not surprising that 
Kiss1 mRNA is increased in the ARC during their pre-ovulatory LH surge when E2 
levels are at the highest (Smith et al. 2008). 
In rodents, the suprachiasmatic nucleus (SCN) is the circadian clock and is responsible 
for the timing of the LH surge. Studies show that Kiss1 neurons in the AVPV receive 
direct afferent input from the SCN providing further evidence for their role in regulating 
the pre-ovulatory surge (Christian and Moenter 2010, Khan and Kauffman 2012). Taken 
together, these studies demonstrate that Kiss1 neurons in the AVPV play an important 
role in mediating the positive sex steroid feedback to GnRH neurons that is seen during 
the pre-ovulatory LH surge.  
1.3.3 Role of kisspeptin in puberty 
In primates, GnRH pulse frequency and amplitude are high in the embryo and neonates. 
Pulse frequency drops to a quiescent state during childhood referred to as the “juvenile 
phase”, then during puberty pulse frequency gradually increases nocturnally as the HPG 
axis reawakens (Plant 2008, Terasawa et al. 2001, Weisz  et al. 1980, Styne et al. 1994; 
Plant et al. 2004; Sisk et al. 2004). In the 1980’s, studies established that GnRH secretion 
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increases at the onset of puberty and that pulsatile administration of exogenous GnRH 
can induce precocious puberty in monkeys (Wildt et al. 1980 and Wantanabe et al. 1989). 
While the trigger for the reawakening of GnRH pulsatility at puberty is not fully 
understood, it is thought that it involves a combination of decreased activity from 
inhibitory inputs and increased activity in excitatory ones (Brann et al. 1994; Sisk and 
Foster, 2004; Ojeda et al.2006, Terasawa et al. 2001, Cookson et al. 2012). Of these 
inputs, the Kiss1/Kiss1R signaling system is thought to be the most potent positive 
trigger for GnRH release at puberty (Irwig et al. 2004, Han et al. 2005 and Pielecka-
Fortuna et al. 2008). The following studies serve to highlight the critical role of the 
KISS1/KISS1R system in regulating reproductive function. Firstly, using linkage analysis 
and genome sequencing, patients with loss-of-function KISS1R mutations were found to 
display a condition referred to as IHH where there is a significant delay in the onset of 
puberty (de Roux et al. 2003, Seminara et al. 2003, d’Anglemont de Tassigny et al. 2007, 
Topaloglu et al. 2012). While loss-of-function mutations in KISS1R are associated with 
IHH, patients with gain-of-function mutations in KISS1R show symptoms of precocious 
puberty (Teles et al. 2008). Recently, children with a gain-of-function mutation in KISS1 
have been diagnosed with precocious puberty due to prolonged serum stability of the 
mutant KISS1 agonist (Silveira et al. 2010). Mice with targeted deletions of Kiss1 and 
Kiss1r recapitulate the IHH phenotypes in humans (Seminara et al. 2003, Funes et al. 
2003, Lapatto et al. 2007). Finally, mice with GnRH neuronal-specific deletion of Kiss1R 
also display the IHH phenotype indicating that although Kiss1R may be expressed in 
other tissues, the GnRH neuron is the site for KISS1R regulation of reproduction (Kirlov 
et al. 2013, Novaira et al. 2014). Kirlov et al. 2013 went further to demonstrate this by 
rescuing the infertile global Kiss1R knockout mice (Seminara et al. 2003) by specifically 
re-introducing Kiss1R into GnRH neurons in mice with a global Kiss1R deletion.  
Increased hypothalamic Kiss1/Kiss1R signalling is detected prior to puberty using 
various experimental techniques and across species. Kiss1 and Kiss1R mRNA increase at 
puberty in rats, mice and monkeys (Navarro et al. 2004, Sun et al. 2007, Han et al. 2005, 
Shahab et al. 2005). In mice, Kiss1 positive neurons also increase exponentially in the 
AVPV/PeN between postnatal day 10 (P10) to P64 (Clarkson et al. 2009). Kiss1 neurons 
start forming close appositions with GnRH neurons in the ME and POA reaching 50% 
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co-localization at 7 weeks (pubertal age in mice) Clarkson et al. 2006). Using monkeys, 
Keen et al. (2008) showed that the increase in Kiss1 mRNA described in previous studies 
translated to increased pulsatile nocturnal Kiss1 secretion which largely coincided with 
GnRH pulses at puberty (Shahab et al. 2005). The higher frequency of GnRH pulses at 
puberty is thought to be due to a combination of increased KISS1 secretion and increased 
sensitivity of GnRH neurons to KISS1. This is demonstrated by increased Kiss1r mRNA 
expression in the AVPV/PeN and a higher GnRH neuronal depolarization and firing rate 
in response to KISS1 in pubertal mice compared to juveniles (Han et al. 2005). KISS1 
administration in juveniles advances the onset of puberty in rats and monkeys (Navarro et 
al. 2004 and Plant et al. 2006) and KISS1 antagonist (Peptide 234) inhibits pulsatile 
GnRH secretion and delays puberty in monkeys (Roseweir et al. 2009 and Pineda et al. 
2010). Taken together, these studies provide evidence that at the time of pubertal onset, 
hypothalamic kisspeptin expression and secretion are increased, GnRH neuronal activity 
also increases, and this leads to an increase in GnRH release which triggers the onset of 
puberty.  
1.4 Pathophysiological causes of clinical infertility involving 
KISS1/KISS1R in humans and mice.  
The foundation for our present understanding of the role of KISS1/KISS1R signalling in 
regulating reproductive function is greatly due to in vivo work done with Kiss1
-/-
 and 
Kiss1r
-/-
 mice (Funes et al., 2003, Seminara et al. 2003, Lapatto et al. 2007, d’Anglemont 
de Tassigny et al. 2007). These mice recapitulated the phenotypes observed in IHH 
patients bearing inactivating KISS1R mutations. While pubertal onset was significantly 
delayed and these mice were completely infertile, these mice still displayed evidence of 
partial sexual maturation and low levels of GnRH release (Seminara et al. 2003, Lapatto 
et al. 2007, Chan et al. 2009, Dungan et al. 2012). This is a parallel finding in some IHH 
patients bearing inactivating KISS1R mutations where low level LH pulses are detected 
and some even experience reversal of symptoms later in life (Seminara et al. 2003, 
Tenebaum-Rakover et al. 2007, Wahab et al. 2011, Nimiri et al. 2011, Topaloglu et al. 
2012, Sidhoum et al. 2014). Overall, these findings indicate that KISS1/KISS1R 
signaling is essential for triggering GnRH release for the timely onset of puberty but is 
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not a strict requirement or absolutely needed for GnRH secretion (Lapatto et al. 2007, 
Chan et al. 2009). This is not very surprising since reproductive capability is essential for 
the survival of any species so therefore over a period of evolutionary time many 
redundant systems possibly developed in order to safeguard fertility. Studies have even 
demonstrated that <3% of KISS1 neurons and <12% GnRH neurons are sufficient to 
maintain fertility in mice (Mayer and Boehm 2011, Herbison et al. 2008).  
1.4.1 Kiss1r -/- mice  
Like humans with inactivating mutant KISS1R, mice with an absence of KISS1R display 
hypogonadotropic hypogonadism and experience abnormal and incomplete pubertal 
maturation and are completely infertile (Seminara et al. 2003, Funes et al. 2003, Lapatto 
et al. 2007, d’Anglemont de Tassigny et al. 2007). Exogenous GnRH can stimulate 
gonadotropin release in these mice but exogenous kisspeptin does not. This indicated that 
the defect was at the hypothalamic level upstream of GnRH secretion and further 
suggests that kisspeptins act through KISS1R expressed on GnRH neurons (Messager et 
al. 2005). The females display an ability to undergo spontaneous estrus and 
folliculogenisis since various stages of follicle development are seen in the mutant ovary, 
however ovulation is impaired as indicated by the absence of corporea lutea. Female 
gonadal weights in mutants are significantly less than wild-types (thread-like) but vary 
between 70 - 90% less than wild-type (Chan et al., 2009, Kirilov et al., 2013, Novaira et 
al., 2014). Testicular weight varies widely in Kiss1r
-/- 
males from significantly decreased 
to comparable to wild-type males. Onset of female puberty was also variable as indicated 
by vaginal opening (VO) where some mutant females experienced delayed VO while 
others never did. Mutant males mirrored the variable phenotype of the mutant females 
where spermatogenesis was severely affected in some while unaffected in others and 
similarly preputial separation (indicator of puberty) only occurred in some Kiss1r
-/- 
while 
never occurring in others (Lapatto et al., 2007, d’Anglemont de Tassigny et al., 2007, 
Chan et al., 2009, Kirilov et al., 2013, Novaira et al., 2014). These findings indicate that 
in the absence of Kiss1r
-/- 
some degree of GnRH secretion is still possible. Authors 
suggest that this may be possible through the many stimulatory afferent inputs to the 
GnRH neuron such as NKB, for example, which is secreted by KNDy neurons in the 
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ARC. Finally, while the GnRH-neuron specific Kiss1r
-/-
 mice (Kirilov et al. 2013 and 
Novaira et al., 2014) were important for showing the importance of KISS1/KISS1R 
signaling in regulating GnRH secretion, the global Kiss1
-/-
  and Kiss1r
-/-
 mice (Seminara 
et al., 2003, Lapatto et al., 2007) were essential for other studies demonstrating that this 
signaling also played a role in diabetes (Hague-Evans et al., 2006, Silvestre et al., 2008), 
placentation, (Bilban et al. 2004, Janneau et al. 2002, Kotani et al. 2001, Hiden et al., 
2007), pregnancy (Jayasena et al. 2009 and Dhillo et al. 2008) and energy homeostasis 
(Castellano et al. 2005, Smith et al. 2006, Hill et al. 2008). 
1.4.2 Kiss1-/- mice  
Mice with an absence of KISS1 display hypogonadotropic hypogonadism like their 
receptor counterparts, and experience abnormal and incomplete pubertal maturation and 
are completely infertile (Seminara et al. 2003, Lapatto et al. 2007, d’Anglemont de 
Tassigny et al. 2007). Exogenous GnRH as well as kisspeptin can stimulate gonadotropin 
release in these mice. However, Kiss1
-/-
 mice were found to display even more 
phenotypic variation compared to Kiss1r
-/-
 mice (Lapatto et al., 2007, Chan et al., 2009). 
One possible explanation for this is that these mice express functional and intact KISS1R. 
Recent studies demonstrated that KISS1R has constitutive (kisspeptin-independent) 
activity (Babwah et al., 2012). This result taken together with previous findings that 
GnRH neurons have a basal firing rate (Moenter, 2010) can explain the increased 
phenotypic variability observed with Kiss1
-/-
 mice compared to Kiss1r
-/-
 being possibly 
due to sustained basal GnRH secretion.  
1.4.3 KISS1R mutant receptors 
Clinically, hypogonadism is characterized by infertility coupled with low sex steroid 
levels and can be as a result of a defect at any level in the hypothalamic-pituitary gonadal 
axis. In the absence of CNS lesions, gonadal defects and with normal pituitary function, 
indicated by a GnRH stimulation test, the cause for hypogonadism would therefore be 
hypothalamic. These patients are further diagnosed as having hypogonadotropic 
hypogonadism (HH) where in addition to infertility and low gonadal steroids, serum 
gonadotropins are also low. In such patients, GnRH deficiency can be due to either 
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aberrant developmental migration or defective GnRH secretion. Aberrant developmental 
migration of GnRH neurons causes a condition termed Kallman syndrome (KS) which is 
characterised by anosmic hypogonadotropic hypogonadism. Main genes that have been 
found to be associated with Kallman’s syndrome are; KAL1, FGFR1/FGF8, 
PROKR/PROK2 (Noel et al. 2011, Bianco et al. 2009). If patients exhibiting the 
symptoms of HH are normosmic, it would indicate that GnRH neuron migration was 
intact along with the co-migration of the olfactory neurons which occurs simultaneously 
during embryonic development. These patients are diagnosed with normosmic or 
idiopathic hypogonadotropic hypogonadism (IHH). Main genes associated with IHH are 
KISS1/KISS1R, NKB/NK3R (Noel et al. 2011, Wahab et al., 2011, Nimiri et al. 2011, 
George et al. 2012). 
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Table 1.1: Overview of genes found to be associated with hypogonadotropic 
hypogonadism in patients. 
 
Gene Function 
Disease  and 
cause 
KAL1 
Encodes for anosmin-1. An extracellular protein 
essential for guiding GnRH neurons along axons 
from the nasal placode to anterior hypothalamus. 
HH – 
abnormal 
GnRH 
migration  
FGFR1/FGF8 
Encodes for the tyrosine kinase receptor; fibroblast 
growth factor receptor1 and ligand, FGF-8. 
Resulting MAPK signaling is essential during 
development for neuronal migration, 
differentiation, survival and proliferation.  
HH – 
abnormal 
GnRH 
migration 
PROKR/PROK2 
Encodes for the GPCR; prokineticin receptor 2 and 
cognate ligand. Signalling cascade is essential for 
development of the neuronal progenitors of the 
olfactory and GnRH neurons.  
HH – 
abnormal 
GnRH 
migration 
KISS1/KISS1R 
Encodes for GPCR; kisspeptin receptor and 
cognate ligand. Signalling cascade is essential for 
the triggering of GnRH release at puberty.  
IHH – 
defective 
GnRH 
secretion  
NK3R/NKB(mice) 
TACR3/TAC3(human) 
Encodes for the GPCR; neurokinin B receptor and 
cognate ligand. NKB is co-expressed in the KNDy 
neurons of the ARC. NKB is thought to act 
synergistically with KISS1 to stimulate GnRH 
release.  
IHH – 
defective 
GnRH 
secretion 
Kallman’s syndrome (KS) and normosmic hypogonadotropic hypogonadism (IHH). 
1
 
                                                 
1 (Bianco et al., 2009, Legoius et al., 1991, Ford-Perriss et al. 2001, Gill et al. 2004, Li et al., 2001, Lin et al., 2002, 
Cheng et al., 2002, Prosser et al., 2007, Pitteloud et al. 2007, deRoux et al., 2003, Seminara et al. 2003, Gottsch et al., 
2004, Irwig et al., 2004, Matsui et al., 2004, Shahab et al., 2005, Navarro et al., 2004, Topalaglu et al., 2009, Rance et 
al., 2009, Navarro et al., 2011, Ramaswamy et al., 2010) 
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While HH is a rare condition, for the cases in which the genetic cause is known, 60% are 
classified as KS while 40% as IHH. The genetic causes for the majority of HH cases 
however, have not been discovered (Bianco et al. 2009). Focusing on the genetic causes 
behind IHH, the kisspeptin and neurokinin B signaling systems play key roles. While 
patients with inactivating mutations of either neurokinin B or its receptor display IHH, 
mice lacking NKB or NK3R display preserved fertility (Siuciak et al., 2007). NKB and 
KISS1 are co-expressed on KNDY neurons and it is thought that NKB modulates 
estradiol-dependent GnRH secretion along with KISS1 (Wakabayashi et al., 2010, 
Navarro et al., 2011, Rance et al., 2010).  
IHH paients associated with inactivating mutations in KISS1R present with different 
degrees of severity of hypogonadism but all share the common phenotype of delayed 
puberty and impaired fertility. Some present with micropenis and cryptorchidism 
indicating that the KISS1/KISS1R cascade is important during the “mini-puberty” during 
fetal development (Wahab et al. 2011, Seminara et al., 2003). All these patients can be 
treated with a regimen of pulsatile exogenous GnRH and gonadotropins to stimulate 
gonadal development and sex steroid production (Lanfranco et al., 2005 and Pallais et al., 
2006). When treated, one female patient bearing the p.L148S mutation was reported to 
conceive and carry a full-term pregnancy with the delivery of a healthy baby (Pallais et 
al. 2006). These results in humans parallel findings in Kiss1
-/-
 and Kiss1r
-/-
 mutant mice 
where KISS1/KISS1R signaling is important for the onset of puberty but is not absolutely 
necessary for GnRH release (Wahab et al. 2011, Chan et al. 2009). Patients with IHH 
corresponding to KISS1R inactivating mutation occurs with a frequency of less than 5% 
however there are no population studies to date which give estimates as to the prevalence 
of this in the general population (Cerrato et al., 2007).  
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Table 1.2: Summary of KISS1R mutations found in patients diagnosed with IHH or 
CPP.  
 
KISS1R mutation
2
 Phenotype Reference 
L148S 
 
IHH Seminara et al 2003 and Wacker et al. 2008 
L102P IHH Tenebaum-Rakover et al. 2007 
R331X & X399R IHH Seminara et al. 2003 
R297L IHH Semple et al. 2005 
155 nuc. Deletion IHH de Roux et al. 2003 
C223R IHH Semple et al. 2005 
1001ins1002C IHH Lanfranco et al. 2005 
F272S IHH Nimiri et al. 2011 
R386P CPP Teles et al. 2008, Bianco et al. 2011 
  
                                                 
2 Mutations include point, deletion and insertion mutations of the KISS1R gene. 
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Figure 1.6: Schematic representations of the known KISS1R mutations reported in 
humans with impaired reproductive function. 
 
Mutations in KISS1R are rare and as they are found throughout the length of the gene so 
there are no specific “hot-spots” of biological significance. Adapted from Pinilla et al. 
2012.  
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Functional studies performed with some of the inactivating KISS1R mutations associated 
with IHH demonstrate that the receptor is impaired at one or more of the following stages 
of expression or function; trafficking through the cytosol resulting in low expression at 
the plasma membrane, impaired ligand binding capacity or impaired ability to activate 
effectors in the signaling cascade. Detailed functional studies have not been done for all 
inactivating KISS1R mutations found in clinical studies so here I will discuss further the 
ones that have been well characterised in the literature.  
1.4.3.1 Loss-of-function KISS1R mutation - L148S 
In 2003 a study described 6 siblings from a consanguineous Saudi-Arabian family 
bearing the homozygous mutation of KISS1R, p.L148S. These patients presented with 
delayed puberty, primary amenorrhea and low gonadotropins (Seminara et al. 2003). This 
mutation affects the second intracellular loop (ICL2) of KISS1R, an important site for G-
protein and β-arrestin association with GPCRs (Fig. 1.6) (Wacker et al. 2008). Functional 
studies showed that the L148S mutant receptor is expressed at the plasma membrane and 
binds kisspetin with equivalent levels and efficiency as the wild-type KISS1R. However, 
it is significantly impaired in stimulating InsP3 formation with kisspeptin treatment and 
further molecular analysis revealed that while L148S binds kisspeptin and interacts with 
Gαq/11 it is unable to catalyse the dissociation of Gα from Gβγ necessary for the activation 
of the G-protein signalling cascade (Wacker et al. 2008). Another female patient in 2006 
bearing the homozygous L148S mutation was able to be treated with exogenous pulsatile 
GnRH and gonadotropins resulting in successful assisted conception full term 
uncomplicated pregnancy and normal vaginal delivery of a healthy baby (Pallais et al., 
2006).  
1.4.3.2 Loss-of-function KISS1R mutation - L102P 
In 2003, a female patient bearing homozygous mutation L102P in KISS1R was 
diagnosed with IHH (de Roux et al. 2003). She presented with delayed puberty, primary 
amenorrhea low gonadotropins and low sex steroid levels. Treatment with exogenous 
pulsatile GnRH and estrogen rescued the phenotype sufficiently to allow the patient to 
carry two normal term pregnancies (de Roux et al 2003, Tenebaum-Rakover et al. 2007 
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and Noel et al. 2011). In 2007, an Arab-Muslim male patient bearing the same 
homozygous L102P mutation was described. He presented with micropenis and bilateral 
cryptorchidism and had two female siblings with primary amenorrhea. This patient was 
examined from 12.5 – 21 years which allowed for a rare long-term study of humans 
carrying an inactivating KISS1R mutation (Tenebaum-Rakover et al 2007). From 12.5 – 
18 years this patient had only basal gonadotropin response to GnRH stimulation but after 
18 years there was a pattern switch leading to significant gonadotropin response to GnRH 
stimulation. This result is unexplained but suggests that while KISS1R function regulates 
timely onset of puberty, it is not strictly required for GnRH release and that there is a 
slow maturation of the HPG axis over time. This is important since “loss-of –function” 
KISS1R mutations were previously thought to be a permanently infertile diagnosis, this 
finding with L102P suggests that this may not always be the case but long-term follow up 
of patients is necessary to further determine this. Functional studies show that the L102P 
mutation affects the ICL1 of KISS1R (Fig. 1.6). While L102P has equal binding affinity 
for kisspeptin as the wild-type KISS1R, it does result in a slight decrease in cell surface 
expression. This slight reduction of the receptor at the plasma membrane does not 
correlate to the 95% reduction in InsP3 formation relative to wild-type KISS1R however 
the molecular explanation for this Gαq/11 uncoupling is still unknown (Tenebaum-
Rakover et al 2007). 
1.4.3.3 Gain-of-function KISS1R mutation - R386P 
First reported in 2008, p.R386P is the only activating KISS1R mutation discovered to 
date. A Brazilian female was diagnosed with central precocious puberty displaying 
progressive breast development from birth. At 8 years she had pubic hair and elevated 
serum estrogen and gonadotropin levels (Teles et al., 2008). Functional studies revealed 
that R386P affects the cytoplasmic tail (C-tail) of KISS1R, which is critical for 
desensitization and internalization of many GPCR’s (Fig. 1.6) (Teles et al., 2008, Luttrell 
et al. 2002). R386P was not significantly different from wild-type receptor in terms of 
binding affinity for kisspeptin, plasma membrane expression, and dose response to 
kisspeptin. However a prolonged response to kisspeptin was observed by increased InsP3 
accumulation and ERK1/2 phosphorylation (Teles et al. 2008). Further functional assays 
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with R386P revealed that this mutation causes significantly reduced rates of degradation 
of the receptor and as a result allows for rapid re-sensitization to the membrane following 
kisspeptin-induced internalization (Bianco et al. 2011). Overall, reduced degradation of 
R386P leads to the prolonged signaling and excessive GnRH release causing the CPP 
observed in affected patients.  
Major limitations of these human studies include a relatively small pool of affected 
patients which are sometimes at young (pre-pubertal) ages and also a lack of long-term 
follow-up of the fertility of these patients. Since KISS1/KISS1R has been proposed to be 
essential for timely onset of puberty but not an absolute requirement for GnRH secretion, 
it would be interesting to see if patients with these inactivating mutations can regain some 
form of reproductive capability later in life.  
1.5 KISS1R as a pharmacological target 
Depending on the desired outcome of the treatment, GnRH agonists, antagonists and sex 
steroids are used clinically to manipulate the HPG axis either by upregulating it in 
patients with a pathological gonadotropin deficit (IHH, delayed puberty, hypothalamic 
amenorrhoea, diabetes associated hypogonadism) or downregulating it in cases with 
pathological gonadotropin excess (PCOS, precocious puberty, menopause, assisted 
reproductive technologies, prostate cancer, breast cancer, endometriosis, uterine fibroids). 
Currently GnRH analogues are used where they either activate or suppress GnRH-R 
function on pituitary gonadotropes resulting in increased or decreased gonadal function 
respectively (Skorupskaite et al. 2014, Harms et al. 2003, Niida et al. 2006, Seminara et 
al. 2006, Tomita et al. 2008). 
1.5.1 Therapies designed to upregulate the HPG axis 
Disease conditions with low level HPG axis function:  
a) Hypothalamic amenorrhoea 
b) IHH 
c) Delayed puberty 
d) Diabetes associated hypogonadism 
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In patients with a pathological deficit in HPG axis activation, as listed above, GnRH 
agonists are administered in a pulsatile fashion so as to stimulate GnRH-R on pituitary 
gonadotropes to trigger endogenous LH and FSH secretion. Some of the GnRH agonists 
currently used are; Leuprolide, Buserelin, Nafarelin, Histerelin and Triptorelin. With the 
novel discovery of KISS1/KISS1R being a potent positive trigger for GnRH secretion it 
may be possible to develop more potent and efficacious treatments using kisspeptin 
agonists. Kisspeptin has been shown to advance puberty in monkeys and mice and 
therefore may be useful as a treatment in children with delayed onset of puberty (Navarro 
et al. 2004 and Plant et al. 2006).  
In healthy men and women kisspeptin treatment has been demonstrated to stimulate 
gonadotropin secretion. These studies revealed that kisspeptin-triggered LH pulses are 
very similar to endogenous LH pulses (Dhillo et al. 2005 and 2007, George et al. 2011, 
Jayasena et al. 2011, Chan et al. 2011and 2012). Studies were also done in 
hypogonadotropic patients and again kisspeptin was able to potently stimulate GnRH 
release and gonadotropin secretion. Women with hypothalamic amenorrhea had a 
sustained gonadotropin response with twice weekly kisspeptin treatment but this response 
was lost when treatment was increased to twice daily due to the rapid desensitization of 
KISS1R. Obesity and diabetes are correlated to hypogonadism and in a study of affected 
male patients kisspeptin was able to stimulate gonadotropin levels to that of healthy 
patients (Jayasena et al. 2010, George et al. 2010 and 2013). A recent study even showed 
that kisspeptin was able to restore normal gonadotropin pulsatility to a patient with 
TAC/TAC3R mutations (Young et al. 2013). Kisspeptin is also being tested for a role in 
fine-tuning the LH surge required for ovarian stimulation in assisted reproductive 
technologies and in one study lead to a normal pregnancy and healthy live birth (Abbara 
et al. 2013). By being able to stimulate a more endogenous pattern of LH pulses, 
kisspeptin may be a more effective alternative in assisted reproductive technologies for 
avoiding the risk of ovarian hyperstimulation syndrome (Skorupskatie et al. 2014).  
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New kisspeptin analogues are being designed and tested, primarily due to the 
antimetastatic properties of kisspeptin initially described (Kotani et al. 2001). However it 
is possible that these analogues can also be used to modulate the HPG axis to treat the 
disease states discussed above (Thompson et al. 2004).  Initially, it was shown that all 
forms of circulating kisspeptin (KP-54, 14, 13 and 10) were able to bind KISS1R with the 
same affinity and had the same potency in mice (Kotani et al. 2001 and Mikkelsen et al. 
2009) However it was later revealed that KP-10 had greater receptor binding affinity but 
poor biological stability in serum since it was prone to faster degradation. Conversely, 
KP-54 was shown to be less susceptible to degradation and was reported at being more 
efficient at triggering gonadotropin release in rats compared to KP-10 (Thompson et al. 
2004, Asami et al. 2013). Pharmacological kisspeptin analogues have been created using 
the knowledge that KP-10 as the minimal structure capable of activating KISS1R and the 
RF-amidated COOH-terminal moiety is essential for KISS1R binding (Clements et al. 
2001, Orsini et al. 2007 and Tomita et al. 2006). TAK 488 and TAK 693 are currently in 
clinical trials after tested for increased potency and greater bioavailability due to reduced 
susceptibility to degradation (Curtis et al. 2010, Matsui et al. 2013 and 2014 and Asami et 
al. 2013).   
1.5.2 Therapies for the down-regulation of the HPG axis 
Conditions where clinical downregulation of the HPG axis can be useful:  
a) Polycystic ovary syndrome (PCOS) 
b) Central precocious puberty (CPP) 
c) In vitro-fertilization (IVF) - preventing premature LH surge during controlled 
ovarian hyperstimulation in A.R.T. 
d) prostate cancer 
e) breast cancer 
f) endometriosis 
g) uterine fibroids 
h) female contraception 
When used for downregulating sex-steroid production, GnRH agonists administered in a 
continuous manner cause the desensitization and internalization of pituitary GnRH-R. 
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However due to the unique structure of GnRH-R, there is a long desensitization period of 
3 - 4 weeks during which symptoms get severely exacerbated known as the  “flare-up” 
phenomenon (Millar et al. 2010, George et al. 2012). In certain conditions such as 
malignant prostate and breast cancers therefore, use of GnRH agonists are 
contraindicated. In such cases GnRH antagonists may be an alternative treatment where 
they competitively inhibit pituitary GnRH-R from activation by endogenous GnRH. 
Examples of GnRH antagonists include; Cetrorelix, Ganirelix, Abarelix, Degarelix and 
Elagolix. Currently GnRH antagonists are not approved for use in Canada but in the past 
were efficacious as prostate cancer treatments (Akaza et al. 2010 and Matsui et al. 2012). 
While they are effective in reducing serum LH levels and do not provoke a flare-up of 
symptoms, GnRH antagonists as well as the agonists tend to lead to a drastic reduction of 
LH below castration levels (Fig. 1.7). When levels of sex steroids drop to such a low 
level, the rate of bone loss greatly exceeds the rate of bone regeneration and bone 
thinning results. Therefore, with both GnRH agonists and antagonists, levels of sex 
steroids have to be titrated and “add-back” therapy of exogenous estrogens and 
progesterones must be co-prescribed to avoid onset of osteoporosis. They have been 
associated with an acute histamine response however but more modern versions if GnRH 
antagonists seem to have overcome this issue.   
Similar to GnRH agonists, continuous administration of kisspeptin agonists causes 
desensitization of hypothalamic KISS1R leading to potent decreases in LH secretion 
(Seminara et al. 2006, Ramaswamy et al. 2007, Thompson et al 2006). While a single 
bolus application of kisspeptin can potently stimulate GnRH release, continuous 
application can lead to homologous desensitization and internalization of KISS1R so that 
it is no longer available to respond to increasing amounts of agonist.  
In vivo evidence for KISS1R desensitization was demonstrated in monkeys when 
castrated juvenile male monkeys exposed to continuous IV adminstration of KP-10, 
showed an initial rise in LH in the first 3 hours followed by basal levels for the remainder 
of the experiment. To further prove that the decreased response was not just due to GnRH 
depletion, NMDA, another trigger for GnRH secretion, was administered and evoked a 
GnRH response (Seminara et al. 2006).  Another study using intact adult male monkeys 
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produced similar results (Ramasawmy et al. 2007). Continuous kisspeptin exposure in 
rats also demonstrated KISS1R desensitization using LH and testosterone as surrogate 
markers for GnRH secretion (Thompson et al. 2006). These in vivo studies demonstrate 
that KISS1R desensitizes rapidly compared to GnRHR which can take weeks to 
desensitize with continuous agonist treatment (Pinilla et al. 2012 and Millar, 2010). 
Studies in the Babwah laboratory demonstrated that GRK2 mediates KISS1R 
homologous desensitization and inferred that β-arrestin may also be involved (Pampillo 
et al. 2009) and here in this dissertation we confirm that β-arrestin does in fact mediate 
the homologous desensitization of KISS1R thereby revealing the mechanism behind this 
process. Finally, women treated with kispeptin twice weekly displayed a rise in serum 
gonadotropins, however when the frequency was increased to twice daily administration, 
gonadotropins dropped to basal levels (Jayasena et al. 2010). With further studies to 
elucidate the mechanism, the rapid rate of KISS1R desensitization (hours) compared to 
the known prolonged rate for GnRH-R (weeks) (McArdle et al. 1999, Tello et al. 2012), 
demonstrates that the continuous infusion of kisspeptin agonists can be a potentially more 
effective treatment than the continuous GnRH agonists currently being used. 
Furthermore, the “flare-up” period is significantly contracted and since kisspeptin 
agonists do not reduce LH levels below basal, there will not be the associated risk of 
osteoporosis (Fig. 1.7) (Matsui et al. 2014). While some conditions like malignant 
prostate and breast cancer require complete ablation of gonadotropin and sex steroids, 
benign prostatic hyperplasia, endometriosis and uterine fibroids do not require such a 
complete suppression and so kisspeptin agonists may be a better therapeutic alternative 
(Matsui et al. 2014).  
In addition to using kisspeptin agonists to desensitize hypothalamic KISS1R, kisspeptin 
antagonists have also been developed. Similar to kisspeptin agonists they have been 
shown to rapidly and effectively reduce LH secretion while not reducing it lower than 
basal levels (Fig. 1.7) (Roseweir et al. 2009). One kisspeptin antagonist called Peptide 
234 has been tested in mice, rats, monkeys and sheep and conclusively demonstrated that 
it inhibited kisspeptin neuron firing rate, reduced GnRH neuron firing rate, delays 
pubertal onset in rodents, inhibits LH surge post-castration and the pre-ovulatory LH 
surge (Roseweir et al. 2009).   
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Other potential applications of kisspeptin antagonists or continuous treatment with 
kisspeptin agonists to downregulate the HPG axis include; as an alternative female 
contraception and reducing the pre-ovulatory LH surge in ART procedures. Currently 
female contraception is largely based on oral doses of supraphysiological levels of sex 
steroids are used to negatively feedback and reduce gonadotropins needed for ovulation. 
Kisspeptin agonists or antagonists can be used to reduce LH levels and prevent the 
ovulatory LH surge without lowering it below basal levels so follicular development and 
estrogen secretion would still continue but ovulation would not occur (Pinilla et al. 2012 
and Millar 2010, Jayasena et al. 2014). IVF procedures involve a period of controlled 
ovarian hyperstimulation where continuous GnRH agonists are given to inhibit ovulation 
while follicular development is stimulated then exogenous gonadotropins are applied to 
trigger timed ovulation for ovum transfer. Kisspeptins antagonists may be better 
alternatives here since they effectively ablate the ovulatory LH surge yet maintain basal 
levels so lower levels of stimulatory gonadotropins need to be applied for timed ovum 
collection (Durnerin et al. 2008 and Drakakis et al. 2009). The supraphysiological 
hormone levels used in current IVF treatment has been shown negatively impact 
endometrial receptivity to implantation and early gestational success (Hayden, 2008, 
Marchini et al. 1991, Ubaldi et al. 1997, Kolibianakis et al. 2002, Devroey et al. 2004). 
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Figure 1.7: Schematic diagram showing differences in LH response to kisspeptin 
analogues compared to GnRH analogues. 
Treatment with kisspeptin agonists (A) or kisspeptin antagonists (B) do not lower LH 
levels below basal. Unlike GnRH agonists (C) and antagonists (D) which not only reduce 
LH levels to castration levels but with GnRH agonists (C) a significantly long period of 
initial flare-up occurs. Adapted from Pinilla et al. 2012 with data from Seminara et al. 
2006, Ramaswamy et al. 2007, Thompson et al 2006 and Roseweir et al. 2009.  
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1.6 KISS1R and G-protein signaling 
Guanine nucleotide binding proteins (G-proteins) are the most widely evolved 
intracellular signal transducers in biological systems (Pierce et al. 2002 and Luttrell, 
2008). Heterotrimeric G-proteins consist of three subunits, α, β and γ and exert their 
effects by coupling to seven transmembrane receptors (7TMRs) also referred to as G-
protein coupled receptors (GPCRs) (Offermanns, 2003). The Gα-subunit is bound to 
GDP in the inactive state and has a high affinity for the βγ-subunit dimer. When agonists 
activate GPCRs it causes a conformational change allowing for the activation of the Gα-
subunit through the exchange of GDP with GTP. The activated Gα-subunit dissociates 
from the Gβγ- complex and activates associated G-protein signalling cascades (Helper et 
al. 1992, Neer et al. 1995, Gudermann et al. 1996 and Hamm, 1998). The Gα-subunit has 
intrinsic GTPase activity which catalyses the hydrolysis of GTP back to GDP causing the 
inactivation of Gα and re-association to the Gβγ- complex in the basal inactive state. 
Many types of G-protein subunits have been discovered and are associated with specific 
effectors and signalling events (Table 3). The exact mechanism that regulates the 
specificity of the GPCR-G-protein-Effector interaction is still unknown but 
conformational change is thought to play an important role (Gudermann et al. 1997, 
Schoneberg et al. 1999, Palczewski et al. 2000, Luttrell, 2008). Gα subunits have two 
main domains; the GTP-GDP binding domain and the α-helical domain that binds 
effectors and Gβγ subunits. While the central guanine nucleotide-binding pocket is highly 
conserved among Gα subunits (sharing 40% amino acid sequence homology), the C- and 
N-termini are more unique and play important roles in receptor and effector association 
as well as Gβγ dimer binding respectively (Luttrell, 2008, Kohout et al. 2004 and 
Holloway et al. 2002).  
KISS1R is a GPCR that signals primarily through Gαq/11 proteins (Figs. 1.5 and 1.6) 
(Kotani et al. 2001, Ohtaki et al. 2001 and Muir et al. 2001). The Gαq family stimulates 
pertussis toxin insensitive PLCβ hydrolysis of phosphatidylinositol 4,5-bisphosphate 
(PIP2) into the second messengers inositol 1,4,5-triphosphate (InsP3) and diacylglycerol 
(DAG) (Table 3). Many receptors that regulate the reproductive axis are Gαq –coupled 
GPCRs including hypothalamic KISS1R and NK3B as well as GnRH-RI expressed in 
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pituitary gonadotropes. Of the four members of the Gαq family, Gαq and Gα11 are 
ubiquitously expressed whereas Gα14 is primarily expressed in kidney, testis and lung and 
Gα15/16 is only expressed in some hematopoietic cells (Exton, 1996, Rhee, 2001, 
Amatruda et al. 1991, Wilkie et al. 1991, Tanka et al. 2000). KISS1R is a Gαq/11 –coupled 
receptor, where the term Gαq/11 indicates the level of functional redundancy and receptor 
affinity between Gαq and Gα11. In addition to sharing 88% amino acid sequence, 
receptors such as α1-adrenergic and vasopressin that couple to Gαq/11 show no preference 
for association or activation between Gαq and Gα11 and both G-protein subtypes are able 
to effectively activate PLCβ1,3 and 4 and poorly activate PLCβ2 (Wange et al. 1991, Wu 
et al. 1992, Jiang et al. 1994, Offermanns et al.1994, Xu et al. 1998 and Rhee, 2001).  
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Table 1.3:  Summary of the various classes of Gα-subunits. 
 
G-protein 
family
3
 
Subtypes 
Cognate 
GPCR 
example 
Primary effector 
molecules 
Main intracellular 
signalling events 
Gαs 
Gαs , GαsXL , 
Gαolf 
FSH-R      
LH-R         
β2AR 
Adenylate cyclase 
Stimulates cAMP 
production 
Gαi/o 
Gαi1, Gαi2, Gαi3, 
Gαio, Gαo, Gαgust 
NPY-R Adenylate cyclase 
Inhibits cAMP 
production 
Gαq 
Gαq, Gα11, Gα14, 
Gα15/16                    
(15= mouse, 16 = human) 
GnRH-RI 
KISS1R      
NK3B  AT1AR 
Phospholipase C-β 
(PLCβ) 
Stimulates InsP3 and 
DAG production 
Gα12 Gα12, Gα13 AT1AR 
Rho GTPase 
activation 
Stimulates stress 
fibre formation 
  
                                                 
3 Four distinct Gα-subunit families exist which signal through discrete effectors and second messengers. See list of 
receptor abbreviations. (InsP3 – inositol 1,4,5-triphosphate; DAG – diacylglycerol) (Lambert, 2008 and Offermans, 
1999 and Offermans 2003). 
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1.6.1 Gαq (Gnaq) and Gα11 (Gna11) mouse models 
To further explore the biological significance of the functional redundancy and 
ubiquitous expression of Gαq and Gα11 mice with inactivating (null) mutations for each 
were created. It was surprising to discover that of all the mice generated with inactivating 
mutations in each Gα-subunit gene (Gnaq-/-, Gna11-/-, Gna14-/- and Gna15/16-/-) only 
those lacking Gαq (Gnaq
-/-
) demonstrated phenotypic defects (Davignon et al. 2000, 
Offermanns et al. 1998). This indicates that while Gαq may be able to compensate for the 
other ubiquitous Gα11 in vivo, the converse does not hold true since mice with intact 
Gna11 in the absence of Gnaq display an affected phenotype (Table 1.4) . While Gnaq
-/- 
mice are viable they have obvious defects in motor coordination and ataxia due to 
disrupted cerebellar development. Studies in the Gnaq
-/- 
mice demonstrated that Gαq is 
essential during the third postnatal week for the elimination of multiple climbing fibers 
innervations to cerebellar purkinje cells (Offermanns et al. 1997). Gnaq
-/- 
mice also 
display impaired platelet-dependent thromboembolism and hemorrhagic diathesis. 
Platelets unlike most mammalian cells only express Gαq and not Gα11 so a loss of Gαq 
results in a lack of PLCβ stimulation, Ca2+ intracellular increase and an overall lack of 
platelet aggregation and degranulation (Offermanns et al. 1997). Furthermore, mice 
lacking various combinations of Gαq and Gα11 alleles demonstrate gene dosage effects on 
phenotype and this is summarised in Table 4 below (Offermanns, 1999).   
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Table 1.4: Gene dosage effects of Gαq and Gα11 expression on phenotypic 
abnormalities.
4
 
 
 #Gαq 
alleles 
#Gα11 
alleles 
Gnaq Gna11 Phenotype 
A 1 1 -/+ -/+ None 
B 2 0 +/+ -/- None 
C 0 2 -/- +/+ 
Viable with cerebellar ataxia and 
platelet aggregation defect 
D 1 0 -/+ -/- 
Not viable – die at P0 due to cardiac 
defects 
E 0 1 -/- -/+ 
Not viable – die at P0 due to cardiac 
and craniofacial defects 
F 0 0 -/- -/- 
Not viable – die at E11 due to 
myocardial hypoplasia 
  
                                                 
4 While Gαq seems to be able to functionally compensate for Gα11 in vivo, the converse does not hold true and total 
allelic contribution from both genes are critical in determining the functional state of the Gαq/11 signalling cascade. 
(Adapted from Offermans, 1999). 
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When both Gna11 alleles are inactivated in the presence of functional Gnaq (Table 4 row 
B) there is no obvious defect but when both Gnaq alleles are inactivated in the presence 
of functional Gna11 (Table 4 row C) cerebellar ataxia and platelet hemostasis defects are 
observed (Offermanns et al. 1998 and 1999). Also while at least one functional allele of 
the four is needed to allow full-term birth (Table 4 rows D and E), at least two functional 
alleles are required for postnatal viability (Table 4 rows A, B and C). Double 
homozygous loss of Gαq and Gα11 (Gnaq
-/-
;Gna11
-/-
) (Table 4 row F) develop normally 
until E9.5 then growth is retarded and evidence of a thinning of the myocardial layer of 
the heart results in death at about E11 (Offermanns et al. 1998).   
To circumvent embryonic lethality and enable further study of the roles of Gαq and Gα11 
at the molecular and physiological level, two strategies were employed. Firstly, MEFs 
from E10.5 mouse embryos were used to create Gnaq
-/-
;Gna11
-/-
 MEFs for in vitro 
analysis of intracellular mechanisms and secondly, Cre-LoxP-mediated recombination 
was used to create conditional Gnaq
-/-
;Gna11
-/-
 mouse mutants. Since Gna11
-/-
 mice were 
fertile, viable and lacked obvious phenotypic defects, the conditional Gnaq
-/-
;Gna11
-/-
 
mice were created by Cre-mediated inactivation of Gnaq in the background of Gna11 
deficiency (Zywietz et al. 2001 and Wettschureck et al. 2001). Numerous studies have 
used the Gnaq
-/-
;Gna11
-/-
 MEFs to study the role of Gαq/11 signalling downstream of 
GPCRs. We have also used them previously to demonstrate that KISS1R was capable of 
activating ERK1/2 in a Gαq/11- independent manner (Szereszewski et al. 2010, Blaukat et 
al. 2000 and Adjobo-Hermana et al. 2008). While they are a very useful tool for 
elucidating molecular mechanisms, they are still a cellular model made from embryonic 
mouse fibroblasts and do not provide information about the physiological response 
associated with Gαq/11- independent signalling; to achieve this the conditional Gnaq
-/-
;Gna11
-/-
 mouse models are required. Wettschureck et al. (2001), created and 
characterized mice in which allowed for conditional inactivation of Gnaq in Gna11 
deficient mice by Cre-mediated recombination caused the excision of exon 6 in the Gnaq 
gene (Gnaq
fl/fl
; Gna11
-/-
). Various Cre expressing lines under the regulation of tissue-
specific promoters have been used in conjunction with the Gnaq
fl/fl
;Gna11
-/- 
mice such as; 
MLC2a-Cre (cardiomyocyte-specific), Nestin-Cre (neuron and glial-specific), P0-Cre 
(neural-crest specific), Camkcre4 (specific to the principal neurons in the forebrain) and 
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all these studies have demonstrated almost complete efficiency of Gαq/11 ablation in target 
tissues (Kero et al. 2007, Wettschureck et al. 2001, 2005, 2006, 2007, Dagmara et al. 
2005). In our studies described later, we used Gnrh-Cre and these well characterised 
Gnaq
fl/fl
;Gna11
-/- 
mice to create mice in which Gαq/11was inactivated only in 
hypothalamic GnRH neurons (Yoon et al. 2005, Skynner et al 1999 and Wintermantel et 
al. 2001).  
1.6.2 Gαq/11 signaling through extracellular-signal regulated 
kinases (ERK 1/2) 
Mitogen-activated protein kinase (MAPK) is a collective term for three families of 
intracellular signaling cascades namely, the extracellular signal-regulated 1 and 2 kinases 
(ERK 1/2), p38 kinases and c-Jun N-terminal kinases (JNKs). These cascades regulate 
intracellular signaling by phosphorylating specific substrates in the cytosol and nucleus 
(Gutkind, 2000 and Rozengurt, 2007). Not only is it the best characterized MAPK, but 
ERK 1/2 phosphorylation has been demonstrated to be a critical step preceeding GnRH 
secretion (Castellano et al. 2006) therefore we focused on the activity of this pathway in 
our in vivo studies. When Gαq/11 is activated by the receptor it triggers a series of events 
(Figure 1.5) that eventually leads to the activation of PKC. One consequence of this is the 
activation of Ras (a GTPase) and Raf (a MAP3 kinase). Raf phosphorylates MEK (a 
MAPK kinase) which in turn phosphorylates and activates ERK 1 (p44) and ERK 2 (p42) 
(Gutkind, 2000). One substrate for ERK 1/2 is ribosomal protein kinase (RSK) which 
phosphorylates ribosomal protein S6 and therefore regulated transcription and gene 
expression (Caunt et al. 2006) 
1.7 KISS1R and β-arrestin interaction and consequences 
1.7.1 β-arrestin structure 
There are four arrestin proteins divided into two subfamilies; visual arrestins (arrestin-1 
and -4) and β-arrestins (arrestin-2 and -3) (Attramadal et al. 1992, Lohse et al. 1990). 
Arrestin-1 is expressed in both rods and cones of the retina while arrestin-4 is solely 
expressed in the cones (Murakami et al. 1993 and Craft et al. 1994). β-arrestin-1 and -2 
also referred to as arrestin-2 and -3 respectively are ubiquitously expressed and share 
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over 78% amino acid sequence homology (Lohse et al. 1992).  Based on the known 
crystal structure of visual arrestin in combination with mutagenesis studies, the putative 
structure of the β-arrestins has been suggested (Fig. 1.8) (Gurevich et al. 1995). The N-
terminal domain (A) is thought to be involved in recognition of agonist bound GPCRs 
and the C-terminal domain (B) contains secondary receptor binding sites. The N- and C-
domains are separated by a phosphate sensor region in the polar core of the protein and in 
the inactive state the C-terminus associates with this region. Upon binding a 
phosphorylated agonist-bound GPCR, the C-terminus is released from this association 
and the β-arrestin protein adopts an active conformation (Gurevich et al. 1995 and Hirsch 
et al. 1999). Both visual arrestins and β-arrestins contain regulatory regions, R1 and R2 
but in β-arrestins only the R2 domains contain the necessary phosphorylation sites to 
allow them to scaffold to members of the endocytotic pathway. Specifically, the R2 
domain has been shown to contain a LIEF binding motif that allows for the recruitment 
of clathrin and the β2-adaptin subunit of the AP-2 complex, both clathrin and AP-2 are 
key molecules involved in the endocytotic internalization of plasma membrane GPCRs 
(Krupnick et al. 1997 and Laporte et al. 2000).  
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Figure 1.8: Graphical representation of the structure of β-arrestins. 
The N-terminal domain (A) is involved in the recognition of phosphorylated GPCRs and 
the C-terminal domain (B) contains secondary GPCR binding sites. P is a phosphate 
sensor region to which the C-terminus binds in the inactive state. R1 and R2 are 
regulatory domains involved with β-arrestin mediated GPCR internalization via clathrin-
coated pits (Adapted from Luttrell and Lefkowitz, 2002 and Ferguson, 2001). 
  
48 
 
1.7.2 β-arrestin function 
β-arrestins have been best described for their critical role in mediating GPCR signal 
termination by homologous desensitization but they have also been shown to be involved 
in GPCR internalization by endocytosis, receptor resensitization and down regulation as 
well as secondary signal transducers.  
As described for the prototypical receptor, homologous desensitization involves the 
action of two protein families; GPCR serine/threonine kinases (GRKs) and β-arrestins 
(Freedman and Lefkowitz, 1996 and Krupnick and Benovic, 1998). Briefly, there are 
seven GRKs identified to date, GRK1 and -7 are expressed in the retina and GRK4 is 
expressed in testes, kidney and cerebellum (Ribas et al. 2007 and Sallese et al 2000).  
GRK2, -3, -5 and -6 are ubiquitously expressed but while GRK5 and -6 are constitutively 
associated with the plasma membrane, GRK2 and -3 are not (Pitcher et al. 1996, Premont 
et al. 1996, Stoffel et al. 1997). GRKs are recruited to agonist bound GPCRs and have 
been shown to phosphorylate the intracellular loops (IL) 2, IL3 or carboxy-terminal C-tail 
and demonstrate receptor specificity (Dhami et al. 2005 and Dhami and Ferguson, 2006). 
After prolonged exposure to the agonist, GRKs are recruited and phosphorylate the 
receptor which disrupts the interaction with the associated G-protein (Ferguson, 2001 and 
Luttrell and Lefkowitz, 2002). GRK-mediated receptor phosphorylation promotes high-
affinity binding of β-arrestins which sterically uncouples the receptor from its G-protein 
and interdicts further signaling (Ferguson, 2001 and Luttrell and Lefkowitz, 2002).  
In fact, studies with β2AR demonstrate that β-arrestins have a ten to thirty fold greater 
affinity for the GRK-phosphorylated receptor compared to the unphosphorylated (Lohse 
et al. 1992). Using MEFs lacking either or both β-arrestins, recent studies demonstrated 
that β2AR and AT1aR desensitization was mediated by both β-arrestin isoforms (Kohout 
et al. 2001).  
Subsequent to homologous desensitization, GPCRs are commonly targeted for 
internalization or sequestration by clathrin-mediated endocytosis (Luttrell et al. 2010). 
After β-arrestins bind phosphorylated GPCRs, the C-terminus is freed from binding to the 
internal polar core. The C-terminus of β-arrestin contains binding sites for clathrin and 
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β2-adaptin (Fig. 1.8) (Goodman et al. 1996, Krupnick et al. 1997). β2-adaptin is a subunit 
in an AP-2 complex which coordinates GPCR internalization by binding to the various 
molecules necessary including clathrin, dynamin and EPS-15 (Kirchhausen, 1999, 
Fergusson et al. 1996, Zhang et al. 1996, Laporte et al. 2000). While most GPCRs 
undergo β-arrestin-mediated sequestration, not all do such as PAR-1, SST2A and N-
formyl peptide receptor (Paing et al. 2002, Vines et al. 2003 and Brasselet et al. 2002). 
These particular receptors also demonstrate that GPCRs may undergo β-arrestin-mediated 
desensitization and not necessarily be sequestered in a β-arrestin-dependent manner as 
well. In vitro studies using MEFs lacking either or both β-arrestins showed that β-
arrestin-2 was more potent than β-arrestin-1 in mediating β2AR internalization while 
either β-arrestin isoform was sufficient for AT1aR internalization (Kohout et al. 2001). 
GPCRs have been categorized based on the degree of association with β-arrestins into 
Class A or Class B (Barak et al. 1997, Oakley et al. 2001 and 2000). This is not to be 
confused with the structural scheme of GPCR classification however which also uses the 
terminology of Class A, B, C etc. (Bockaert et al. 1999, Sharman et al. 2011). Overall, 
class A receptors transiently bind β-arrestin-2 with higher affinity than β-arrestin-1 so 
that after internalization the receptor- β-arrestin complex dissociates while class B 
receptors stably bind both β-arrestin isoforms with equal affinity so that it remains 
associated with the receptor post-internalization (Luttrell, 2008).  µ-opioid, endothelin A 
and dopamins D1A are examples of class A receptors and AT1AR, neurotensin 1, 
vasopressin V2, neurokinin NK-1 receptors are examples of those in class B. Studies 
demonstrated that GRK phosphorylation sites on the C-tail of the GPCR were responsible 
for determining the stability of their association with β-arrestin (Oakley et al. 2000 and 
Tohgo et al. 2003). Furthermore, the stability of this association also determines the 
intracellular fate of the internalized GPCRs; whether they are recycled as is the case for 
most class A receptors or whether like most class B receptors, are targeted for lysosomal 
degradation (Oakley et al. 1999, 2000, Shenoy and Lefkowitz, 2011, Kang et al. 2013). 
In order for a GPCR to be recycled or resensitized to the plasma membrane it often 
requires agonist dissociation and GPCR dephosphorylation. This is commonly achieved 
in acidified vesicles associated with GPCR-specific protein phosphatase (PP2A) (Sibley 
et al. 1986, Pitcher et al. 1995, Krueger et al. 1997, Ferguson, 2001). Alternatively, 
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internalized β-arrestin bound GPCRs may be targeted for degredation in lysosomes which 
results in a downregulation of receptor expression at the plasma membrane (Dery et al. 
1999 and Anborgh et al. 2000).  
1.7.3 β-arrestin-dependent signaling and biased signaling 
β-arrestins also have been shown to be able to bind various signalling molecules and 
thereby act as an adapter or scaffolding protein facilitating G-protein independent 
signaling downstream of GPCRs (Defea, 2008 and Kovacs et al. 2009, Luttrell et al. 
2010). In vitro studies with β2AR, NK-1R and CXCR-1R demonstrate that after 
internalization of these β-arrestin bound receptors, members of the Src family of tyrosine 
kinases were able to bind β-arrestin and directly interact with the receptors (Luttrell et al. 
1999, De Fea et al. 2000, Barlic et al. 2000, Imamura et al. 2001). These findings 
revealed that β-arrestin played critical roles in termination of G-protein dependent 
signaling and also mediating G-protein independent signaling. Further studies 
demonstrated that β-arrestins served as critical scaffolding agents for members of the 
mitogen-activated protein kinase (MAPK) cascade. In this role β-arrestins serve three 
important molecular functions; to increase efficiency by binding sequential agents in 
close proximity, to allow for intracellular compartmentalization of signaling and to 
ensure specificity response by preventing crosstalk with other signaling cascades (Luttrell 
and Lefkowitz, 2002). Briefly the MAPKs consist of three families which phosphorylate 
cytosolic and nuclear targets to regulate responses including gene expression, cell 
proliferation and apoptosis. The three families are; extracellular-signal regulated 1 and 2 
kinases (ERK1/2), p38 kinases and c-Jun N-terminal kinases (JNKs) (Gutkind, 2000, 
Rozengurt, 2007). While GPCRs activate many intracellular signalling systems, ERK1/2 
phosphorylation has been the best characterised and widely established in the literature. 
Additionally, both G-protein and β-arrestin pathways seem to be able to signal to ERK1/2 
demonstrating that it is a crucial cascade capable of integrating and regulating cellular 
and biological responses (Luttrell and Lefkowitz, 2002).  
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While both pathways activate ERK1/2 the G-protein mediated ERK1/2 response tends to 
be rapid but transient and for some receptors (PAR1 and AT1aR) is capable of 
translocating to the nucleus where it can regulate gene transcription. The β-arrestin 
mediated ERK1/2 response occurs later after agonist exposure but is more persistent 
however β-arrestin-activated ERK1/2 remains sequestered in the cytosol (Tohgo et al. 
2002, Ahn et al. 2004, Shenoy et al. 2006, Kobayashi et al. 2005, DeFea, 2008). The two 
β-arrestin isoforms have been shown to sometimes differentially regulate ERK1/2 
phosphorylation. For some receptors, β-arrestin-1 and -2 act synergistically to trigger 
ERK1/2 activation (PAR2, PTH1R and β2AR) while for others such as AT1aR the 
isoforms have reciprocal effects (Ahn et al. 2004, DeFea et al. 2000, Shenoy et al. 2006, 
Getsy-Palmer et al. 2006).  
With the discovery that GPCRs can signal via both G-protein and β-arrestin-dependent 
pathways came the emergence of a novel paradigm referred to as biased signalling. A 
biased agonist is one which stabilizes receptor conformation so that it would 
preferentially interact with certain signaling molecules over others (Violin and 
Lefkowitz, 2007, Kenakin, 2007). Ligands for various GPCRs have since been described 
which stimulate the β-arrestin pathway and antagonize the G-protein cascade for 
example. In vivo however, these pathways may not only be antagonistic but can also be 
cooperative as explained later. To tease apart the G-protein-dependent from the β-
arrestin-dependent responses various strategies have been employed such as; G-protein 
uncoupled mutant receptors, G-protein pathway chemical inhibitors, β-arrestin RNA 
interference (siRNA/shRNA), β-arrestin null MEFs and mice (Bohn et al. 1998, Conner 
et al. 1997, Kohout et al. 2001, Ahn et al. 2004, Wei et al. 2003, Drake et al. 2008).  
For AT1AR, a combination of techniques has been used to demonstrate that this receptor 
is capable of signaling to ERK1/2 in the absence of G-protein. AT1AR-DRY/AAY; a 
Gαq/11 uncoupled AT1AR mutant receptor was used to show that while the receptor is 
incapable of activating the Gαq/11 pathway, it was still able to activate ERK1/2 via a β-
arrestin-2-dependent mechanism (Wei et al. 2003). To confirm this finding, SII, a 
mutated AT1AR agonist that binds AT1AR but is incapable of activating the Gαq/11 
pathway was shown to activate β-arrestin-2-dependent ERK1/2 phosphorylation (Wei et 
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al. 2003). Taken together, these findings indicate that AT1AR is capable of signaling to 
ERK1/2 via both Gαq/11 and β-arrestin mediated mechanisms and also that SII is an 
example of a β-arrestin biased agonist.  
Biased signaling was also demonstrated for β2AR by in vitro experiments using a Gαs-
uncoupled receptor mutant, β2AR
TYY 
and a β2AR inverse agonists, ICI 118,551and 
carvedilol (Shenoy et al. 2006, Azzi et al. 2003, Wisler et al 2007 and Drake et al 2008). 
These experiments revealed that while the Gs pathway was inactive, the receptor was still 
capable of signaling to ERK1/2 in a β-arrestin-dependent manner.  
In the previous examples, the G-protein pathways are independent from the β-arrestin-
mediated pathways however for some GPCRs, these pathways may act cooperatively as 
with CCR7. When stimulated with CCL19, CCR7 is capable of activating both Gαi/o and 
β-arrestin signaling but administration of pertussis toxin, a potent Gαi/o inhibitor, 
abolishes all ERK1/2 activation (Lefkowitz and Shenoy, 2005, Kohout et al. 2004, Zidar 
et al. 2009). Therefore, for CCR7, the Gαi/o and β-arrestin pathways cooperatively act to 
stimulate ERK1/2 phosphorylation.  
1.7.4 Physiological relevance of biased signaling 
With the recognition that GPCRs are capable of having multiple active states and that 
signaling can be G-protein dependent or independent (and frequently β-arrestin-
dependent), the potential for developing novel drugs to manipulate GPCR response has 
greatly increased. The following are some examples of the biological consequences of 
biased signaling and some examples of how it can be used to improve existing therapies.  
One of the roles of AT1AR in vivo is the regulation of vascular cell growth in the heart 
and associated blood vessels. AT1AR can be activated by the endogenous ligand, 
angiotensin II, but can also be put into an active state after the cell experiences 
mechanical stretch as occurs in patients with hypertension (Rakesh et al. 2010). 
Angiotensin II stimulates Gαq/11 signalling which leads to myocyte hypertrophy in 
response to short-term increases in cardiac load as is experienced with exercise for 
example. Recent studies have shown that in the absence of agonist mechanical stress 
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induces signalling via the β-arrestin pathway, independent of Gαq/11 activation, which 
mediates cardio-protective mechanisms including, ERK1/2 phosphorylation, EGFR 
transactivation and reduced myocyte apoptosis (Rakesh et al. 2010, Wei et al. 2003). 
Current drugs used are angiotensin receptor blockers (ARBs) and while they effectively 
block the hypertropic effects of the Gαq/11 pathway they unfortunately also block the 
potential cardioprotective response from the β-arrestin pathway. Work is currently 
underway to develop novel β-arrestin-biased agonists for AT1AR which would both lower 
blood pressure by abolishing Gαq/11 signalling while promoting the β-arrestin pathway 
that will assist in protecting the cells from potential damage due to the increased blood 
pressure (Rakesh et al. 2010).  
Currently, β-blockers are commonly prescribed to treat hypertension, glaucoma, 
congestive heart failure and myocardial infarction (Patel et al. 2009, Andresen, 2011). 
These drugs act by inhibiting β2AR, the receptor for adrenaline. One of these β-blockers 
was carvedilol and was considered to simply be a β2AR antagonist until studies in 2007 
revealed that it was in fact a β-arrestin-biased agonist (Packer et al. 1996, Vanderhoff et 
al. 1998, Kim et al. 2008, Wisler et al. 2007, Drake at al. 2008). While blocking the 
harmful effects of adrenaline-stimulated Gs signaling downstream of β2AR, carvedilol 
was shown to promote β-arrestin transactivation of EGFR and ERK1/2 phosphorylation 
important for cardioprotective function (Noma et al. 2007, Kim et al. 2008, Drake et al. 
2008). EGFR activation is associated with antihypertensive properties such as nitric oxide 
production that is important for vascular muscle relaxation (Namiki et al. 1990 and 
Kurosaki et al. 2000). Although the mechanisms behind biased signalling are not fully 
understood yet, carvedilol is an example of a biased agonist that has been used for years 
with excellent clinical results and further demonstrates that they may provide additional 
benefits than conventional GPCR agonists and antagonists currently used.  
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1.7.5 Mice bearing genetic deletions for β-arrestin and derived 
MEF cell lines 
As mentioned previously, various tools are used for teasing apart the G-protein and β-
arrestin pathways downstream of GPCRs.  Two of the tools used to characterise the 
physiological roles of β-arrestin in vivo are the mouse models that were developed 
lacking either β-arrestin-1 or β-arrestin-2 (Conner et al. 1997 and Bohn et al. 1999). Both 
Arrb1
-/-
 and Arrb2
-/-
 mice are viable, fertile, producing normal sized litters and show no 
obvious phenotypic defects until challenged with certain GPCR agonists. This indicated 
that while the β-arrestin isoforms shared 78% amino acid sequence homology and were 
mostly functionally redundant there were still certain functions that were distinctly 
regulated by each isoform. The role of β-arrestin-1 in β2AR desensitization is evident in 
the challenged phenotype of the Arrb1
-/- 
mice (Table 5 row B). This is not surprising 
given the importance of β2AR in cardiac function and when Arrb1
-/- 
mice were 
challenged with isoproternol, a potent β2AR agonist, they exhibited an exaggerated 
hemodynamic response due to prolonged signaling and reduced β2AR desensitization 
(Conner et al. 1997). Similarly, the role of β-arrestin-2 in µOR desensitization is 
demonstrated by prolonged morphine analgesic effect in Arrb2
-/- 
mice (Table 5 row A). 
The potentiation of µOR signaling in response to morphine is due to reduced µOR 
desensitization in the central nervous system resulting in tachyphylaxis or increased drug 
tolerance (Bohn et al. 1999). While the mice lacking single isoforms of β-arrestin are 
useful in identifying differential functions of Arrb1
-/-
 or Arrb2
-/-
 in vivo, they are not as 
useful for separating β-arrestin-dependent vs. G-protein dependent responses in vivo. 
Ideally, a model lacking both β-arrestin isoforms would be applicable for these studies 
but Arrb1
-/-
;Arrb2
-/- 
mice die at birth due to pulmonary hypoplasia (Table 5 row E) 
(Zhang et al. 2010).  
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Table 1.5: Phenotypes associated with lack of Arrb expression in mice. 
 
 
 #Arrb1 
alleles 
#Arrb2 
alleles 
Arrb1 Arrb2 Phenotype
5
 
A 2 0 +/+ -/- Prolonged morphine analgesia (µOR) 
B 0 2 -/- +/+ Hyperactive cardiac response (β2AR) 
C 0 1 -/- -/+ No reported defects 
D 1 0 -/+ -/- No reported defects 
E 0 0 -/- -/- Die at birth - Pulmonary hyperplasia 
  
                                                 
5 Arrb1 and Arrb2 seem to be able to functionally compensate for each other during development since mice lacking 
either isoform are viable and fertile and only demonstrate a phenotype when pharmacologically challenged (row A and 
B). Homozygous loss of both Arrb isoforms results in mice that die at birth due to pulmonary hyperplasia (Conner et al. 
1997, Bohn et al. 1999, Zhang et al. 2010).  
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To circumvent the experimental limitation of perinatal lethality in Arrb1
-/-
;Arrb2
-/- 
mice, 
mouse embryonic fibroblasts (MEFs) were generated from mice between E10.5 – E 13.5 
(Kohout et al. 2001). As such five cell lines were established for further in vitro 
investigation:  
- β-arrestin-1 knockout (KO):  Arrb1-/-   
- β-arrestin-1 wild-type (WT):  Arrb1+/+ 
- β-arrestin-2 knockout (KO):  Arrb2-/- 
- β-arrestin-2 wild-type (WT):  Arrb2+/+ 
- β-arrestin-1-2 double knockout (DKO):  Arrb1-/-;Arrb2-/-  
The wild-type parental line for the β-arrestin DKO line is also β-arrestin-2 WT 
(Arrb2
+/+
). These cell lines have since been used extensively in studies to elucidate the 
role for β-arrestin in regulating GPCR function. One of the initial studies demonstrated 
that while β-arrestin-1 and -2 equally regulated β2AR desensitization and AT1AR 
desensitization and internalization, they differentially regulated β2AR internalization 
(Kohout et al. 2001). Desensitization for PAR1 was also shown to be differentially 
regulated by the isoforms where β-arrestin-1 plays a critical role in vitro. Overall, these 
studies show that while the mouse models bearing genetic deletions of β-arrestin are 
useful for examining physiological relevance of β-arrestin function, until conditional 
inactivating models are created the true biological contribution of β-arrestin cannot be 
evaluated. The MEFs therefore facilitate the understanding of the molecular mechanisms 
regulating β-arrestin function in vitro.  
1.7.6 KISS1R and β-arrestins 
As mentioned earlier, KISS1/ KISS1R signalling has extensive physiological function 
with respect to reproduction and fertility in vivo. However, the underlying intracellular 
mechanisms governing KISS1R mediated-GnRH secretion is still not fully understood 
and even less is known about the molecular mechanisms involved in terminating this 
response. While KISS1R has been described as a Gαq/11 coupled GPCR that signals to 
ERK1/2 and triggers GnRH secretion (Kotani et al. 2001, Ohtaki et al. 2001, Seminara et 
al. 2003, Castellano et al. 2006), recent in vitro studies demonstrated that in the absence 
of G-protein signaling, KISS1R can activate ERK1/2 through a β-arrestin mediated 
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mechanism (Pampillo et al. 2009, Szereszewski et al. 2010). The physiological relevance 
of this alternative signaling pathway has not yet been investigated until these current 
studies described later, where GnRH and gonadotropin secretion was measured. The in 
vivo results from these studies potentially have huge therapeutic value for certain patients 
such as those diagnosed with IHH bearing inactivating KISS1R mutations, women 
suffering from hypothalamic amenorrhea or men suffering from hypogonadism. With 
further characterization of this pathway it is even possible that the β-arrestin biased 
agonists may also mediate previously unknown fertility-enhancing mechanisms similar to 
those discovered for carvedilol and β2AR.  
The underlying mechanism behind KISS1R signal termination has not been fully 
elucidated but they are best understood for the prototypical GPCR, β2AR, (Ferguson, 
2001, Luttrell and Lefkowitz, 2002) and a similar series of intracellular events have been 
proposed for KISS1R (Fig. 1.5). Animal and human in vivo studies demonstrated 
evidence for KISS1R desensitization as a result of continuous kisspeptin exposure 
(Seminara et al. 2006, Plant et al. 2006, Thompson et al. 2006, Ramaswamy et al. 2007, 
Messager et al. 2005, Jayasena et al. 2010, George et al 2010, Chan et al. 2011). Using 
HEK 293 cells our lab provided evidence for GRK2 mediation of KISS1R desensitization 
following prolonged kisspeptin exposure in addition to rapid ligand-induced KISS1R 
internalization (Pampillo et al. 2009). Current studies described later, provide strong 
evidence for the role of β-arrestin in KISS1R desensitization. Other studies using 125I-
labelled kisspeptin in CHO cells confirmed that KISS1R underwent desensitization, 
ligand-induced internalization and further demonstrated that KISS1R was also rapidly 
resensitized to the plasma membrane from an intracellular receptor pool (Bianco et al. 
2011). This study also suggested that unlike most GPCRs, KISS1R does not undergo 
lysosomal degradation upon internalization but is degraded by a proteasome mediated 
process. While uncommon, proteasomal degredation has also been described for β2AR, 
µOR and δOR (Chaturvedi et al. 2001 and Shenoy et al. 2001). The physiological basis 
for better understanding KISS1R desensitization is as an alternative treatment to the 
GnRH-R desensitization therapies currently used to treat a range of disorders including 
CPP, endometriosis, uterine fibroids, sex-steroid dependent cancers (prostate and breast 
for example), PCOS. Current therapies involve an extended period of symptom “flare-
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up” which is contraindicated in some cancer patients for example. Also GnRH analogues 
lower sex-steroid levels below basal to castration level which affects bone structure. 
KISS1R desensitization has been shown to occur rapidly in vivo and KISS1 analogues do 
not lower sex steroid levels below basal levels. KISS1 analogues have also been proposed 
as alternatives for GnRH analogues currently used in fertility IVF and for the 
supraphysiological androgen treatment currently used in female contraceptives.  
1.8 Current study overview 
While KISS1/KISS1R signaling has been shown to critically regulate GnRH secretion 
and by extension HPG axis function and fertility, only a small number of studies have 
provided mechanistic insight into the KISS1R intracellular signaling cascades which 
regulate this physiological function. The overall goal of this study is to identify novel 
KISS1R-dependent mechanisms that regulate GnRH secretion and thereby fertility. It is 
our hope that these studies would lay the foundation on which future mechanistic and 
pharmacological investigations with KISS1R can build towards the development of more 
effective treatment strategies in patients. We hypothesized that KISS1R can signal 
through both Gαq/11 and Gαq/11 – independent pathways, the latter involving β-arrestins 
and investigated the following aims:  
a) KISS1R triggers LH secretion in mice that is in part, β-arrestin-dependent. 
b) The naturally occurring Gαq/11 uncoupled KISS1R mutant, L148S is capable of 
Gαq/11 – independent signaling measured by ERK1/2 phosphorylation.  
c) L148S-dependent Gαq/11 – independent ERK1/2 phosphorylation is partially β-
arrestin-dependent. 
d) β-arrestin mediates KISS1R homologous desensitization, as measured by InsP3 
accumulation.  
e) Endogenous Gαq/11-independent signaling in the Gnrh neuron is able to trigger 
puberty and sustain reproductive function in mice. 
f) KISS1R can signal through the Gαq/11 – independent pathway in the Gnrh neuron 
to stimulate LH, FSH and testosterone secretion.  
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2.1 Introduction 
Gonadotropin-releasing hormone (GnRH)-containing neurons originate in the olfactory 
placode during embryonic development and migrate along olfactory/vomeronasal nerves 
into the forebrain (Schwanzel-Fukuda et al. 1989, Wray 2001). They migrate caudally to 
final sites within the hypothalamus where they send projections to and secrete GnRH into 
the median eminence. GnRH is transported by the hypophysial portal vessels to reach 
anterior pituitary gonadotropes where it stimulates luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) synthesis and secretion and thereby reproduction (Belchetz et 
al. 1978, Clayton, 1987 and 1988, Savoy-Moore et al. 1987, Wildt et al. 1981, Kaiser et 
al. 1997, Thompson et al 2013 and 2014). In the past decade, hypothalamic kisspeptin 
(KISS1) and the kisspeptin receptor (KISS1R) have been established as the most potent 
positive regulators of GnRH secretion and are critical for the timely onset of puberty 
(Kotani et al 2001, Ohtaki et al. 2001, Muir et al. 2001, de Roux et al 2003, Seminara et 
al. 2003). Kisspeptin neurons in the arcuate nucleus (ARC) and anteroventral 
periventricular nucleus (AVPV) synapse directly on and activate KISS1R on the 
membrane of hypothalamic GnRH neurons (Messager et al. 2005, d’Anglemont de 
Tassigny et al. 2008, Gottsch et al. 2004, Smith et al. 2005, Han et al. 2005). This triggers 
GnRH secretion which in turn stimulates pituitary gonadotropin release that is necessary 
for driving gametogenisis and gonadal sex steroid production. (Irwig et al. 2004, 
Seminara et al. 2003, deRoux et al. 2003, Novaira et al. 2014).  
Pubertal onset requires the re-activation of GnRH secretion from a basally active state to 
increase the secretion of gonadal hormones responsible of the secondary sexual 
developments observed in adolescents (Seminara et al. 2003, Funes et al. 2003, deRoux 
et al. 2003, Han et al. 2005, Lapatto et al. 2007, Kirilov et al. 2013, Novaira er al. 2014). 
This role of KISS1/KISS1R in regulating reproduction is highly conserved in many 
species; mice, rats, pigs, sheep, goats, hamsters, horses, monkeys and humans. 
(Ramaswamy et al. 2007, Navarro et al. 2004, Tenenbaum-Rakover et al. 2007, Shahab et 
al. 2005, Keen et al. 2008, Roseweir et al. 2009). Humans bearing KISS1 or KISS1R 
mutations display impaired fertility and reproductive development and mice with genetic 
ablations of either Kiss1 or Kiss1r are infertile and recapitulate the hypogonadotropic 
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phenotype of affected humans, further demonstrating the critical importance of kisspeptin 
signalling for the proper functioning of the hypothalamic-pituitary-gonadal (HPG) axis.  
(Seminara et al. 2003, Funes et al. 2003, deRoux et al. 2003, Lapatto et al. 2007, Wahab 
et al. 2011 and Noel 2011). Kisspeptin administration in both humans and rodents has 
been used to stimulate or restore fertility thus revealing the therapeutic potential of this 
novel pathway (Dhillo et al. 2005, Jayasena et al. 2009, Jayasena et al. 2010, Navarro et 
al. 2004).  
When activated by KISS1, KISS1R couples to two G-proteins encoded by Gnaq (Gαq) 
and Gna11 (Gα11) and triggers the activation of phospholipase C (PLC) which in turn 
hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2) and results in inositol 1,4,5 
trisphosphate (InsP3) and diacylglycerol formation, calcium release, protein kinase C 
(PKC) mobilization, ERK1/2 activation, membrane depolarization and GnRH secretion 
(Kotani et al. 2001, Muir et al. 2001, Ohtaki et al. 2001, Castellano et al. 2006, Wacker et 
al. 2008, Liu et al. 2008, Szereszewski et al. 2010 and Babwah et al. 2012).  Current 
pharmacological drugs target GPCRs to not only potentiate their signaling but also to 
terminate it. One process by which GPCR signal termination occurs naturally is referred 
to as homologous desensitization. Once a GPCR undergoes homologous desensitization it 
is incapable of further G-protein signaling even in the constant presence of agonist 
(Ferguson, 2001, Ganietdinov et al. 2004). Members of two main protein families 
regulate homologous desensitization, namely, G-protein-coupled receptor kinases 
(GRKs) and β-arrestins (Ferguson, 2001 and Luttrell et al. 2002). While in vivo studies in 
humans and animals indicate that continuous kisspeptin exposure causes KISS1R 
desensitization, there are limited reports which investigate the underlying mechanism. 
(Belchetz et al. 1978, Seminara et al. 2006, Ramaswamy et al 2007, Thompson et al 
2006, Tovar et al 2006, d’Anglemont de Tassigny et al. 2008) To date we have identified 
a role for G protein-coupled receptor kinase 2 (GRK2) in mediating Gαq/11-dependent 
KISS1R signal termination and provided evidence to suggest β-arrestin involvement 
(Pampillo et al. 2009). We hypothesize and demonstrate here for the first time that β-
arrestins mediate KISS1R homologous desensitization. Since inositol phosphate (InsP3) is 
a secondary messenger formed in the Gαq/11-dependent KISS1R signaling cascade, we 
used InsP3 levels as an inverse indicator for KISS1R desensitization. Firstly we 
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investigated the effect of the loss or absence of β-arrestin in vitro, on InsP3 formation. We 
used two separate cellular systems and approaches, firstly, we used shRNA to stably 
downregulate β-arrestin expression in a well established GnRH neuronal cell line; GT1-7 
(Mellon et al. 1990) and secondly we used mouse embryonic fibroblasts (MEFs) derived 
from genetically modified mice completely lacking expression of either or both β-arrestin 
isoforms (Kohout et al. 2001, Bohn et al. 1998, Conner et al. 1997). Results from these 
experiments demonstrated that diminished β-arrestin expression corresponded to higher 
InsP3 levels over a range of kisspeptin concentrations which is interpreted as reduced 
KISS1R desensitization. To complement and further validate these experiments we used 
a reciprocal approach in a COS-7 cell line with low endogenous β-arrestin levels.  Over-
expression of β-arrestin in COS-7 corresponded to lower InsP3 formation interpreted as 
increased KISS1R desensitization. Taken together these results demonstrated that β-
arrestin mediates KISS1R homologous desensitization.  
In addition to their classical role in GPCR desensitization, β-arrestins also act as signal 
transducers in their own right. β-arrestin-dependent signaling has been described for 
many GPCRs including β2 adrenergic receptor, angiotensin II type 1A receptor and the 
vasopressin (V2) receptor (DeFea 2008, Kovacs et al. 2009 and Luttrell et al. 2010). β-
arrestins have been shown to bind a number of signaling molecules including ERK1/2, 
Ras and Raf1 thereby acting as a molecular scaffold to facilitate G-protein independent 
interactions between a specific GPCR and these major signaling molecules (Luttrell et al. 
1999, DeFea et al. 2000 and Luttrell and Lefkowitz 2002). Previous studies in the 
Babwah laboratory using in vitro cell systems demonstrated that KISS1R can bind β-
arrestin and signal to ERK1/2 in a β-arrestin dependent manner (Szereszewski et al. 2010 
and Pampillo et al. 2009).  Since ERK1/2 mediates GnRH secretion we hypothesized that 
β-arrestin would also mediate KISS1R triggered GnRH secretion (Castellano et al. 2006). 
To test this hypothesis we measured LH secretion, an established surrogate marker for 
GnRH secretion in mice lacking either β-arrestin-1 or β-arrestin-2 (Clarke et al. 1982, 
Messanger et al. 2005, Novaira et al. 2014). The results revealed that kisspeptin-
dependent LH secretion was significantly diminished relative to wild-type mice thus 
supporting the hypothesis that β-arrestin mediates kisspeptin-induced GnRH secretion.  
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To date, a small but growing number of naturally occurring KISS1R “loss-of-function” or 
“inactivating” mutations (Nimiri et al. 2011, Noel et al 2011 and Wahab et al. 2011) and 
one “gain-of-function” mutation (Teles et al. 2008) have been identified. At the 
physiological level, the term “loss-of-function” reflects the association with idiopathic 
hypogonadotropic hypogonadism (IHH) (Seminara et al. 2003); a disorder of the 
hypothalamus or pituitary that is characterized by the absence of spontaneous sexual 
maturation in the presence of low or inappropriately normal gonadotropin levels in 
humans. At the cellular level, KISS1R “loss-of-function” is characterized by its 
diminished capacity to activate the Gαq/11 signaling pathway. Based on our finding that, 
in addition to using Gαq/11, Kiss1r also employs the β-arrestin pathway to mediate LH 
secretion, patients bearing some KISS1R mutations might continue to secrete LH, albeit 
at diminished levels. If that is so, such patients might display a less severe form of IHH 
and may even experience a reversal of IHH. One of the first loss-of-function KISS1R 
mutants identified was L148S. L148S was isolated from a consanguineous Saudi Arabian 
family in whom members bearing the mutated receptor gene in the homozygous state 
were diagnosed with IHH and infertility (Bo-Abbas et al. 2003, Seminara et al. 2003). In 
an in vitro assay, L148S was shown to be strongly defective in triggering InsP3 formation 
and therefore “functionally-uncoupled” from Gαq/11 at kisspeptin concentrations that 
triggered a maximum response with WT KISS1R (Seminara et al. 2003). A subsequent 
study showed that, while L148S was unable to trigger the ligand-induced catalytic 
activation of Gαq/11 and signal via this pathway, it remained physically coupled to Gαq/11 
(Wacker et al. 2008). That study also showed that L148S had a similar intracellular 
activity to WT KISS1R in terms of expression level, kisspeptin binding, membrane 
localization and interaction with various intracellular proteins. Consistent with this 
finding was our observation that, like WT KISS1R, L148S also physically associated 
with β-arrestins (Szereszewski et al. 2010). Another naturally occurring KISS1R loss-of-
function mutant associated with IHH and infertility, L102P, was discovered but based on 
a detailed phenotypic and endocrine profiling of five patients bearing the mutation, the 
authors observed that gonadotropic deficiency was highly variable, ranging from partial 
to complete (Tenebaum-Rakover et al. 2007). L102P was shown to be strongly uncoupled 
from InsP3 formation at the supra-physiological concentration of 1 µM Kp (Horikoshi et 
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al. 2003), leading the authors to conclude that KISS1R loss-of-function mutations do not 
necessarily cause complete gonadotropic deficiency (deRoux et al. 2003, Tenebaum-
Rakover et al. 2007, Nimiri et al. 2011). While it was clearly recognized that, based on 
InsP3 formation, L102P was a loss-of-function mutant that only delayed pubertal 
development, the mechanism by which this was possible was not understood. We 
hypothesize that some Gαq/11-uncoupled KISS1R mutants like L148S and L102P retain 
some ability to signal, although such signaling would be diminished. Such signaling 
should be sufficient to trigger some degree of GnRH secretion and activation of the 
gonadotropic axis, albeit to a lesser extent. To test this hypothesis, L148S was expressed 
in human embryonic kidney (HEK) 293 cells and it was confirmed that, while it was 
strongly uncoupled from the Gαq/11 pathway, it retained the ability to trigger significant 
ERK1/2 phosphorylation following kisspeptin treatment (Ahow et al. 2014). The Babwah 
lab previously demonstrated that wild-type KISS1R can bind and signal to ERK1/2 in a 
β-arrestin dependent manner and here we showed that KISS1R stimulation of LH 
secretion is in part, β-arrestin-dependent (Szereszewski et al. 2010 and Ahow et al. 2014). 
We therefore hypothesized that β-arrestin also mediated the kisspeptin triggered ERK1/2 
phosphorylation observed with the Gαq/11-uncoupled mutant, L148S. When expressed in 
MEFs completely lacking β-arrestin expression, L148S lost the ability to activate 
ERK1/2 following kisspeptin stimulation confirming that this response is β-arrestin-
dependent (Ahow et al. 2014). Taken together with the in vivo results we can conclude 
that KISS1R signals via both Gαq/11 and β-arrestin to regulate GnRH secretion and that 
some KISS1R mutants that are uncoupled from Gαq/11 retain the ability to signal 
independently of Gαq/11, likely via β-arrestin, to mediate GnRH secretion. 
So far, our in vitro results demonstrated that KISS1R signals strongly through β-arrestin 
and while absence of either β-arrestin isoform in vivo reduced kisspeptin-dependent LH 
secretion, overall fertility of these mice was unaffected (Ahow et al. 2014). This can be 
attributed to isoform compensation where the expressed β-arrestin isoform functionally 
compensates for the one that is absent (Lohse et al. 1992, Kohout et al. 2001, Zhang et al. 
2010). Therefore a mouse model completely lacking both β-arrestin isoforms would be 
useful for investigating the importance of β-arrestins on kisspeptin-dependent LH 
secretion however these mice are neonatal lethal and conditional models are not available 
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(Zhang et al. 2010, Kohout et al. 2001). For this reason instead of looking at the role of 
only β-arrestin signaling, we took a slightly different approach to investigate the 
significance of Gαq/11-independent signaling downstream of KISS1R on LH secretion and 
fertility. In order to accomplish this we created a conditional GnRH-neuron specific 
Gαq/11 double knockout mouse (Gnaq
d/d
) by interbreeding a Gnaq
fl/fl
;Gna11
-/-
 mouse line 
with a well established Gnrh-Cre line (Offermanns et al. 1997 and Yoon et al. 2001). 
While the Gαq/11 pathway downstream of the KISS1/KISS1R system is the most 
characterised cascade for GnRH release, based on the combination of in vivo and in vitro 
results described above, we hypothesize that in the Gnaq
d/d
 mouse, KISS1R would still be 
able to trigger kisspeptin-dependent LH secretion via Gαq/11 independent mechanisms, 
albeit at a diminished level. We further hypothesize that in the absence of exogenous 
stimulation Gnaq
d/d 
mice would be sub-fertile and not completely infertile due in part to 
endogenous KISS1R mediated GnRH secretion via Gαq/11 independent pathways. After 
creating the Gnaq
d/d 
mice we first ensured that loss of Gαq and Gα11 did not affect GnRH 
neuronal development and migration. After creating Gnaq
d/d
 and littermate control mice 
we performed extensive characterization of the spatial and temporal expression of Cre 
recombinase activity. We confirmed that recombination occurred well before puberty in 
e18 mice and that it was specific to hypothalamic GnRH neurons. To investigate if Gαq/11 
independent mechanisms were sufficient to maintain some level of fertility we assessed 
various phenotypic and anatomic indicators of puberty and reproductive function. While 
there was no significant difference in body weight between Gnaq
d/d 
mice and their 
littermate controls, both male and female Gnaq
d/d 
mice displayed delayed onset of 
puberty and significantly smaller reproductive organs. Gnaq
d/d 
females demonstrated 
irregular estrous cycles and were completely infertile while Gnaq
d/d 
males were able to 
impregnate and sire litters with 60% of wild-type female partners. These results indicate 
that endogenous Gαq/11- independent mechanisms were sufficient to sustain some degree 
of GnRH neuron function and secretion. Next we wanted to investigate if kisspeptin-
stimulated GnRH release was also still possible in the Gnaq
d/d 
mice. We found that while 
kisspeptin triggered diminished levels of LH, FSH and testosterone in Gnaq
d/d 
mice 
compared to littermate controls (hypogonadotropic), this response was still significantly 
greater than vehicle treatment. We propose that this diminished Gαq/11 independent 
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response is sufficient for partial functioning of the HPG axis allowing for delayed 
puberty and sub-fertility observed in the Gnaq
d/d 
mice. Furthermore, when pre-treated 
with a GnRH inhibitor, antide, (Gottsch et al. 2004 and Dansforth et al. 2005) kisspeptin 
is no longer able to trigger gonadotropin secretion in Gnaq
d/d 
and control littermates 
confirming that the response observed in Gnaq
d/d 
mice could only be due to upstream 
kisspeptin-triggered GnRH secretion.  
Overall, we have demonstrated that KISS1R is able to signal independently of Gαq/11 
proteins to regulate reproduction and fertility. This has great clinical significance for 
patients suffering from idiopathic hypogonadotropic hypogonadism (IHH), a condition 
characterized by the absence of the timely onset of pubertal maturation in the presence of 
low or inappropriately normal gonadotropin levels (Seminara et al 2003, deRoux et al. 
2003, Nimiri et al. 2011, Wahab et al. 2011, Noel et al 2011). Some of these IHH patients 
carry inactivating KISS1R mutations which completely impair the receptor’s ability to 
activate Gαq/11 signaling in the GnRH neurons and as such disrupts normal HPG axis 
function (Tenebaum-Rakover et al. 2007 and Seminara et al 2003). Studies of these 
patients revealed that while they were infertile, gonadotropic deficiency was highly 
variable, ranging from partial to complete and that for some, a reversal of the IHH 
symptoms occurred later in life. These studies therefore suggested that KISS1R 
inactivation does not impede sexual maturation, rather just delays the onset however the 
underlying mechanism was not understood (Tenebaum-Rakover et al. 2007). Here we 
describe a novel Gαq/11-independent pathway downstream of KISS1R in the GnRH 
neuron where kisspeptin is still able to trigger significant, albeit diminished, 
gonadotropin secretion and that this pathway is regulated by β-arrestins to some extent. 
We therefore propose that some patients bearing KISS1R mutations that uncouple the 
receptor from Gαq/11 still retain some capacity for Gαq/11-independent GnRH secretion, 
through β-arrestins. We suggest this as a potential molecular explanation for the variable 
gonadotropin levels and symptom reversal reported for some patients diagnosed with 
IHH. This is an important finding that not only provides novel insight at the molecular 
level of KISS1R signaling in the GnRH neuron but also identifies a potentially new 
therapeutic approach by which specific cases of clinical infertility can be treated.  
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2.2 Materials and Methods 
2.2.1 Materials 
Kisspeptin 10 (KP-10, #445888, human metastin 45-54) was purchased from Calbiochem 
(La Jolla, USA). KP-54 (#SCP0186, human metastin 68-121), Buserelin (#B3303, 
GnRH-R agonist) and Antide (#A8802, GnRH antagonist) were all purchased from 
Sigma (St. Louis, MO, USA). Unless stated, all other biochemical reagents were acquired 
from Sigma, Fisher, and VWR Scientific. The following plasmid constructs were 
described previously: untagged WT KISS1R (formerly referred to as GPR54) and 
untagged L148S (Seminara et al. 2003); FLAG-KISS1R (WT) (formerly referred to as 
FLAG-GPR54) (Pampillo et al. 2009); WT KISS1R-EYFP (Szereszewski et al. 2010); 
GFP-PH-PLC-δ1 (Babwah et al. 2012) and myc-KISS1R (WT) (Min et al. 2014). FLAG-
L148S and L148S-EYFP were created by conducting site-directed mutagenesis 
(QuickChange kit, Stratagene, CA, USA) to introduce the mutation in the corresponding 
epitope-tagged WT receptor. Using the previously constructed myc-L148S-PCS2+ (Gill 
et al. 2008), myc-L148S was subcloned into the pcDNA3 expression vector. Proteome 
Profiler kit (#ARY003B) was purchased from R & D systems (Minneapolis, MN, USA) 
and was used according to manufacturer’s instructions to detect an array of human-
phospho-kinases. Human Gnaq and Gna14 were purchased from Origene, (SC_125360 
and SC_122675 respectively). All constructs were subjected to automated DNA 
sequencing to confirm sequence integrity. 
2.2.2 Animal Husbandry and Genotyping  
Animals were housed at the London Regional Cancer Program Animal Facility (London, 
Ontario, Canada) at controlled temperature and a 12 h light-dark cycle. Animal care and 
handling were done according to the guidelines of the University of Western Ontario 
(Canada) Animal Care Committee approved by the Canadian Council on Animal Care 
(See Appendix 3). 
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2.2.3 Arrb1-/- and Arrb2-/- mice  
Genetically modified mice lacking β-arrestin-1 and -2 (Arrb1-/- and Arrb2-/- respectively) 
were generated as previously described (Conner et al. 1997 and Bohn et al. 1999). 
Homozygous Arrb1
-/-
 and heterozygous Arrb2
+/-
 mice were obtained from R. J. Lefkowitz 
(Duke University Medical Center, Durham, NC, USA). The Arrb1
-/-
 and Arrb2
-/-
 lines 
were in the C57BL/6J and 129/S1/SvImJ backgrounds, respectively. Arrb2
-/-
 mice and 
their wild-type littermates (Arrb2
+/+
) were generated by breeding heterozygous animals. 
Mouse genotyping was performed by PCR using Arrb2-WT-forward 
GATCAAAGCCCTCGATGATC (intron 2) and Arrb2-KO-forward 
GCTAAAGCGCATGCTCCAGA (Neo), which are specific for wild type (WT) and 
knockout (KO), respectively, and the primer Arrb-2-reverse 
ACAGGGTCCACTTTGTCCA (exon 3), which is in common for both WT and KO. 
PCR products are 605 bp and 300 bp for Arrb2
+/+
 and Arrb2
-/-
 alleles, respectively. 
Homozygous Arrb1
-/-
 mice were crossed to WT C57BL/6J mice to generate a segregating 
colony. Due to the design of the targeting sequences, Arrb1
-/-
 mice could not be 
distinguished from Arrb1
+/-
 mice by PCR analysis as was done for Arrb2 segregating 
populations. Instead, segregating Arrb1 colonies were genotyped at Transnetyx, Inc. 
(Cordova, TN) based on the determination of Neo copy numbers (Conner et al. 1997) and 
data were verified by western blotting. All experiments were performed using 8 week-old 
post-pubertal male mice to preclude the effects of the estrous cycle on GnRH secretion in 
females. 
2.2.4 Generation of mice lacking both Gαq and Gα11 in GnRH 
neurons:  (Gnaqfl/fl;Gna11-/-;Gnrh-Cre) 
Gnaq
fl/fl
;Gna11
-/-
 and Gnrh-Cre mice were generated as previously described Offermans 
et al. 1997, Wintermantel et al. 2006, Yoon et al. 2005 and Skynner et al. 1999). 
Gnaq
fl/fl
;Gna11
-/- 
mice were obtained from Dr. S. Offermanns (University of Heidelberg, 
Heidelberg, Germany) and Gnrh-Cre mice were obtained from Dr. C. Dulac (Harvard 
University, Cambridge, MA, USA). The Gnaq
fl/fl
;Gna11
-/-
 and Gnrh-Cre lines were in the 
C57BL/6J background. The parental line was created by crossing the Gnrh-Cre mice 
(Yoon et al. 2005) to Gnaq
fl/fl
;Gna11
-/-
 mice (Offermans et al. 1997). Resulting progeny 
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of genotype Gnaq
fl/+
;Gna11
-/- 
;Gnrh-Cre were crossed with Gnaq
fl/fl
;Gna11
-/- 
 to generate 
a segregating population with both experimental and control genotypes (Pampillo and 
Babwah, unpublished data). The experimental mice contained a GnRH neuron specific 
deletion of Gnaq in the background of full body deletion of Gna11: Gnaq
fl/fl
;Gna11
-/- 
; 
Gnrh-Cre (hereafter referred to as dKO or Gnaq
d/d
). The littermate controls were 
Gnaq
fl/fl
; Gna11
-/-
 (hereafter referred to as control or Gnaq
fl/fl
).   
Mouse genotyping was performed by four PCR reactions using the following primers 
(listed 5’-3’) ; Gnaq forward GCATGCGTGTCCTTTATGTGAG and Gnaq reverse 
AGCTTAGTCTGGTGACAGAAGC amplify a 600 bp or 700 bp band corresponding to 
the wild-type (Gnaq
+/+
) or floxed allele (Gnaq
fl/fl
) respectively. Gna11-WT forward 
AGCATG CTGTAAGACCGTAG and Gna11-WT reverse 
GCCCCTTGTACAGATGGCAG amplify a 820 bp band corresponding to the wild-type 
allele for Gna11
+/+
. Gna11-KO forward CAGGGGTAGGTGATGATTGTGC and 
Gna11-WT reverse GACTAGTGAGACGTGCTACTTCC amplify a 450 bp band 
corresponding to the deleted allele for Gna11
-/-
. Gnrh-Cre forward 
CTGGTGTAGCTGAT GATCCG and Gnrh-Cre reverse 
ATGGCTAATCGCCATCTTCC amplify a 354 bp band corresponding to the inserted 
Cre cassette under the regulation of the Gnrh promoter.  
Analysis of Cre recombination was done by PCR amplification of genomic DNA from 
hypothalamic tissues using primers (listed 5’-3’) GCATGCGTGTCCTTTATGTGAG 
and TGGATATTCAAAGTATCACACTCAC which gave a 2.3 kb product that 
corresponded to the floxed allele (Gnaq
fl/fl
) and a 0.5 kb product that corresponded to the 
recombined allele (Gnaq). Because recombination occurs in the GnRH neurons only 
and hypothalamic tissue contains a mix of GnRH and non-GnRH neurons, Gnaq
d/d 
mice 
would have both the 2.3 kb and 0.5 kb bands (Wettschureck et al. 2001). RT-PCR 
analysis of Gnrh gene expression was done to show that the hypothalamic tissue 
collected contained GnRH expressing neurons. The following primers (listed 5’-3’) were 
used; Gnrh forward; GCATTCTACTGCTGACTGTGTGTT and Gnrh reverse; 
GTTCTGCCATTTGATCCACCT and a resulting 144 bp product corresponded with the 
Gnrh allele. To further assess whether Cre recombinase was expressed, RNA extracted 
101 
 
from the hypothalamus, pituitary and ovaries of experimental and control mice was used 
in reverse transcription-PCR (RT-PCR) with the primers 5’-GCATTACCGGTCG 
ATGCAACGAGTGATGAG-3’ and 5’- GAGTGAAC GAACCTGGTCGAAATCAG 
TGCG-3’ and a 300 bp product corresponded with Cre expression.   
2.2.5 Developmental Characterization of Gnrh-Cre expression in 
mice 
The well-characterized GnRH-Cre line targets essentially all GnRH neurons (Yoon et al. 
2005 and Wintermantel et al. 2006). Further characterization was necessary however, 
since it was essential in this study for Cre recombination occur before puberty which 
coincided with approximately post-natal day 35 in the wild-type strain used in this study. 
To achieve this, Gnrh-Cre mice were crossed with a ROSA26::LoxP-Stop-LoxP-Green 
Flourescent Protein (GFP) reporter line (Soriano1999). The resulting progeny of 
genotype ROSA26::LoxPStop-LoxP-GFP; Gnrh-Cre were sacrificed at E18, 1,2 and 3 
weeks of age. Mice were transcardially perfused with 4% paraformaldehyde (PFA). 
Brains were removed and post-fixed for 3 h in 8% PFA; then infiltrated with 30% 
sucrose. Coronal sections, 30 µm thick, were cut on a Leica freezing microtome and 
blocked in 10% normal donkey serum for 1 h at room temperature and incubated 
overnight at 4 °C in a rabbit anti-GnRH primary antibody (HU60, donated by Dr. H. 
Urbanski). The primary antibody was used at a concentration of 1:1000.  
Following primary antisera, tissue sections were washed in PBS and blocked in 10% 
normal donkey serum then incubated at room temperature in secondary antisera for 2 h 
(AlexaFlour 568, 1:2000 goat anti-rabbit, Invitrogen). Sections were subsequently stained 
with Hoechst (Invitrogen) 1:10,000 for 3 min to detect nuclei and then washed in PBS 
and mounted on positively charged microscope slides and allowed to dry before being 
cover-slipped with Immunomount (Fisher Scientific, USA).  Sections were viewed and 
images captured using Olympus Fluoview 1000 laser scanning confocal microscope 20X 
and 40X objectives were used. Colocalization studies were performed using multiple 
excitation (405, 488, 559) and emission (band pass 425-475, 500-545 nm and 575-675 
nm for Hoechst, endogenous ROSA26::GFP, and AlexaFluor 568 respectively) filter sets. 
Multi-colour images were acquired in the sequential acquisition mode to avoid cross-
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excitation. Ten consecutive coronal sections per brain, spanning the rostral-caudal 
hypothalamic axis, were analyzed by confocal microscopy where neuronal soma (S) were 
scored for green (GFP) and red (GnRH) signals.  
2.2.6 Analysis of GnRH neurons by immunohistochemistry in 
Arrb1-/- , Arrb2-/-, Gnaqd/d mice and their respective littermate 
controls.  
Following CO2 euthanasia, mice were transcardially perfused with 0.08 % heparinized 
saline followed by 4 % paraformaldehyde (PFA). Brains were removed and post-fixed 
overnight in 4% PFA; then embedded in 5 % agarose and cut into 50 µm thick coronal 
sections using a vibrating microtome (Leica VT1000S). Tissue sections were then 
blocked in 5 % normal goat serum for 1 h at 4 °C and incubated over two nights at 4 °C 
in primary antisera with antibodies directed against the GnRH peptide. The following 
anti-GnRH primary antiserum were used, polyclonal EL14 (Ellinwood et al. 1985) at a 
1:5,000 dilution, polyclonal PA1-122, (Affinity BioReagents, Golden, CO) at a 1:300 
dilution and monoclonal QED, (19304, QED bioscience, San Diego, CA) at a 1:5,000 
dilution. For eight week old Arrb1
-/-
 and Arrb2
-/- 
mice primary antiserum EL14 was used 
and alternate sections were incubated in either PA1-122 or QED. For E18 Arrb1
-/-
;Arrb2
-
/- 
mice, and for eight week old Gnaq
d/d
 and Gnaq
fl/fl
 mice, only primary antiserum EL14 
was used.  
Following primary antisera, tissue sections were incubated at room temperature in 
secondary antisera for 2 h. For sections incubated in EL14 or PA1-122, a biotin 
conjugated donkey anti-rabbit secondary antibody (Jackson Immunoresearch, West 
Grove, PA) was used at 1:2,500. For sections incubated in the QED, a biotin conjugated 
donkey anti-mouse secondary antibody (Jackson Immunoresearch, West Grove, PA) was 
used at 1:5,000. Secondary antibody labeling was amplified using a Vectastain ABC Elite 
kit (Vector Laboratories, Burlingame, CA) for 1h at room temperature. Reaction product 
was visualized after 5 min incubation in Tris-buffered saline (TBS, pH 7.5) containing 
0.025% diaminobenzidine, 0.02% nickel and 0.02% H2O2. Free-floating tissue sections 
were washed in TBS mounted on gelatin-coated glass microscope slides and allowed to 
dry before being cover-slipped with Permount (Fisher Scientific, USA). Sections were 
103 
 
viewed and images were captured using an Olympus BH2 microscope with an Insight QE 
digital camera with Spot Advanced Software. Coronal brain slices along the rostral-
caudal axis were ordered and aligned relative to the organum vasculosum of the lamina 
terminalis (OVLT) and an investigator blind to genotype manually counted GnRH 
neuronal cell bodies using a 40x objective (Gill et al. 2008). The effect of genotype on 
the number and location of GnRH neurons was determined by 2-way ANOVA as a 
repeated measure using SPSS software (SPSS Inc., Chicago, IL). Values are reported as 
mean ± SEM and P < 0.05 was considered statistically significant.  
2.2.7 Buserelin (GnRH-agonist) and KP-54 treatment in Arrb1-/- , 
Arrb2-/- mice and respective littermate controls.  
Eight week-old male mice (Arrb1
-/-
, Arrb2
-/- 
and their respective WT littermate controls) 
were administered 3 ng Buserelin/g body weight (for the Buserelin-challenge) or 100 
nmol KP-54/Kg body weight (for the Kp-challenge). Both KP-54 and Buserelin were 
delivered into the abdominal peritoneal cavity referred to as an intraperitoneal (i.p.) 
injection. For the Buserelin- and Kp-challenged mice, 20 and 60 min later, respectively, 
mice were anesthetized by CO2 exposure followed by cervical dislocation and blood was 
collected immediately after by cardiac puncture and serum extracted for hormone assays 
as described later.  
2.2.8 KP-54 and antide (GnRH-antagonist) treatment in Gnaqd/d 
mice and littermate controls.  
To avoid cycle-dependent LH surges from interfering with kisspeptin-induced LH 
secretion, seven week old virgin Gnaq
d/d
 and Gnaq
fl/fl
 female mice were anesthetized 
using 1.5% isoflurane (4% for induction) in an oxygen/nitrous oxide 30% /70% mixture 
and an ovariectomy was performed by dorsal incision as described by Strom et al. 2012. 
Females were allowed to recover for 14 days post-surgery. Ovariectomized females and 
males 9 weeks of age were administered a single i.p. injection of 100 µl of vehicle 
(saline) or 100 µl of 100 nmol Kp-54/Kg body weight (d’Anglemont de Tassigny et al. 
2008 and Kirilov et al. 2013). 1 h later, mice were anesthetized by CO2 exposure 
followed by cervical dislocation and blood was collected immediately thereafter by 
terminal cardiac puncture (Hoff 2000).  
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In a separate cohort of nine week old ovariectomized females and males, mice received 
two 100 µl subcutaneous injections of the GnRH antagonist, antide (Sigma A8802) (1.25 
ug/g body weight dissolved in sterile saline). Antide was administered at 24 h and 1 h 
before i.p. injection of 100 µl of vehicle (saline) or 100 µl of 100 nmol KP-54/Kg body 
weight (Barkan et al. 2004, Gottsch et al. 2004 and Dansforth et al. 2005). 1 h after the 
final injection blood was collected by terminal cardiac puncture.  
2.2.9 Serum hormone Assays.  
Blood was allowed to clot at room temperature for 120 min. The clot was then removed 
with a wooden applicator stick and the remaining serum centrifuged at 2000 X g for 20 
min at RT. Serum was stored at -80 
o
C and analyzed for LH, FSH and testosterone by the 
Endocrine Technology and Support Lab (ETSL), Oregon National Primate Research 
Center (Beaverton, OR, USA). Mouse serum LH was analyzed by a traditional double-
antibody RIA procedure similar to that described previously (Pau et al. 1986). The 
detection limit of the assay was 0.1-0.2 ng/ml. The interassay variation was <12% and the 
intra-assay variation was <8%. Mouse serum FSH was analyzed by a traditional double-
antibody RIA procedure similar to that described previously (Pau et al. 1986). The 
detection limit of the assay was 0.01-0.02 ng/tube, or 0.1-0.2 ng/ml. The interassay and 
intrassay variation was less than 12 % and 8%, respectively.  Mouse serum testosterone 
(T) was measured by ether extraction and radioimmunoassay (RIA) as described 
previously (Rasmussen et al. 1984). Hormonal values were corrected for extraction losses 
determined by radioactive trace recovery at the same time with sample extraction; hot 
recovery usually is better than 90%. The sensitivity was 5 pg/tube for T RIA. The effect 
of administered drugs on serum hormone levels was determined by Student’s t-test using 
GraphPad Prism software (Graph Pad, San Diego, CA). Values are reported as ± SEM 
and P < 0.05 was considered statistically significant. 
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2.2.10 Pubertal onset, estrous cycle and fertility assessment of 
Gnaqd/d mice and littermate controls.  
 Mice were genotyped and weaned by 3 weeks of age. Various phenotypic measurements 
were taken from male and female mice from about 2 weeks to 16 weeks of age. Body 
weight (g) was recorded weekly while mice were examined daily from 2 weeks until day 
of vaginal opening in females and preputial separation in males. Anogenital distance 
(mm) was recorded every 3 -7 days in males. Vaginal opening, preputial separation and 
anogenital distance are established indices for assessing sexual maturation in mice 
(Lapatto et al 2007, Herbison et al. 2008 and Chan et al. 2009). Vaginal opening occurs 
with increased estrogen secretion (Caligioni 2009, Herbison et al. 2008, Ojeda and 
Urbanski 1994 and Nelson et al. 1982). Preputial separation and anogenital distance are 
both dependent on testosterone exposure during puberty (Lapatto et al. 2007, 
Parakarainen et al. 2005, Novaira 2014). Assessment of preputial separation consisted of 
the application of gentle pressure to manually retract the prepuce (Noviara et al. 2014 and 
Korenbrot et al. 1977).  
Estrous cycle assessment was performed using a combination of visual observation of 
vulva appearance and examination of vaginal cytology following vaginal lavage and 
crystal violet staining. The visual method has been fully described in Byers et al. (2012) 
and Champlin et al. (1973) and was used to confirm cytological assessment. Vaginal 
smears were collected between 08:00 – 10:00 daily for 17 days as described by Caligioni 
(2009) using a vaginal lavage technique where a small volume of saline (0.9%) was used 
to gently flush the vagina then placed on a slide and stained with 0.1% crystal violet 
solution. Care was taken to not penetrate the vaginal orifice since pseudopregnancy can 
result (McLean et al. 2012 and Adler et al. 1970). Estrous cycle stage, classified as 
proestrus, estrus and metestrus/diestrus, was determined based on the proportion of the 
following three cell types found in the smear; cornified epithelial, nucleated epithelial 
and leukocytes (Novaira et al. 2014, Byers et al. 2012, McLean et al. 2012 and Caligioni 
2009). Estrous cycle was examined in the same female mice over two post-pubertal 
periods, 8-11 weeks of age and 13-16 weeks of age to assess if a regular pattern of 
cyclicity developed at a later age in the experimental females. Number of oestrus phases 
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during the 17 day period was compared between experimental and control mice with 
unpaired two-tailed t-tests.  All phenotyping experiments were done without the 
knowledge of the genotype. 
Intact 7 week old male and female Gnaq
d/d
 mice were placed in a cage with a wild-type 
mouse of the opposite gender for 18 – 21 days and proven fertility and pregnancy in 
females was noted (Lapatto et al. 2007).   
2.2.11 Anatomy and histology of reproductive organs for Gnaqd/d 
mice and littermate controls  
All mice used were 8-16 weeks of age and were intact and previously untreated and 
unmated. Ovaries and uteri were taken from females in the metestrus stage since this 
stage is the clearest to identify by vaginal cytology and testes were taken from the males. 
Total body weight (g) and tissue appearance and fresh weight (mg) were noted. Tissues 
were fixed in 4% paraformaldehyde-PBS overnight then dehydrated in 70% ethanol for 
24 h prior to paraffin embedding, sectioning (5 µm thick) and staining for hematoxylin 
and eosin by the London Health Science Centre Pathology Core (London, ON, Canada). 
Ovarian and testicular sections were examined and photographed with an Aperio 
ScanScope XT in conjunction with ImageScope software.  
2.2.12 Quantitative real-time PCR for Gnaqd/d mice and littermate 
controls 
Real-time qPCR was used to investigate the expression of genes in the hypothalamus and 
pituitary of control and dKO mice. The genes chosen for investigation are major 
regulators of the neuroendocrine reproductive axis. RNA was isolated from mouse tissues 
using the Qiagen RNeasy mini kit according to manufacturer’s instructions (Qiagen, 
Missassauga, ON, Canada).  RNA concentration was determined by optical density 
(260/280 nm) on an N-1000 spectrophotometer (NanoDrop, Wilmington, DE). 1.0 µg 
RNA was reverse-transcribed using SuperScript II (Invitrogen, Burlington, ON, Canada). 
Reactions were performed according to manufacturer’s recommendations using random 
hexamer primers (Amersham, Piscataway, NJ). Real-time qPCR was performed in 
duplicate for each sample and done a total of three independent times using IQ SYBR 
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Green Master Mix (Bio-Rad Laboratories). The primers used are listed in the following 
Table 2.1.  
To determine PCR efficiency, a 10-fold serial dilution of cDNA was performed as 
described previously (Wong et al. 2005).  All sample reactions were performed as five 
independent trials with accompanying serial dilution standard curves and water blanks for 
each gene and treatment time. Each gene was normalized to Actb as an internal control 
and dKO values were presented relative to WT using the Pfaffl method (Pfaffl, 2001). 
Reaction efficiencies used in these calculations were derived from the standard curves 
and PCR conditions were optimized to generate >95% efficiency.  
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Table 2.1: Primers used for qPCR analysis in Gnaq
d/d
 mice and littermate controls.  
 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
Expected 
product size 
(bp) 
Kiss1r 
GCCACAGACGTCACTTTC
CTAC 
CGGGAACACAGTCACAT
ACCA 
186 
Kiss1 
AGCTGCTGCTTCTCCTCT
GT 
AGGCTTGCTCTCTGCATA
CC 
140 
Gnrhr1 
GCTCTCAAGGATGAAGGT
GCTT 
CCAGGCTAATCACCACCA
TCAT 
197 
Gnrh1 
CCTGGGGGAAAGAGAAA
CACT 
TCACAAGCCTCAGGGTC 
AATG 
246 
Lhb (LH β) 
TGTCCTAGCATGGTCCGA
GT 
AGGAAAGGAGACTATGG
GGTCTA 
138 
Fshb (FSH β) 
AGAGAAGGAAGAGTGCC
GTTTCTG 
ACATACTTTCTGGGTATT
GGGCCG 
118 
Gnaq 
GGTGTCTGCTTTTGAGAA
TCCATATG 
ATTCGCTAAGCGCTACTA
GA 
344 
Gna11 
GGAGAACATCATCTTCAG
GATGG 
CAGGGGTAGGTGATGAT
TGTGC 
201 
Gna14 
TCACTGCACTCTCTAGAG
ACC 
GAAAGAGGGCATGGCGA
TAC 
155 
Actb (β-actin) 
CTGTCGAGTCGCGTCCAC
CC 
ACATGCCGGAGCCGTTGT
CG 
128 
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2.2.13 Cell culture and Transfection 
Human embryonic kidney cells (HEK 293) and African Green Monkey embryonic 
kidney cells (COS-7) cells were from the American Tissue Culture Collection. HEK 293 
cells were cultured in MEM supplemented with 10% (v/v) FBS, 1% (v/v) non-essential 
amino acids and gentamicin (5 µg/ml). The immortalized mouse GnRH-neuronal cell line 
(GT1-7) was obtained from Pamela Mellon (University of California, San Diego) 
(Mellon et al. 1990). COS-7 and GT1-7 cells were grown in monolayer in DMEM 
supplemented with 10% FBS, 4.5 mg/ml glucose, 1% penicillin/streptomycin (v/v) and 
1% (v/v) sodium pyruvate. Mouse embryonic fibroblast (MEF) cell lines derived from 
the β-arrestin-1 knockout, β-arrestin-2 knockout, β -arrestin-1/2 double knockout mice 
(Kohout et al. 2001). The β-arrestin-2 single and β-arrestin-1/2 double knockout mice 
were derived from the same WT strain and accordingly, the same WT MEFs (referred to 
as WT2) serve as their WT parents in this study. MEF β-arrestin-1 knockout, β-arrestin-2 
knockout, β -arrestin-1/2 double knockout  and their corresponding wild-type parental 
cell line were maintained in DMEM supplemented with 10% FBS, 1% 
penicillin/streptomycin (v/v) and 1%(v/v) non-essential amino acids. All cell lines were 
maintained at 37°C in a humidified atmosphere containing 5% CO2. FBS was purchased 
from Sigma (St. Louis, MO, USA); all other reagents were from Life Technologies 
(Burlington, ON, Canada). All cells were transfected with plasmid DNA constructs as 
detailed in the results and figures. 
HEK 293 and COS-7 cells were transiently transfected with plasmid DNA using a 
modified calcium phosphate method as previously described (Bhattacharya et al. 2004). 
When confluent, all MEF cell lines were transiently transfected with either 20 µg of 
KISS1R-EYFP or L148S-EYFP cDNA by electroporation using the Bio-Rad Gene Pulser 
Xcell System (exponential decay protocol: 230 V, 950 mF) with Bio-Rad 0.4 cm 
electroporation cuvettes. Following electroporation (16–18 h), cells were split to petri 
dishes. The cells were then allowed to recover for approximately 6 h prior to overnight 
serum starvation in serum-free media (Szereszewski et al. 2010). GT1-7 neurons were 
transfected using Lipofectamine 2000 (Invitrogen) according to manufacturer’s 
instructions.  
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Arrb1 and Arrb2 were stably downregulated in GT1-7 neurons using shRNA cloned in 
the pGFP-V-RS vector (OriGene Technologies). The following are the Arrb1 and Arrb2 
and scrambled control shRNA sequences that were used (listed 5’- 3’); 
GACTCCAGTAGACACCAATCTCATAGAGC, GTGGCTCAGCTAGAACAAGAT 
GACCAGGT and TGACCACCCTGACCTACGTCGTGCAGTGC respectively. 
Heterogeneous populations of stable transfectants were selected in media containing 0.5 
µg/ml of puromycin and maintained on media containing 0.25 µg/ml of puromycin. β-
arrestin knockdown was confirmed by western blot analysis. These cell lines were also 
co-transfected with FLAG-KISS1R and receptor expression was selected for and 
maintained with 400 µg/ml and 300 µg/ml respectively Gentamicin (G418), a selective 
antibiotic for the neomycin resistance gene expressed by the FLAG-KISS1R plasmid.  
2.2.14 Western Blot Analysis  
Non-transfected and transfected HEK 293 cells expressing untagged and tagged WT 
KISS1R and L148S constructs were used in ERK1/2 and Stat3 phosphorylation assays. 
The tags used were FLAG, EYFP and myc where position of the tag or epitope in the 
nomenclature of the construct used indicated if attached to the C- or N- terminus of the 
receptor sequence. KISS1-YFP- and L148S-YFP-expressing cells were assessed visually 
for transfection efficiency and only dishes where 75% of the cells displayed YFP 
expression were used. HEK 293 cells were also transiently co-transfected with 10 μg of 
receptor DNA (KISS1R-YFP or YFP-L148S) and a range of 0, 0.5, 2.5 or 5 μg of the 
cDNA encoding for either Gq or G14. Prior to each assay, cells were serum-starved for 
30 mins in Hanks' balanced salt solution (HBSS: 1.2 mM KH2PO4, 5 mM NaHCO3, 20 
mM HEPES, 11 mM glucose, 116 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5 mM 
CaCl2, pH 7.4). Assays were then conducted by treating these cells with one of the 
following concentrations of KP-10 (0, 0.1 and 3.0 µM) for 10 min. Following KP 
treatment, cells were placed on ice then solubilized in lysis buffer (10 mM Tris, pH 7.4, 
100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM 
Na3VO4, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton-X 100, 10% glycerol, 1 mM 
AEBSF, 60 µg/mL aprotinin, 10 µg/mL leupeptin, 1 µg/mL pepstatin) and then clarified 
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by centrifugation for 20 min. at 23 000 RCF. 50 µg of protein was subjected to SDS-
PAGE and subsequently transferred to nitrocellulose membranes for immunoblotting.  
Immunoblots were then analyzed for phosphorylated ERK1/2 using rabbit monoclonal 
antibody Phospho p44/42 MAPK (Thr202/Tyr204) (1:2,000) (Cell Signaling #4370), 
while total ERK1/2 was analyzed using a rabbit monoclonal antibody p44/42 MAPK 
(1:1,000) (Cell Signaling #4695). Immunoblots were also analyzed for β-arrestin-1 and -2 
using mouse anti-β-arrestin-1 and -2 antibodies (1: 300) (BD Biosciences, Mississauga, 
ON, Canada, rabbit anti-Phospho-Stat3 (Ser727) (1:1000) (Cell Signaling #9134) and 
mouse monoclonal anti-β-actin (1:2000) (AbCam#8224). Chemiluminescent detection 
was performed using an anti-rabbit horseradish peroxidase-conjugated secondary 
antibody (1:2500) and developed with ECL (GE Healthcare, Piscataway, NJ). 
Immunoblots were scanned and quantified by densitometry using the Versadoc Imaging 
System 5000 MP and Image Lab 3.0 software (Bio-Rad, Hercules, CA). The means ± S.E 
are shown for values obtained for the number of independent experiments indicated in the 
Figure Legends. GraphPad Prism software (Graph Pad, San Diego, CA) was used to 
analyze data for statistical significance. Statistical significance was determined by one-
way analysis of variance followed by Dunnet’s ad hoc test. 
2.2.15 PLCβ translocation assay by confocal microscopy 
HEK 293 cells co-transfected with (FLAG-, EYFP- or myc-tagged) WT KISS1R or 
L148S as well as GFP-PH-PLC-δ1 were reseeded on collagen-coated 35-mm glass-
bottomed culture dishes. Prior to visualization, the cells were washed three times with 
HBSS (HEPES-buffered salt solution: 1.2 mM KH2PO4, 5 mM NaHCO3, 20 mM 
HEPES, 11 mM glucose, 116 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5 mM CaCl2, 
pH 7.4) and incubated for 1 h at 37 C in HBSS. Confocal analysis was performed on an 
Olympus Fluoview 1000 laser scanning confocal microscope using the 60X Plan 
Apochromat 1.42 oil objective. Enhanced GFP fluorescence was visualized with 
excitation at 488 nm and emission 500-545 nm emission filter set. Regions of interest 
were identified in cells and the fluorescence intensity (arbitrary units) at a given region 
was monitored over time. The change in intensity over time was then presented 
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graphically. Each experiment was conducted five independent times and representative 
images from one independent experiment are presented. 
2.2.16 Inositol Phosphate (InsP3) accumulation assay 
Total inositol phosphates were measured using two slightly different methods as 
previously described (Bianco et al. 2011 and Pampillo et al. 2009). Firstly, for 
investigating whether β-arrestin regulates KISS1R desensitization, COS-7, MEFs and 
GT1-7 cells were transfected as described in the figure legends and cultured for 24 h. 
Secondly, for investigating whether L148S is uncoupled from the Gαq/11pathway, COS-7 
cells transiently expressing 100 ng of receptor (WT KISS1R or L148S) were cultured for 
24 h (collaboration with Dr. Kaiser). 
For the analysis of the role of β-arrestin in KISS1R desensitization, cells grown in 24-
well plates were incubated overnight at 37 
o
C in 400 µl of inositol-free DMEM 
containing 1 µCi of myo-inositol [2-
3
H] (PerkinElmer, Waltham, MA). The following 
day unincorporated myo-[3H]-inositol was removed by washing the cells with HBSS. 
Cells were then pre-incubated for 1 h in 500 µl HBSS at 37 
o
C followed by a 15 min 
incubation in 500 µl HBSS containing 10 mM LiCl. Cells were then incubated for 4 h at 
37 
o
C in 500 µl of HBSS-LiCl in the absence (basal) or presence of KP-10. The following 
dilution series of KP-10 concentrations was used; 3x10
-11
, 3x10
-10
, 3x10
-9
, 3x10
-8
, 3x10
-7
, 
3x10
-6
 and 3x10
-5
M. The reaction was stopped on ice by adding 500 μl of 0.8 M 
perchloric acid and then neutralized with 400 μl of neutralization buffer (0.72 M KOH, 
0.6 M KHCO3) and stored at 4
 o
C overnight to allow for the precipitation of perchlorate 
particles . The following day total and purified [3H]-InsP3 are collected for radioactive 
counting in liquid scintillation using a Wallac LKB 1211 RackBeta liquid scintillation 
counter (Perkin Elmer). Purified readings were normalized against total [3H]inositol 
incorporated into the cells was determined by counting the radioactivity present in 50 μl 
of the cell lysate in 5ml scintillation buffer. Purified [3H]-InsP3 formation was 
determined by anion exchange chromatography of the cell lysates using AG-1-
X8(formate form) 200–400 mesh anion exchange resin (Bio-Rad, Hercules, CA). 900 μl 
of the cell lysate was applied to the anion exchange columns and washed twice with 5 ml 
H2O to remove free [3H]-inositol that was not incorporated into [3H]-inositol 
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phosphates. Columns were then washed twice with 60 mM ammonium formate. [3H]-
InsP3 products were eluted with 4 ml elution solution containing 1 M ammonium formate 
and 0.1 M formic acid. The means ± SE are shown for the number of independent 
experiments indicated in the figure legends. GraphPad Prism software was used to 
analyze data by nonlinear regression using a sigmoidal curve fit with a variable slope, 
and to compare curves for statistical significance. 
For the analysis of L148S stimulation of InsP3 formation in COS-7 cells, the day after 
myo-[3H]-inositol labelling, the cells were pretreated with 10 mM LiCl for 15 min and 
then stimulated with increasing concentrations of KP-10 (1x10
-9
 to 3x10
-6
 M) for 1 h. 
After stimulation, the cells were lysed in ice-cold 20 mM formic acid. The lysates were 
collected and neutralized to pH 7.5 with 300 µl solution containing 7.5 mM HEPES and 
150 mM KOH. [3H]-InsP3 products were isolated through prepared AG 1-X8 resin (Bio-
Rad, Hercules, CA) anion exchange columns by washing with 5 ml of H2O, and then 5 
ml solution containing 5 mM borax and 60 mM sodium formate. [3H]-InsP3 products 
were eluted by 3 ml elution solution containing 0.9 M ammonium formate and 0.1 M 
formic acid. The means ± S.E. are shown for the number of independent experiments 
indicated in the figure legends. GraphPad Prism software was used to analyze data by 
nonlinear regression using a sigmoidal curve fit with a variable slope, and to compare 
curves for statistical significance. 
2.2.17 Statistical Analysis  
Data were analyzed and graphed using the GraphPad Prism4 program (GraphPad 
Software, Inc). Statistical significance was validated when P < 0.05. The specific analysis 
performed is discussed in the relevant sections of the methods. 
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2.3 Results 
2.3.1 KISS1R triggers LH secretion via β-arrestin.  
We have previously reported that WT KISS1R signals via the Gαq/11- and β-arrestin-
dependent pathways to phosphorylate ERK1/2 (Pampillo et al. 2009 and Szereszewski et 
al. 2010). Since ERK1/2 regulate Kp-dependent GnRH secretion (Castellano et al. 2006), 
we hypothesized that KISS1R stimulates GnRH secretion via the β-arrestin pathway. 
While a mouse model completely lacking both Arrb1 (encodes for β-arrestin-1) and 
Arrb2 (encodes for β-arrestin-2) would be ideal for testing this hypothesis, full body 
Arrb1
-/-
;Arrb2
-/-
 dKO mice are perinatal lethal due to pulmonary hypoplasia (Zhang et al. 
2010, Conner et al. 1997, Bohn et al. 1998). Floxed β-arrestin mice have not been created 
yet thereby precluding the creation of Gnrh-neuron specific Arrb1
-/-
;Arrb2
-/- 
dKO mice. 
Furthermore, while it may have been possible to measure Kp-stimulated Gnrh secretion 
from E18 hypothalamic explants using Arrb1
-/-
;Arrb2
-/-
 dKO mice (d’Anglemont de 
Tassigny et al. 2007), our preliminary studies showed that we could not use this approach 
since loss of both isoforms significantly affected the size and distribution of the 
hypothalamic Gnrh neuronal population in the anterior hypothalamus. We therefore used 
the single KO mice lacking either Arrb1 (Arrb1
-/-
) or Arrb2 (Arrb2
-/-
) to test our 
hypothesis (Conner et al. 1997 and Bohn et al. 1999). Based on brood size, while the 
single KO mice are as fertile as their WT littermates, we reasoned that since the 
reproductive axis can withstand significant insults without having an effect on fertility, 
again as measured by brood size (Popa et al. 2013), we might instead be able to detect 
differences at the endocrine level that would support our hypothesis. We therefore 
proposed measuring LH secretion, a well-established surrogate for GnRH secretion in 
several vertebrate species (Seminara et al. 2003, Gottsch et al. 2004, Ramaswamy et al. 
2013), to test whether KISS1R stimulates GnRH secretion via the β-arrestin pathway. 
While this strategy is possible because Gnrh receptor activity on the anterior pituitary is 
not regulated by β-arrestin (Vrecl et al. 1998, McArdle et al. 1999, Heding et al. 2000 
Hislop et al 2001 and Pawson et al. 2008), it still depends on first demonstrating that the 
loss of Arrb1 or Arrb2 did not affect the size and distribution of the hypothalamic Gnrh 
neuronal population in the anterior hypothalamus nor did it affect LH secretion from the 
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pituitary gonadotropes due to developmental or other defects resulting from the whole 
body loss of Arrb1 and Arrb2. 
2.3.1.1 Loss of both β-arrestin-1 and -2 significantly affects GnRH 
immunoreactive neuronal population size and distribution in 
the hypothalamus.  
We generated a segregating progeny with WT control (Arrb1
-/-
;Arrb2
+/+
), heterozygous 
(Arrb1
-/-
;Arrb2
+/-
) and experimental dKO (Arrb1
-/-
;Arrb2
-/-
) littermates by interbreeding 
parents with the genotype,  Arrb1
-/-
;Arrb2
+/-. The effect of the complete loss of β-arrestin 
on the number and location of the adult GnRH cell population was analyzed by 
comparing dKO, WT and heterozygous littermates of 18 day old embryos (E18). 
Representative sagittal images from sections in the nasal compartment, olfactory bulb, 
dorsal forebrain and ventral forebrain are shown (Fig. 2.1). The mean number of GnRH 
immunoreactive neurons in each genotype was plotted in the adjoining bar graph. Based 
on the EL14 GnRH antiserum, Arrb1
-/-
;Arrb2
-/-
 dKO mice (n = 6) had significantly less 
GnRH immunoreactive cell counts (P < 0.05) when compared to either WT 
(Arrb1
+/+
;Arrb2
+/+
) (n=3) or heterozygous (Arrb1
-/-
;Arrb2
+/-
) (n = 3) littermates. This 
finding indicates that GnRH neuronal development is significantly affected in Arrb1
-/-
;Arrb2
-/-
dKO embryos and would therefore not be suitable models for this study. This 
analysis was done in collaboration with Dr. Stuart Tobet.  
 
 
 
116 
 
 
Figure 2.1: Loss of both Arrb1 and Arrb2 significantly affects GnRH 
immunoreactive population size and distribution in brain of E18 mice.  
All embryos were generated in the background of Arrb1 deletion and either Arrb2 WT 
control (Arrb1
-/-
; Arrb2
+/+
), Arrb2 heterozygous (Arrb1
-/-
;Arrb2
+/-
) or Arrb2 KO (Arrb1
-/-
;Arrb2
-/-
) (dKO) genotype. Number of embryos used in this analysis were WT n = 3 and 
Het and dKO n = 6. A-L. Photomicrographs of sagittal brain sections from E18 mice 
where GnRH neurons were revealed with IHC using the EL14 antibody. Each section 
was divided into four regions for analysis; Nasal Compartment (NC), Olfactory Bulb 
(OB); Dorsal Forebrain (DF) and Ventral Forebrain (VF). WT; (A,D,G,J) Het; (B,E,H,K) 
and dKO embryos (C,F,I,L).  Inset: Bar chart showing total GnRH immunoreactive 
neuronal cell count in dKO embryos was significantly lower than for WT or Het 
embryos. Error bars represent SEM.  * and # represent P<0.05 when WT and Het are 
compared to dKO respectively. 
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2.3.1.2 Loss of either β-arrestin-1 or -2 has no effect on the GnRH 
immunoreactive neuronal population size and distribution in 
the hypothalamus.  
The effect of β-arrestin-1 or -2 on the number and location of the adult GnRH cell 
population was analyzed by comparing eight week-old male KOs to their respective WT 
littermates. Representative coronal images from sections at the level of the OVLT are 
shown (Fig. 2.2A and E). The mean number of GnRH immunoreactive neurons in each 
section was plotted as a histogram [Arrb1
-/-
 (n = 6) and Arrb1
+/+
 littermates (n = 6); 
Arrb2
-/-
 (n = 5) and Arrb2
+/+
 littermates (n = 5)] (Fig. 2.2B and F). As expected, for both 
Arrb1
-/- 
and Arrb2
-/- 
the highest number of GnRH immunoreactive neurons was generally 
found at or near the OVLT with fewer cells in sections rostral and caudal to the OVLT 
(Fig. 2.2 B, D, F and G) (Gill et al. 2008). Genotype (KO vs. WT) also had no significant 
effect on the total GnRH immunoreactive cell counts for β-arrestin-1 (Fig. 2.2C) and β-
arrestin-2 (Fig. 2.2G) (P > 0.1). This finding, based on the EL14 GnRH antiserum, was 
corroborated using two other GnRH antisera, PA1-122 and QED. PAI-122 data are 
shown for the β-arrestin-1 WT and KO mice (n = 3 for WT and KO) (Fig. 2.2C and D) 
and QED data are shown for the β-arrestin-2 WT and KO mice (n = 5 for WT and KO) 
(Fig. 2.2G and H). With respect to the location of GnRH immunoreactive neurons, 
genotype (KO vs. WT) also had no significant effect in the Arrb1
-/-
 vs. Arrb1
+/+
 mice (P 
> 0.1) (Fig. 2.2B, D, F and H) and Arrb2
-/-
 vs. Arrb2
+/+
 mice (P > 0.1) (Fig. 2.2B, D, F 
and H). Overall, these findings suggest that the β-arrestin-1 and -2 single KO mice could 
be used to test whether KISS1R stimulates GnRH secretion via the β-arrestin pathway 
because the GnRH neuronal population was fundamentally “intact”.  
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Figure 2.2: 
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Figure 2.2: Loss of either Arrb1 or Arrb2 has no effect on the Gnrh immunoreactive 
neuronal population size and distribution in the hypothalamus.  
 (A and E): Photomicrographs of coronal brain sections at the level of the OVLT from 8 
week old Arrb1
-/-
 and Arrb2
-/-
 mice and their WT littermates. In photomicrographs, 
GnRH neurons were revealed in the brain slices by IHC using the EL14 antibody and the 
OVLT was used as a neuroanatomical reference point for rostral to caudal alignment of 
coronal sections. (B, D, F and H): Histograms displaying the rostral-caudal distribution of 
GnRH immunoreactive neurons from WT and KO mice aligned at the OVLT. Plot 
represents average GnRH immunoreactive neurons per 50 µm coronal section. GnRH 
immunoreactive neurons were identified with the EL14 antibody (B: Arrb1
-/-
 mice; F: 
Arrb2
-/-
 mice), PA1-122 antibody (D: Arrb1
-/-
 mice) and QED antibody (H: Arrb2
-/-
 
mice). Total number of GnRH immunoreactive neurons identified with the EL14 and 
PA1-122 antibody (C: Arrb1
-/-
 mice) and El14 and QED antibody (G: Arrb2
-/-
 mice). 
Error bars represent SEM.  
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2.3.1.3 Loss of either β-arrestin-1 or -2 has no effect on Buserelin-
triggered LH secretion.  
Next, we determined whether the loss of β-arrestin in the pituitary gonadotropes affected 
LH secretion due to developmental or other defects along the hypothalamic-pituitary axis. 
To do this, eight week-old male Arrb1
-/-
 and Arrb2
-/-
 mice and their WT littermates were 
administered Buserelin (GnRH agonist) i.p. and serum LH was measured 20 min later. 
There was no difference in Buserelin-triggered LH secretion in the single KO mice 
relative to their WT littermates [P > 0.2 for Arrb1
-/-
 (3.8 ± 0.2 ng/ml LH; n = 11) vs. WT 
(3.3 ± 0.4 ng/ml LH; n = 13); P > 0.2 for Arrb2
-/-
 (2.7 ± 10.3 ng/ml LH; n = 15) vs. WT 
(2.7 ± 0.1 ng/ml LH; n = 9)] (Fig. 2.3A and B). Thus, the loss of either β-arrestin isoform 
in pituitary gonadotropes did not affect Buserelin-stimulated LH secretion and these 
single KO mice could be used to test whether KISS1R stimulates GnRH secretion via the 
β-arrestin pathway. 
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Figure 2.3: Loss of either Arrb1 or Arrb2 does not affect Buserelin-triggered LH 
secretion 
Serum LH levels were measured by RIA. Mice were either left untreated or treated with 
saline or 3 ng Buserelin/g body weight. Twenty min later blood was collected and serum 
prepared. Buserelin-triggered LH levels in (A) Arrb1
-/-
 and (B) Arrb2
-/-
 mice were 
significantly higher (P < 0.001) than levels from their respective untreated and saline 
treated controls. Buserelin-triggered LH levels were not different (P > 0.2) between 
Arrb1
-/-
 and Arrb2
-/-
 mice and their WT littermate controls, respectively. Numbers above 
each bar represent n value for each treatment. Only male mice were used to preclude the 
effects of estrous cycle variation on GnRH secretion in females. Error bars represent 
SEM.  
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2.3.1.4 Loss of either β-arrestin-1 or -2 significantly reduces 
kisspeptin-triggered LH secretion.  
To determine what effect a loss of either β-arrestin-1 or -2 has on LH secretion, eight 
week-old male Arrb1
-/-
 and Arrb2
-/-
 mice and their WT littermates were administered KP-
54 i.p. and serum LH was measured 1h later. The 1h time point was chosen based on 
previous publications (Seminara et al. 2003, Lapatto et al. 2007, Kirilov et al. 2013) as 
well as our own time course assay that demonstrated robust serum LH elevation after KP-
54 administration (Appendix 1 Fig. 1). There was significant reduction in Kp-triggered 
LH secretion in each of the single KO mice relative to their WT littermates [P < 0.001 for 
Arrb1
-/-
 (12.1 ± 0.4 ng/ml LH; n = 14) vs. WT (15.4 ± 0.8 ng/ml LH; n = 10); P < 0.001 
for Arrb2
-/-
 (13.2 ± 0.8 ng/ml LH; n = 14) vs. WT (18.4 ± 1.1 ng/ml LH; n = 12)] (Fig. 
2.4A and B). Thus, the loss of either β-arrestin isoform diminished Kp-stimulated LH 
secretion and β-arrestin-1 and -2 regulate LH secretion in young adult male mice. 
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Figure 2.4: Loss of either Arrb1 or Arrb2 significantly diminishes KP-54 triggered 
LH secretion. 
Serum LH levels were measured by RIA. Mice were either left untreated or treated with 
saline or 100 nmol KP-54/kg body weight. 1h later, blood was collected and serum 
prepared. KP-54-triggered LH levels in Arrb1
-/-
 and Arrb2
-/-
 mice were significantly 
higher (P < 0.001) than levels from their respective untreated and saline treated controls. 
Kp-54-triggered LH levels were significantly lower (P < 0.001) in  Arrb1
-/-
 and Arrb2
-/-
 
mice compared to their respective WT littermate controls. Only male mice were used to 
preclude the effects of estrous cycle variation on GnRH secretion in females. Error bars 
represent SEM.  
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2.3.2 L148S displays Gαq/11-independent signaling 
WT KISS1R displays Gαq/11-independent signaling via β-arrestin (Pampillo et al. 2009 
and Szereszewski et al. 2010). L148S is a naturally occurring Gαq/11-uncoupled KISS1R 
mutant associated with infertility and IHH in patients (Seminara et al. 2003 and Wacker 
et al. 2008). We also determined that like WT KISS1R, L148S also physically associates 
with β-arrestin-1 and -2 (Szereszewski et al. 2010). Additionally, it was reported that 
L148S is expressed at WT levels, localizes to the cell surface, binds Kp and continues to 
interact with many signaling and regulatory molecules identical to WT KISS1R (Wacker 
et al. 2008). These observations lead to the hypothesis that while L148S is uncoupled 
from InsP3 formation it retains the capacity to undergo kisspeptin-triggered Gαq/11-
independent signaling via β-arrestin. We further propose that these KISS1R Gαq/11-
independent pathways may regulate functionally distinct intracellular responses from the 
Gαq/11-dependent cascade.  
2.3.2.1 L148S triggers significant Gαq/11-independent ERK1/2 
phosphorylation 
Relative to kisspeptin-treated WT KISS1R-expressing cells, kisspeptin-treated L148S-
expressing cells triggered about 2.5-fold less ERK1/2 phosphorylation (P < 0.05) (Fig. 
2.5A, B and D). However, following 0.1 and 3.0 µM Kp-10 stimulation, L148S-triggered 
ERK1/2 phosphorylation was approximately 2-fold greater (P < 0.05) than unstimulated 
L148S-expressing cells (Fig. 2.5B and D) and both unstimulated and stimulated non-
transfected cells (Fig. 2.5B, C and D). All these studies were conducted with the 
untagged WT and L148S receptor.   
Since we routinely use tagged receptors to study KISS1R signaling, we determined how 
tagged-WT and -L148S receptors compared to the untagged receptors with respect to 
ERK activation. Tagged (YFP, FLAG and myc) WT and L148S receptors triggered 
similar levels (P > 0.05) of ERK activation compared to the untagged WT and L148S 
receptors, respectively, following 0.1 and 3.0 µM KP-10 stimulation (Fig. 2.5 vs. Figs. 
2.6 and 2.7). These results indicate that the presence of tags or epitopes (YFP, FLAG and 
myc) did not alter the signaling potential of WT and mutant KISS1R. kisspeptin-treated 
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L148S-expressing cells triggered significant (P < 0.05) ERK1/2 activation compared to 
both unstimulated L148S-expressing cells and stimulated non-transfected cells (Figs. 2.5, 
2.6 and 2.7). These findings were verified independently in both the Babwah and Kaiser 
laboratories and expression constructs were routinely sequenced to verify their nucleotide 
composition.  
 
 
 
Figure 2.5: L148S triggers ERK1/2 phosphorylation.  
Representative autoradiographs from the Babwah laboratory (A-C) and densitometric 
analysis from the Kaiser laboratory (D) showing the expression of total and 
phosphorylated ERK1/2 in untagged-L148S, non-transfected (NT) and WT untagged-
KISS1R overexpressing HEK 293 cells following 10-min KP-10 treatment (0, 0.1 and 3.0 
µM). Western blot analyses were done using monoclonal anti-ERK1/2 and anti-phospho 
ERK1/2 antibodies. The data represent the mean of 3 independent experiments. *: P < 
0.05, pERK/total ERK ratio compared with 0 µM in WT group; #: P < 0.05, pERK/total 
ERK ratio compared with 0 µM in L148S group. Error bars represent SEM.  
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Figure 2.6: L148S triggers ERK1/2 phosphorylation regardless of epitope tag 
Representative autoradiographs (A, C and E) and densitometric analysis (B,D and F) 
from the Kaiser laboratory showing the expression of total and phosphorylated ERK1/2 
in WT KISS1R (YFP-, FLAG- and myc-tagged), L148S (YFP-, FLAG- and myc-tagged) 
and non-transfected (NT) overexpressing HEK 293 cells following 10-min KP-10 
treatment (0, 0.1 and 3.0 µM). Western blot analyses were done using monoclonal anti-
ERK1/2 and anti-phospho ERK1/2 antibodies. The data represent the mean of 3 
independent experiments. *: P < 0.05, pERK/total ERK ratio compared with 0 µM in WT 
group; #: P < 0.05, pERK/total ERK ratio compared with 0 µM in L148S group. Error 
bars represent SEM. 
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Figure 2.7: L148S triggers ERK1/2 phosphorylation 
Representative autoradiographs (A) and densitometric analysis (B) from the Babwah 
laboratory confirming results in Figs. 2.6 and 2.7 done by the Kaiser Laboratory. YR: 
KISS1R-YFP, YL: YFP-L148S, FR: FLAG-KISS1R, FL: FLAG-L148S, UR: untagged 
KISS1R, UL: untagged L148S, ML: myc-L148S, EYFP V: vector control for YFP 
constructs, NT: non-transfected HEK 293 cells. Cells were treated with KP-10 (0, 0.1 and 
3.0µM) for 10 min.  Western blot analyses were done using monoclonal anti-ERK1/2 and 
anti-phospho ERK1/2 antibodies. The data represent the mean of at least 3 independent 
experiments. *P < 0.05, pERK/total ERK ratio compared with 0 µM of the same 
transfection in that group; #P < 0.05, pERK/total ERK ratio compared with 0 µM in 
L148S group. Error bars represent SEM.  
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2.3.2.2 L148S triggers significant ERK1/2 phosphorylation via the 
β-arrestin pathway.  
Since the Gαq/11-uncoupled mutant, L148S physically associates with β-arrestin-1 and -2 
(Pampillo et al. 2009) we hypothesized that L148S-dependent ERK1/2 phosphorylation 
(Figs. 2.5, 2.6 and 2.7) is β-arrestin-dependent. This was tested by assessing L148S-
dependent ERK1/2 phosphorylation following KP-10 treatment in the presence and 
absence of β-arrestin-1 and -2. As seen, when L148S was expressed in WT MEFs, 
following KP-10 treatment, it triggered significant ERK1/2 phosphorylation (P < 0.05) 
(Fig. 2.8). However, when L148S was expressed in MEFs lacking both β-arrestin-1 and -
2, the ability to trigger Kp-dependent ERK1/2 phosphorylation was almost completely 
abolished (Fig. 2.8), thus supporting our hypothesis that L148S-triggered ERK1/2 
phosphorylation is β-arrestin-dependent.  
 
Figure 2.8: L148S triggers ERK1/2 in a β-arrestin-dependent manner. 
Representative autoradiograph (A) and densitometric analysis (B) showing the expression 
of total and phosphorylated ERK1/2 in YFP-L148S overexpressing MEFs. β-arrestin-1/2 
dKO MEFs and corresponding WT control MEFs were treated for 10 min with KP-10 at 
100 nM. Western blot analysis was done using monoclonal anti-ERK1/2 and anti-
phospho ERK1/2 antibodies. The data represent the mean of three independent 
experiments. *P<0.05, pERK/totak ERK ratio compared with 0µM in WT MEFs. Error 
bars represent SEM.  
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2.3.2.3 L148S is strongly uncoupled from Gαq/11 signaling at Kp-10 
concentrations that trigger robust signaling via WT KISS1R.  
L148S is impaired in G-protein activation by inhibiting the dissociation of Gα and Gβγ- 
subunits and, as a result, is uncoupled from InsP3 formation (Seminara et al. 2003 and 
Wacker et al. 2008). In the present study we also show that, while WT KISS1R triggered 
InsP3 formation over a wide range of KP-10 concentrations (1.0 x 10
-9
 to 3 x 10
-6
 M of 
KP-10) with an EC50 of 1.5 x 10
-9
 M, L148S was significantly diminished (P < 0.05) in 
its capacity to do so, displaying an EC50 of 1.7 x 10
-8
 M that was not significantly 
different (P > 0.05) from the InsP3-generating capacity of non-transfected cells (Fig. 2.9). 
Although these findings confirm previous reports that L148S is strongly uncoupled from 
Gαq/11 signaling, (Seminara et al. 2003 and Wacker et al. 2008) it was important to 
confirm these findings in parallel with the evidence that ERK1/2 phosphorylation was 
still occurring (Figs. 2.5, 2.6 and 2.7). Thus, the small yet significant L148S-dependent 
ERK1/2 phosphorylation that we observed was unlikely due to differences such as in 
expression constructs, experimental techniques and cell lines that may exist between the 
current and previous studies.  
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Figure 2.9: L148S is strongly uncoupled from Gαq/11 signaling 
COS7 cells were transiently transfected with WT KISS1R or L148S. Kp-10 stimulated 
InsP3 accumulation was measured by conversion of pre-labeled [2
3
H] myo-inositol to 
[
3
H]InsP. Data are percentage of maximum response. *P < 0.01. The result is pooled data 
from three independent experiments. All assays were performed in triplicate. Error bars 
represent SEM. 
 
2.3.2.4 WT KISS1R and L148S differentially regulate PIP2 
hydrolysis.  
While L148S-expressing cells were not significantly different (P > 0.05) from non-
transfected cells in their InsP3-generating capacity, to further strengthen the finding that 
L148S is functionally uncoupled from the Gαq/11 signaling pathway, we monitored the 
spatial distribution of GFP-PH-PLC-δ1following kisspeptin treatment in cells co-
expressing either WT KISS1R or L148S. The spatial localization of GFP-PH-PLC-δ1in 
the cell reflects the activation state of Gαq/11. In the unstimulated cell, GFP-PH-PLC-δ1 is 
localized to the plasma membrane but upon stimulation, GFP-PH-PLC-δ1 is released 
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from the plasma membrane as a consequence of both PIP2 hydrolysis and the high 
affinity of the PLC-δ1 PH domain for InsP3 (Hirose et al. 1999). In cells expressing GFP-
PH-PLC-δ1, but lacking KISS1R, GFP-PH-PLC-δ1 was localized at the plasma 
membrane, even after Kp-10 treatment, due to the interaction of the PLC-δ1 PH domain 
with membrane PIP2 (Fig. 2.10A-C). However, in cells co-expressing GFP-PH-PLC- δ1 
and FLAG-KISS1R (WT), in response to KP-10 treatment, GFP-PH-PLC- δ1 was 
released from the plasma membrane and accumulated in the cytosol of the cell (Fig. 
2.10D-G).  
Our previously published study (Babwah et al. 2012) demonstrated that 100 nM KP-10 
was sufficient to trigger a robust redistribution of GFP-PH-PLC-δ1 in cells co-expressing 
WT KISS1R. However, the present study was conducted with 3 µM KP-10 to determine 
whether a high concentration of KP-10, which triggers a robust L148S-distal signaling 
response (that is, ERK activation) (Figs. 2.5, 2.6 and 2.7), would stimulate a Gαq/11-
coupled L148S-proximal signaling event (that is, PIP2 hydrolysis). If it did not, we would 
conclude that L148S is strongly uncoupled from the Gαq/11 signaling pathway and that 
L148S-dependent ERK activation is primarily the consequence of Gαq/11-independent 
signaling. As seen, when either FLAG-L148S (Fig. 2.10H-J) or myc-L148S (Fig. 2.10K-
M) were co-expressed with GFP-PH-PLC-δ1, 3 µM KP-10 completely failed to stimulate 
the cellular redistribution of GFP-PH-PLC-δ1 (Fig. 2.10H-M) and was indistinguishable 
from Kp-treated cells expressing GFP-PH-PLC-δ1 alone (Fig. 2.10A-C). Cells co-
expressing GFP-PH-PLC- δ1 with either FLAG-L148S (Fig. 2.10H-J) or myc-L148S 
(Fig. 2.10K-M) were imaged for up to about 17 minutes following KP-10 treatment. Even 
if there was weak L148S-dependent InsP3 formation over this period, transient cellular 
accumulation of InsP3 was still insufficient to trigger detectable levels of PIP2 hydrolysis 
as determined by a cellular redistribution of GFP-PH-PLC-δ1. Based on the GFP-PH-
PLC-δ1cellular redistribution data, it appears that at up to 3 µM KP-10, L148S is strongly 
uncoupled from the Gαq/11 signaling pathway. 
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Figure 2.10:  
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Figure 2.10 continued:  
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Figure 2.10: L148S is strongly uncoupled from Gαq/11 signaling.  
(A-M) representative images selected from a time series of laser scanning confocal 
microscopic images showing the plasma membrane and cytosolic localization of GFP-
PH-PLC-δ1 in non-transfected HEK 293 cells (A-C) and in HEK 293 cells expressing 
WT KISS1R or L148S (D-G: FLAG-WT-KISS1R-expressing cells; H-J: FLAG-L148S-
expressing cells; (K-M): myc-L148S-expressing cells) in the absence of agonist (0 s) and 
in response to 3 µM KP-10 treatment (added gently and in a drop-wise manner to cells 
cultured on a confocal dish) approximately one min later (see solid white arrowheads on 
X-axis of graphs C, G, J and M). Cytosolic regions of interest in cells (shown by small 
white circle in panels A, B, D-F, H, I, K, L) were analyzed quantitatively by determining 
the changes in GFP fluorescence over time. These changes are presented graphically (C, 
G, J and M). These studies were conducted five independent times and representative 
images from one experiment are shown.  (A-C): Approximately 14 min after KP-10-
treatment, translocation of GFP-PH-PLC-δ1 from the plasma membrane to the cytosol 
was visually undetectable.  This confirms that translocation is dependent on 
KISS1/KISS1R signaling. (D-G): At approximately 440 sec (7.5 min) after adding KP-10 
(open arrow-head) GFP-PH-PLC-δ1 began translocating from the plasma membrane to 
the cytosol indicating that the KISS1R-coupled Gαq/11 pathway was activated. (H-J): 
Translocation of GFP-PH-PLC-δ1 from the plasma membrane to the cytosol was visually 
undetectable following 15 min of KP-10-treatment of cells expressing FLAG-L148S. (K-
M): Translocation of GFP-PH-PLC-δ1 from the plasma membrane to the cytosol was 
visually undetectable following 16 min of KP-10-treatment of cells expressing myc-
L148S. 
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2.3.2.5 WT KISS1R and L148S differentially regulate STAT3 
phosphorylation.  
In agreement with our previous reports (Pampillo et al. 2009 and Szereszewski et al. 
2010), we demonstrated here that L148S can signal to ERK1/2 through Gαq/11 –
independent mechanisms, likely involving β-arrestins (Figs 2.5 – 2.8). Next we wanted to 
further analyze differences between the Gαq/11 –dependent and independent pathways in 
terms of regulation of intracellular signaling molecules other than ERK1/2. Using a 
Proteome Profiler system we were able to assess kisspeptin-triggered site-specific 
phosphorylation of 45 human kinases and compare differences in phosphorylation 
between untagged WT KISS1R and L148S (Fig. 2.11A).  Consistent with previous 
results in Figs. 2.5-2.7, after 0.1 µM KP-10 stimulation, KISS1R expressing cells had a 
significant increase in ERK1/2 phosphorylation relative to unstimulated KISS1R 
expressing cells (Fig. 2.11B) (P<0.05). L148S also triggered significant Kp-stimulated 
ERK1/2 phosphorylation relative to untreated cells (Fig. 2.11B) but this response was 
diminished compared to KISS1R confirming results seen above in Figs. 2.5, 2.6 and 2.7 
(P<0.05). While WT KISS1R was able to stimulate significant STAT3 (S727) 
phosphorylation (P<0.05) following 0.1 µM KP-10 stimulation, L148S could not (Fig. 
2.11C). This suggests that while ERK1/2 lies downstream of both Gαq/11 dependent and 
independent KISS1R signaling, STAT3 may only be part of the Gαq/11 pathway. Western 
blot analysis was done to verify the phospho-kinase array results (Fig. 2.12). 
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Figure 2.11: Human Phospho-Kinase Array identified signaling molecules that are 
solely part of the Gαq/11-dependent pathway. 
 (A) Representative autoradiograph of the Human Phospho-Kinase Array. (B and C). 
Densitometric analysis of mean pixel intensity for spots detecting phospho-ERK1/2 and 
phospho-STAT3. (B) Following Kp-10 treatment, KISS1R expressing HEK 293 cells 
showed an approximate 8-fold significant increase in ERK1/2 phosphorylation (*P < 
0.05) while cells expressing L148S demonstrated a diminished yet significant 2-fold 
approximate increase in ERK1/2 phosphorylation (*P < 0.05). (C) Following Kp-10 
treatment, KISS1R expressing HEK 293 cells showed an approximate 1-fold significant 
increase in STAT3 phosphorylation (*P < 0.05) while cells expressing L148S 
demonstrated no significant difference in STAT3 phosphorylation. Densitometric 
analysis represents the mean of 3 independent experiments where mean pixel intensity is 
normalized to reference controls on array. Error bars represent SEM.  Other molecules 
identified include p38, CREB and RSK1/2/3 (See Appendix 2).  
 
 
 
137 
 
  
 
 
 
 
 
 
Figure 2.12: L148S cannot trigger STAT3 phosphorylation. 
Representative autoradiographs (A) and densitometric analysis (B) showing expression of 
total and phosphorylated ERK1/2 and STAT3 in YR: KISS1R-YFP, YL: L148S-YFP, 
UR: untagged KISS1R, UL: untagged L148S, NT: non-transfected HEK 293 cells. Cells 
were treated with Kp-10 (0 and 0.1 µM) for 10 minutes. While WT KISS1R (YR and 
UR) are able to stimulate STAT3 phosphorylation, L148S (UL) is not *P<0.05.  
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2.3.3 β-arrestin-1 and -2 regulate KISS1R homologous 
desensitization.   
Since we now have established that KISS1R signals through Gαq/11-independent 
mechanisms, one of which is β-arrestin, we wanted to investigate if β-arrestin also was 
involved in the attenuation of KISS1R signaling. Traditionally, β-arrestins mediate 
GPCR signal termination by homologous desensitization (Conner et al. 1997, Bohn et al. 
1999, Kohout et al. 2001, Ferguson 2001, Luttrell et al. 2010). We have shown that 
GRK-2 was involved in KISS1R desensitization and indirectly suggested that β-arrestins 
may also be involved (Pampillo et al. 2009 and Szereszewski et al. 2010). Here we 
investigate more directly the role of β-arrestin in KISS1R homologous desensitization. 
We used three cell models and three experimental approaches to validate our findings in 
order to show that the results were conserved and not cell or technique-specific. Since 
inositol phosphate (InsP3) formation is an early and direct outcome in KISS1/KISS1R 
signaling through the Gαq/11 pathway, we used it here as an inverse indicator for the 
termination of this cascade by homologous desensitization. By measuring InsP3 formation 
over a range of kisspeptin concentrations for a fixed time period as described previously 
(Pampillo et al. 2009) we were able to investigate the effect of β-arrestin expression on 
KISS1R desensitization (Fig. 2.13). Using an immortalized mouse GnRH neuronal cell 
line, GT1-7, we used shRNA to create lines which stably downregulated β-arrestin-1 and 
-2 and verified the decreased expression by western blot (Fig. 2.13A and B). If β-arrestin 
regulated KISS1R homologous desensitization we would expect that the shRNA knock-
down lines would undergo less signal termination demonstrated by greater levels of InsP3 
accumulation. This is exactly what we see in the GT1-7 (Fig. 2.13A) where both β-
arrestin-1 and -2 KD lines show more InsP3 accumulation at all Kp-10 concentrations 
compared to the line expressing KISS1R. At 3x10
-5
 M KP-10, β-arrestin-2 KD produced 
3-fold more InsP3 than the receptor only line (P<0.05). This result is further recapitulated 
in the MEF cell lines which were derived from genetically modified mice that lacked β-
arrestin-1, -2 or both isoforms (Fig. 2.13D) (Kohout et al 2001). At 3x10
-5
 M KP-10, all 
of these MEF KO lines had significantly more InsP3 accumulation than their control 
lines. While the single β-arrestin knockout MEFs had 3-4 fold more InsP3 compared to 
parental lines, the double β-arrestin-1-2 knockout MEFs had 20-fold more InsP3 
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accumulation (P<0.05) further demonstrating the importance of both β-arrestins for 
KISS1R desensitization. Finally we used a reciprocal approach in the primate cell line, 
COS-7. Due to the relatively low levels of endogenous β-arrestins in COS-7 cells 
(Menard et al. 1997) we were able to use this line to over-express β-arrestin and as we 
expected the converse held true. Overexpression of β-arrestin triggered an increase in 
KISS1R desensitization as demonstrated by the downward and rightward shift in the dose 
response curves (Fig. 2.13C). Both the β-arrestin-1 and the β-arrestin-2 overexpressed 
cells show significantly less InsP3 accumulation (3 and 2-fold respectively) than the 
receptor only-expressing line at 3x10
-5
 M KP-10 (P < 0.05). Taken together, these results 
prove that the β-arrestin regulate KISS1R homologous desensitization.  
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Figure 2.13: β-arrestin-1 and -2-dependent homologous desensitization of KISS1R is 
conserved in various cell types. 
(A). GT1-7 cells stably transfected with 10 µg FLAG-KISS1R only or with shRNA 
against either β-arrestin-1 (β-arr-1 KD) or β-arrestin -2 (β-arr-2 KD). Over a range of 
kisspeptin concentrations, the lines with reduced expression of either β-arrestin-1 or -2 
produced a greater quantity of InsP3 at each KP-10 dose. Data points represent the mean 
for three independent experiments. InsP3 accumulation in the β-arrestin-2 KD line is 
significantly more than the receptor only line at 3x10
-5
 M KP-10. *P < 0.005. (B). 
Representative western blot showing 86% and 72% diminished protein expression of β-
arrestin-1 and -2 respectively, in the GT1-7 shRNA stables relative to scrambled shRNA 
control. A similar level of down-regulation was detected at the level of mRNA expression 
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(data not shown). (C). COS-7 cells transiently transfected with 10 µg FLAG-KISS1R 
alone or with 5 µg EYFP-β-arrestin-1 or -2. COS-7 cells with increased expression of 
either β-arrestin-1 or -2 produced a lower quantity of InsP3 over a range of kisspeptin 
concentrations. At 3x10
-5
 M KP-10, both the β-arrestin-1 and the β-arrestin-2 
overexpressed cells show significantly less InsP3 than the KISS1R only expressing cells 
*P<0.05. (D). MEFs genetically lacking β-arrestin-1 or -2 or both isoforms were 
transiently transfected with 10 µg KISS1R-EYFP. All MEF cell lines expressing 
diminished or no β-arrestin produced more InsP3 and at 3x10
-5 
M was significantly 
greater compared to the WT parental lines. *P<0.05. Data points for all curves represent 
the mean for three independent experiments. Error bars represent SEM.  
 
2.3.4 KISS1R signals via Gαq/11 -independent mechanisms to 
regulate fertility 
At this point we just demonstrated that both KISS1R-triggered LH secretion and L148S-
triggered ERK1/2 phosphorylation can occur in a β-arrestin-dependent manner. These 
results therefore suggest an important role for β-arrestin in regulating GnRH secretion 
and fertility and we would expect mice lacking β-arrestin to display infertility or sub-
fertility. While we were able to detect diminished kisspeptin-stimulated LH release, 
overall fertility as described by brood size, was unaffected in the single β-arrestin 
knockout mice due to functional isoform compensation between the β-arrestin proteins. 
Since β-arrestin double knockout mice are perinatal lethal this precluded further 
investigation of the physiological impact of β-arrestins on fertility.  
Nevertheless, the in vivo and in vitro studies detailed above suggest that Gαq/11 –
independent pathways play a role in regulating GnRH release and one of these pathways 
may involve β-arrestin. We therefore took slightly different approach by investigating the 
importance of Gαq/11 –independent pathways in the GnRH neuron affecting GnRH 
secretion and fertility. To accomplish this we created the GnRH-neuron specific Gαq/11 
double knockout mouse model. We hypothesized that Gαq/11-independent mechanisms in 
the GnRH neuron would be able to trigger sufficient GnRH secretion to attain and 
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maintain puberty and fertility in mice. Our results revealed that while puberty was 
delayed it still occurred and males were sub-fertile indicating that the endogenous Gαq/11-
independent pathways sustained partial function of the GnRH neuron.  
2.3.4.1 Generation of GnRH-neuron specific Gnaq;Gna11 double 
deletion mice.  
A conditional deletion of Gαq/11 in GnRH neurons was generated by breeding 
Gnaq
fl/fl
;Gna11
-/-
 mice (Offermans et al. 1998, Wettschureck et al. 2001 and Kero et al. 
2007) with Gnrh-Cre transgenic mice (Yoon et al. 2005). The Gnrh-Cre line used in 
these studies allows for Cre expression in GnRH neurons only and has been extensively 
characterized and used for the modification of several genes in this cell type (Yoon et al. 
2005, Skynner et al. 1999 and Wintermantel et al. 2006, Wolfe et al. 2008, Leshan et al. 
2009). The Gnaq
fl/fl
;Gna11
-/-
 parental line has also been extensively characterized and 
used with many conditional Cre expressing lines to understand the roles of Gαq/11 
signaling in various tissues and organs in the body (Kero et al. 2007, Wettschureck et al. 
2001, 2005, 2006, 2007, Dagmara et al. 2005). Upon expression and action of the Cre 
recombinase enzyme, exon 6 of the Gnaq gene is excised resulting in loss of function of 
Gαq in GnRH neurons the background of a full body Gα11 deletion (Offermans et al. 
1998, Wettschureck et al. 2001, 2005, Kero et al. 2007 and Breen et al. 2013). 
Experimental mice are designated (dKO) or (Gnaq
d/d
) and the control littermates are 
designated (Gnaq
fl/fl
). 
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Figure 2.14: Confirmation of the successful creation of GnRH-neuron specific Gαq/11 
double knockout mice. 
For all these experiments, 8 week old littermates were used. A. RT-PCR analysis of 
hypothalamic tissue confirms the expression of Cre recombinase in the hypothalamus of 
the Gnaq
d/d
 mice but not in the Gnaq
fl/fl
 littermate or negative RT-PCR control.  B. RT-
PCR analysis of hypothalamic tissue confirms the expression of GnRH all samples as 
expected and not the negative RT-PCR control. C. PCR analysis of genomic DNA from 
hypothalamic tissue produces a 2.3 kb product in mice bearing a floxed allele (Gnaq
fl/fl
) 
and a 0.5 kb recombination product (Gnaq) (confirming Cre-dependent excision of the 
sequence between the LoxP sites) in mice bearing the floxed allele and also expressing 
Cre Recombinase. Hypothalamic tissue contains a mix of GnRH neurons and non-GnRH 
cells so both products (2.3 kb and 0.5 kb) are detected in the hypothalamus of the Gnaq
d/d 
mouse while only the 2.3 kb product is detected in the Gnaq
fl/fl
 littermate. D. RT-PCR 
analysis showing Cre expression is only detected in the hypothalamus (H) of the 
(Gnaq
d/d
) mouse and not in the other tiers of the HPG axis; Pituitary (P) and Ovary (O) 
nor in the Gnaq
fl/fl
 littermate. 
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2.3.4.2 Cre Recombinase activity in Gnrh-Cre mice used to 
generate Gnaqd/d mice.  
The well characterized Gnrh-Cre line used for this study essentially targets all (97%) 
GnRH neurons (Srinivas et al. 2001 and Yoon et al. 2005, Kirilov et al 2013). For our 
purposes it was important that recombination occurred during early development, before 
pubertal onset. Therefore to determine when recombination of Gnaq occurred we crossed 
the Gnrh-Cre line to a ROSA26::LoxP-Stop-LoxP-GFP reporter line (Soriano 1999) and 
examined brain slices from offspring at  E18, 1, 2 and 3 weeks of age. At each age (E18, 
1, 2 and 3 weeks) three independent analyses were done where neuronal soma were 
scored for both ROSA26::GFP and GnRH immunostained signals in ten consecutive 
tissue coronal brain sections spanning the rostral-caudal hypothalamic axis. We found 
that as early as E18 (Fig. 2.15), Cre recombination (as determined by GFP expression) 
occurred in at least 97% of all GnRH-positive neurons. The possibility remains that the 
remaining 3% of GnRH neurons did not possess a recombination event or that GFP 
fluorescence was too low to be efficiently detected. We also detected GFP-expressing 
cells in the intermediate division of the lateral septum (LSi) which has been already 
describes as a site where GnRH is transiently expressed in early development in the 
mouse (Skynner et al.1999). From this result we conclude that Gαq/11 was effectively 
deleted from essentially all GnRH neurons and possibly from a very small population of 
LSi neurons in Gnaq
fl/fl
; Gna11
-/-
 ; Gnrh-Cre
+
 mice.  
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Figure 2.15: The Gnrh-Cre line shows high Cre recombinase activity where 
essentially all Gnrh neurons co-express ROSA26::GFP. 
A-F. Representative image of a 30µm thick coronal brain section at the level of the 
OVLT in E18 mice generated by crossing a Gnrh-Cre mouse to a ROSA26::loxP-Stop-
loxP-GFP reporter mouse and subsequently immunostained for GnRH and counterstained 
for nuclei with DAPI. A-C. Low power image of a coronal brain slice showing show Cre 
recombinase activity in the lateral septum (LS) and peri-ventricular zone of the rostral 
hypothalamus. Cre activity in the lateral septum (LS) is well described in this line and 
occurs during fetal development (Skynner et al. 1999). It is believed that in early 
development these cells express GnRH but stop doing so at a later date (x20 
magnification). D-F. High power image (x40 magnification) of the periventricular zone 
of the same coronal slice. The GFP expression seemed to be restricted to the soma (S) 
while GnRH was detected in both the soma and processes (P) of the GnRH neurons. (LS: 
Lateral Septum, S: Soma; P: processes).  
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2.3.4.3 Loss of Gαq and Gα11 has no effect on GnRH 
immunoreactive neuronal population size and distribution in 
the hypothalamus.  
In order to use the GnRH-neuron-specific Gαq/11 dKO mouse to investigate the impact of 
Gαq/11 –independent signaling on fertility, we first needed to demonstrate that the loss of 
both Gnaq and Gna11 in the GnRH neuron did not disrupt GnRH neuronal migration 
and/or survival during early mouse development.  The number and location of GnRH 
neurons in coronal brain slices from 8 week old Gnaq
d/d
 mice was compared to littermate 
controls (Gnaq
fl/fl
) (collaborative study with Dr. Tobet, Colorado State University). 
Representative images from coronal sections at the level of the OVLT are shown (Fig. 
2.16A and B). The mean number of GnRH immunoreactive neurons in each section was 
plotted as a histogram (n = 6) for both genotypes (Fig. 2.16D). As expected, the highest 
number of GnRH immunoreactive neurons was generally found at or near the OVLT with 
fewer cells in sections rostral and caudal to the OVLT (Gill et al. 2008). Genotype 
(Gnaq
d/d
 vs. Gnaq
fl/fl
) had no significant effect on the total GnRH immunoreactive cell 
counts (P > 0.1) (Fig. 2.16C). Overall, these findings suggest that the GnRH neuronal 
population was fundamentally intact and that the Gnaq
d/d
 mice could be used for 
analyzing the importance of Gαq/11 independent signaling on GnRH secretion.  
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Figure 2.16: Loss of Gnaq and Gna11 has no effect on the GnRH immunoreactive 
neuronal population size and distribution in the hypothalamus. 
(A and B): Photomicrographs of coronal brain sections at the level of the OVLT from 8 
week old Gnaq
d/d
 and Gnaq
fl/fl
 mice. GnRH neurons were revealed in the brain slices by 
IHC using the EL14 antibody and the OVLT was used as a neuroanatomical reference 
point for rostral to caudal alignment of coronal sections. (C): Total number of GnRH 
immunoreactive neurons identified with the EL14. Error bars represent SEM (n=6 for 
both genotypes). (D): Histogram displaying the rostral-caudal distribution of GnRH 
immunoreactive neurons from WT and KO mice aligned at the OVLT. Plot represents 
average GnRH immunoreactive neurons per 50 µm coronal section. GnRH 
immunoreactive neurons were identified with the EL14 antibody.     
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2.3.4.4 Pubertal onset is delayed but not impeded in Gnaqd/d mice.  
External anatomic abnormalities were not detected in Gnaq
d/d 
mice when compared to 
their littermate controls Gnaq
fl/fl
. Weight gain over time was comparable between the 
genotypes for each gender Females; Gnaq
fl/fl
 vs. Gnaq
d/d
 = 20.7± 0.9g; n = 13 and 22.9± 
0.7g; n = 14(P > 0.1). Males; Gnaq
fl/fl
 vs. Gnaq
d/d
 = 26.2 ± 0.6g; n = 22 and 27.1± 0.9g; n 
= 23 (P > 0.1) (Fig. 2.16). We used multiple established indices to assess the reproductive 
phenotype if the Gnaq
d/d 
mice. Pubertal onset in females was assessed by vaginal opening 
(VO) and in males by preputial separation (PPS) and anogenital distance (AG) (Fig. 
2.18). (Lapatto et al. 2007, Parakarainen et al. 2005, Novaira 2014, Herbison et al. 2008 
and Chan et al. 2009 Caligioni 2009).Over the age range assessed, anogenital distance 
(mm) in males was not significantly different between genotypes except at 16 day old 
where control Gnaq
fl/fl
 measured approximately 1.2 mm longer than Gnaq
d/d
 littermates 
(Fig. 2.18A) (P < 0.05). PPS was significantly delayed by about 4 days in Gnaq
d/d 
males 
compared to their Gnaq
fl/fl 
littermates (Fig. 2.18 B)  (P<0.0001). VO was also 
significantly delayed by about 4 days in Gnaq
d/d 
females compared to Gnaq
fl/fl 
littermates 
(Fig. 2.18 C) (P<0.05). Delays in PPS and VO are not due to differences in body weight 
since there was no significant difference between the genotypes (Fig. 2.17).  
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Figure 2.17: Loss of Gnrh neuron-specific Gnaq and Gna11 has no effect on the 
weight gain of mice. 
(A). Average body weight of 8 week old mice show that while males tended to be heavier 
than females there was no significant difference in body weight between genotypes 
within the same gender. Females; Gnaq
fl/fl
 vs. Gnaq
d/d
 = 20.7± 0.9 g; n = 13 and 22.9± 0.7 
g; n = 14(P>0.1). Males; Gnaq
fl/fl
 vs. Gnaq
d/d
 = 26.2 ± 0.6 g; n = 22 and 27.1± 0.9 g; n = 
23 (P>0.1). Error bars represent SEM. (B). Average female weight over age. At 16 days 
old, Gnaq
fl/fl 
were significantly heavier than Gnaq
d/d 
littermates (9.3 ± 0.5 g; n = 17 vs. 
7.9 ± 0.4 g; n =18 (P<0.05). At 100 and 108 days this result was reversed where  Gnaq
d/d 
were significantly heavier than Gnaq
fl/fl
 littermates. (19.7 ± 0.6 g; n = 7 vs. 21.9 ± 0.4 g; n 
= 6 (P < 0.05)) and (20.3 ± 0.6 g; n = 7 vs. 22.7 ± 0.5 g; n = 6 (*P < 0.05)). Error bars 
represent SEM. (C). Average male weight over age was not significantly different except 
at 16 days old Gnaq
fl/fl 
were significantly heavier than Gnaq
d/d 
littermates (9.2 ± 0.4 g; n = 
15 vs. 7.2 ± 0.5 g; n = 11 (*P < 0.05)). Error bars represent SEM. 
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Figure 2.18: Loss of Gnaq and Gna11 in the GnRH neuron delays but does not 
prevent pubertal onset. 
 (A). Anogenital distance (mm) in males over age was not significantly different between 
genotypes except for 16 days old where Gnaq
fl/fl
 > Gnaq
d/d
; 6.7 ± 0.2 mm; n = 8 vs. 5.5 ± 
0.6 mm; n = 6 (P < 0.05). (B). Graphical representation of the time course of the day of 
preputial separation in males showing that Gnaq
d/d 
took significantly longer than Gnaq
fl/fl 
littermates; 36.8 ± 0.8 days; n = 21  vs. 32.1 ± 0.6 days; n = 25 (*P < 0.0001). (C). 
Graphical representation of the time course of the day of vaginal opening in females 
showing that Gnaq
d/d 
took significantly longer than Gnaq
fl/fl 
littermates; 39.4 ± 1.6 days; n 
= 21 vs. 35.6 ± 1.0 days; n = 22 (P < 0.05) Error bars represent SEM. 
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2.3.4.5 Estrous cycling is abnormal in Gnaqd/d mice but sporadic 
estrus phases are still observed.  
To further characterize female reproductive development we used a combination of daily 
vulva examination and vaginal cytological assessment following vaginal lavage to 
evaluate estrous cyclicity over a period of 17 days (Novaira et al. 2014). Each female was 
tested at two ages, 8-11 weeks and 13-16 weeks of age. Control Gnaq
fl/fl 
mice had an 
average cycle length of 5.23 ± 0.21 days (n = 6) (Fig. 2.19A and B). Gnaq
d/d 
mice did not 
display a normal estrous cycling pattern so cycle length could not be calculated (n=6). In 
order to make a comparison, the total number of times the mice were found in estrus over 
the assessment period was analyzed (Chan et al. 2009). We found that at both age ranges 
examined Gnaq
d/d 
mice displayed significantly fewer estrous stages than control Gnaq
fl/fl 
litermates; 8-11 weeks; 1.3 ± 0.4; n = 6  vs 3.5 ± 0.2; n = 6 (P<0.05). 11-13 weeks; 3.7 ± 
0.4; n = 6 vs. 1.5 ± 0.4; n = 6 (P < 0.05) (Fig. 2.19C).  
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Figure 2.19:  
 
153 
 
Figure 2.19: Loss of Gnaq and Gna11 in the GnRH neuron causes abnormal estrous 
cyclicity but does not prevent sporadic estrus from occuring. 
(A-B). Graphic representation of estrous cycle as determined by vulva observation and 
vaginal cytology followed for 17 days at 8-11weeks of age then again at 13-16weeks (n = 
6). (A). Control Gnaq
fl/fl 
females with average cycle length of 5.2 ± 0.2 days (n = 6). (B). 
Gnaq
d/d 
females did not display normal cyclicity so cycle length could not be calculated. 
(C). Total number of estrus stages over assessment period. Gnaq
d/d 
mice displayed 
significantly fewer estrous stages than control Gnaq
fl/fl 
litermates at both ages. 8-11 
weeks; 1.3 ± 0.4, n = 6 vs 3.5 ± 0.2, n = 6 (*P<0.05). 11-13 weeks; 3.7 ± 0.4; n = 6 vs. 
1.5 ± 0.4; n = 6 (P < 0.05). Error bars represent SEM.  
 
2.3.4.6 Reproductive tract abnormalities and impaired fertility in 
Gnaqd/d mice  
Post-pubertal (8 weeks old) untested and previously unmated Gnaq
d/d 
male and female 
mice were paired to fertile proven dams and studs respectively for 18-21 days. 9 of 15 
male Gnaq
d/d 
mice (60%) were able to impregnate females; however 100% of Gnaq
d/d 
females (15 in total) failed to become pregnant (Fig. 2.20C). When Gnaq
d/d 
males and 
females were paired to each other under the exact same conditions, as expected, no 
successful mating occurred demonstrating that the double deletion of Gnaq and Gna11 
the GnRH neuron compromises reproductive capacity. As seen in Fig. 2.20A and B, 
female reproductive tracts are significantly smaller (37%) in Gnaq
d/d 
mice compared to 
Gnaq
fl/fl 
controls (36.7 ± 5.4 mg; n = 14 vs. 99.3 ± 9.3 mg; n =13 (P < 0.0001). This result 
is not influenced by body weight since there is no significant difference between 
genotypes (Fig. 2.17). Relative to littermates, histological analysis of ovaries and uteri of 
Gnaq
d/d 
females show clear evidence of abnormalities (Fig. 2.21E and F). Gnaq
d/d 
ovaries 
(Fig. 2.21E) shows an absence of corporea lutea (CL) indicating that oogenesis was 
disrupted since primary, preantral and antral follicles are present. So the infrequent 
transition to estrus stages observed with Gnaq
d/d 
females previously (Fig. 2.19) is not 
associated with ovulation. Male testicular weight was also reduced in Gnaq
d/d 
mice 
154 
 
compared to Gnaq
fl/fl 
controls showing a 61% reduction (Fig. 2.20A and B), 131.8 ± 8.6 
mg; n = 23 vs. 216.8 ± 13.7 mg; n = 22 (P<0.0001).  Histological analysis of the testis 
show that Gnaq
d/d 
mice had decreased amounts of luminal sperm compared to Gnaq
fl/fl 
controls (Fig. 2.21D).  
 
Figure 2.20: Loss of Gnaq and Gna11 in the GnRH neuron causes reproductive tract 
abnormalities and impaired fertility. 
(A-B). Gross gonadal anatomy and weight show that Gnaq
d/d 
female reproductive tracts 
are 37% smaller than controls (36.7 mg ± 5.4 n = 14 vs. 99.3 mg ± 9.3 n =13 (P < 
0.0001). Male testicular weight was also significantly reduced in Gnaq
d/d 
mice (61%), 
131.8 mg ± 8.6 n =23 vs. 216.8 mg ± 13.7 n =22 (*P<0.0001).  Average represents SEM. 
Reproductive tracts and gonads were taken from unmated and untreated 8-16 week old 
mice. Females were in metestrus. Scale bars = 10 mm. (C). Fertility assessment of 
Gnaq
d/d 
mice showed that while 60% Gnaq
d/d 
males (9/15) engaged in successful matings, 
100% of females were infertile (15/15).  
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Figure 2.21: Gonadal histology of Gnaq
d/d 
mice demonstrates abnormal phenotype. 
(A). Representative sections of testes shows reduced luminal spermatozoa (S) in the 
seminiferous tubules of Gnaq
d/d 
males compared to Gnaq
fl/fl 
controls which show lumens 
filled with sperm. Spermatogenisis was variable in Gnaq
d/d 
males and those with more 
sperm correlated to their fertility while those with little or none were sterile (not shown). 
(B). Representative section of Gnaq
d/d 
ovary shows an absence of corporea lutea (CL) 
indicating that oogenesis was disrupted since primary, preantral and antral follicular (AF) 
stages are present. Gnaq
fl/fl 
control females show follicles at all stages of development 
including many CL. (C). Representative section of Gnaq
d/d 
uterus were smaller and 
showed fewer glandular structures than Gnaq
fl/fl 
control females (St) Stroma; (L) Uterine 
lumen.  
 
 
156 
 
2.3.5 KISS1R signals through Gαq/11 -independent mechanisms to 
regulate LH secretion 
In vitro studies in the Babwah laboratory showed that both WT KISS1R and L148S 
trigger ERK1/2 phosphorylation independently of Gαq/11 (Figs. 2.5-2.8) (Pampillo et al. 
2009, Szereszewski et al 2010). We also demonstrated that KISS1R signals via β-arrestin 
to regulate GnRH secretion (Fig. 2.4). Then we showed that the endogenous function of 
the GnRH neuron was still somewhat intact in the Gnaq
d/d 
mice since they displayed 
delayed pubertal onset and were still partially fertile (Figs. 2.17-2.21). We now 
hypothesized that like the endogenous function, Kiss1/Kiss1r would be able to signal 
through these Gαq/11-independent pathways to trigger Kp-dependent LH secretion thereby 
providing a potential explanation for the sustained fertility seen in the Gnaq
d/d 
mice. Our 
results revealed that although significantly less than control littermates, Kp-dependent 
LH secretion was still significantly more than basal levels in GnRH-neuron specific 
Gαq/11 double knockout mice. Taken together these findings confirm a novel role for 
Gαq/11-independent signaling in the GnRH neuron in mediating endogenous as well as 
Kp-dependent GnRH release and thereby fertility in mice.  
2.3.5.1 Kisspeptin-triggered gonadotropin and testosterone 
secretion is significantly reduced in Gnaqd/d mice.  
To test this hypothesis, all females used for hormonal secretion assays were 
ovariectomized prior to KP-54 stimulation in order to preclude the effects of the estrus 
cycle on GnRH secretion. Exogenous KP-54 was administered by i.p. injection at a dose 
of 100nmol/Kg and blood was collected for LH and FSH analysis 1 h later. Serum 
gonadotropins were used as well established surrogate markers for GnRH secretion 
(Seminara et al 2003, Chan et al 2009, Gottsch et al 2004 and Ramaswamy et al 2007). 
As expected, the level of kisspeptin-stimulated gonadotropin secretion by the Gnaq
d/d 
females was significantly less than Gnaq
fl/fl
 females (P < 0.005) however it was still 
significantly greater than vehicle treatment (P < 0.005) (Fig. 2.22A and B). Both control 
(Gnaq
fl/fl
) and Gnaq
d/d 
(dKO) females showed significant increases in LH and FSH 
secretion after kisspeptin stimulation when compared to vehicle treatment (Fig. 2.22A 
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and B). These results indicate that there is Gαq/11-independent kisspeptin-stimulated 
GnRH secretion in the female mouse.  
 
 
Figure 2.22: Loss of Gnaq and Gna11 in the GnRH neuron diminishes but does not 
completely abolish KP-54 triggered LH and FSH secretion in the female mouse. 
In this study, 9 week old ovariectomized virgin female mice were used. A. LH secretion 
for KP-54 treated control Gnaq
fl/fl 
females was significantly greater than vehicle treatment 
(12.4 ± 2.4 ng/ml LH; n =10 vs. 2.9 ± 0.8 ng/ml LH; n =5, P< 0.001) and similarly LH 
secretion for KP-54 treated Gnaq
d/d 
females was significantly greater than vehicle 
treatment (0.8 ± 0.1 ng/ml LH; n =10 vs. 0.1 ± 0.02 ng/ml LH; n =7, P< 0.05). B. FSH 
secretion for KP-54 treated control Gnaq
fl/fl 
females was significantly greater than vehicle 
treatment (40.5 ± 2.4 ng/ml FSH; n =10 vs. 30.7 ± 2.7 ng/ml FSH; n =4, P< 0.005) and 
similarly LH secretion for KP-54 treated Gnaq
d/d 
(dKO) females was significantly greater 
than vehicle treatment (10.9 ± 1.2 ng/ml FSH; n = 10 vs. 0.18 ± 0.005 ng/ml FSH; n = 6  , 
P<0.001). Error bars represent SEM.  
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To further test if the hypothesis that in the Gnaq
d/d
 mice, kisspeptin would trigger GnRH 
secretion independently of Gαq/11 held true in males as it did in females, 7 week old 
Gnaq
d/d 
and littermate control mice were used. Unlike females which were 
ovarectomized, intact males were used in this study since they do not experience dramatic 
fluctuations in GnRH secretion. Serum was assayed for LH, FSH and testosterone under 
basal and stimulated conditions. As observed with the Gnaq
d/d
 females, in Gnaq
d/d
 males, 
kisspeptin triggered significant increase in LH and FSH compared to vehicle. This 
indicates that Kiss1r can cause GnRH secretion via a previously unreported Gαq/11-
independent pathway in the male mouse (Fig. 2.23A, B and C). Serum testosterone 
further supports the existence of Gαq/11-independent gonadotropin secretion downstream 
of Kiss1/Kiss1r signaling (Fig. 2.23C).  
Figure 2.23:  
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Figure 2.23: Loss of Gnaq and Gna11 in the GnRH neuron diminishes but does not 
completely abolish KP-54 triggered gonadotropin and testosterone secretion in the 
male mouse. 
In this study, 9 week old intact, virgin male mice were used and were treated with saline 
(vehicle) or KP-54 for 1 hour before blood collection or were pre-treated with Antide 
(An) (GnRH antagonist) prior to saline/KP-54 administration and blood collection.  
Figure 2.23A: LH secretion in response to treatment.  
 In Gnaqfl/fl mice KP-54 triggered significantly more secretion than saline treated 
Gnaq
fl/fl
 mice (9.7 ± 0.6 ng/ml LH; n =16 vs. 0.24 ± 0.05 ng/ml LH; n =11) (a) P< 
0.0001.  
 In Gnaqd/d mice KP-54 triggered significantly more secretion than in saline treated 
Gnaq
d/d
 mice (0.67 ± 0.12 ng/ml LH; n = 9 vs. 0.15 ± 0.02 ng/ml LH; n = 9) (b) P< 
0.05. Also, no significant difference in LH secretion was observed between Gnaq
d/d
 
mice treated with Antide+KP-54 or saline.  
 In Gnaqfl/fl mice KP-54 triggered significantly more secretion than Antide+KP-54 
treated Gnaq
fl/fl
 mice 9.7 ± 0.6 ng/ml LH; n =16 vs. 0.17 ± 0.008 ng/ml LH; n = 8) (c) 
P< 0.05. Also, no significant difference in LH secretion was observed between 
Gnaq
fl/fl
 mice treated with Antide+KP-54 or saline.  
Figure 2.23B: FSH secretion in response to treatment.  
 In Gnaqfl/fl mice KP-54 triggered significantly more secretion than saline treated 
Gnaq
fl/fl
 mice (38.5 ± 1.8 ng/ml FSH; n =16 vs. 22.8 ± 1.9 ng/ml FSH; n =11) (a) P< 
0.05.  
 In Gnaqd/d mice KP-54 triggered significantly more secretion than in saline treated 
Gnaq
d/d
 mice (3.1 ± 1.0 ng/ml FSH; n = 9 vs. 0.6 ± 0.3 ng/ml FSH; n = 9) (b) P< 0.05. 
 In Gnaqfl/fl mice Antide treatment significantly reduces FSH secretion compared to 
saline treated Gnaq
fl/fl 
mice (8.7 ± 0.8 ng/ml FSH; n = 7 vs 22.8 ± 1.9 ng/ml FSH; n = 
11) (c) P< 0.05.  
 In Gnaqfl/fl mice Antide +Kp-54 significantly reduces FSH secretion compared to 
saline and KP-54 treatment in Gnaq
fl/fl
 mice (9.2 ± 1.4 ng/ml FSH; n = 8 vs. 22.8 ± 1.9 
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ng/ml LH; n = 11) and (9.2 ± 1.4 ng/ml FSH; n = 8 vs. 38.5 ± 1.8 ng/ml FSH; n = 16). 
(d) and (e) P< 0.05  
Figure 2.23C: Testosterone secretion in response to treatment.  
 In Gnaqfl/fl mice KP-54 triggered significantly more secretion than saline treated 
Gnaq
fl/fl
 mice (41.3 ± 5.2 ng/ml T; n = 10 vs. 0.4 ± 0.2 ng/ml T; n = 4) * P< 0.05.  
 In Gnaqd/d mice KP-54 triggered significantly more secretion than saline treated 
Gnaq
d/d 
mice (7.1 ± 1.1 ng/ml T; n = 9 vs. 0.5 ± 0.3 ng/ml T; n = 6) *P< 0.05  
 
 
Some studies have suggested that the variable phenotype seen in patients with IHH and 
also in mice lacking either Kiss1 or Kiss1r is due to direct KISS1/KISS1R action on 
pituitary gonadotropes causing LH secretion (Gottsch et al. 2004, Seminara et al. 2003, 
Chan et al. 2009, d’Anglemont de Tassigny et al. 2007, and Tenebaum-Rakover et al. 
2007) . If this was indeed the case, it could provide an alternate explanation for the sub-
fertile phenotype seen with our Gnaq
d/d 
mice. Moreover, since kisspeptin was 
administered systemically, the diminished yet significant increase in LH, FSH and 
testosterone secretion may also be explained by direct action of Kiss1 on the pituitary.  
While more recent studies using GnRH neuronal specific knockouts of KISS1R have 
demonstrated that the GnRH neuron is in fact the singular site for Kiss1/Kiss1r regulation 
of the HPG axis, it was still important for us to show that in our Gnaq
d/d
 the kisspeptin 
stimulated hormonal responses were due to GnRH action on the pituitary (Kirilov et al 
2013, Novaira et al 2014 and Mesanger et al 2005). To do this we pre-treated mice with a 
GnRH specific antagonist, antide, prior to kisspeptin administration (Chan et al 2009 and 
Gottsch et al 2004) and we found that antide effectively ablated kisspeptin-dependent 
LH, FSH and testosterone secretion in both Gnaq
d/d 
and littermate controls (Fig 2.23). 
Therefore kisspeptin-triggered hormone secretion is the result of its action on the GnRH 
neuron and not at the pituitary level thus supporting our hypothesis that KISS1R signals 
independently of Gαq/11 in the GnRH neuron to mediate GnRH secretion.  
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2.3.5.2 Hypothalamic and pituitary gene expression in Gnaqd/d 
mice  
Because genetic deletion of genes may sometimes lead to the development of unexpected 
molecular compensatory mechanisms we compared the expression of major central genes 
involved in the regulation of reproduction in Gnaq
d/d 
mice relative to WT animals from 
the same parental strain (C57BL/6J). We used WT instead of littermate controls since 
these are Gnaq
fl/fl 
mice with Gna11 deletion from entire genome. While Gnaq
fl/fl 
has no 
overt phenotype (Gnaq compensates fully for loss of Gna11) it may have some subtle 
unknown effect at the level of gene expression (Offermans et al 1997, Wettschureck et al 
2001). We choose to investigate the following genes to ensure that differences in 
hormonal secretion (Figs. 2.22 and 2.23) were not due to differences in gene transcription 
at the central level of the HPG axis; Kiss1, Kiss1r, Gnrh-1, Gnrh-r1, Lhb, Fshb.  
Our results show that Kiss1r is expressed in hypothalamus and pituitary at equivalent 
levels in WT and Gnaq
d/d
 mice (Fig. 2.24). Kiss1r pituitary expression is expected and 
has been described in previous studies, however it has been shown to not play a major 
role in gonadotropin secretion (Richard et al 2009, Kirilov et al. 2013 and Novaira et al. 
2014). This result also indicates that loss of Gαq/11 in the GnRH neuron did not lead to 
compensatory up-regulation of Kiss1R in the hypothalamus or pituitary (Gottsch et al 
2004, Chan et al. 2009 and Richard et al 2009).   
As expected, Kiss1 hypothalamic expression is significantly higher in Gnaq
d/d
 than WT 
mice due to reduced negative feedback of gonadal steroids (Fig. 2.24). Negative steroid 
feedback is shown to act at the level of the hypothalamus, not pituitary, specifically on 
kisspeptin neurons in the arcuate nucleus (ARC) (Shahab et al. 2005, Smith et al. 2005, 
Bateman and Patisaul et al. 2008 and Frazao et al. 2013). Since we showed that Gnaq
d/d
 
mice have lower levels of circulating gonadal steroids (Fig. 2.23C) and this would mean 
less negative feedback to reduce Kiss1 expression in those ARC kisspeptin neurons.  
Hypothalamic Gnrh-1 mRNA expression is significantly greater in Gnaq
d/d
 compared to 
WT mice indicating that Gαq/11 signaling regulates GnRH synthesis as well as secretion 
in the GnRH neuron (Fig. 2.24). This is not surprising since Kiss-1 expression is also 
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significantly increased in Gnaq
d/d
 mice and studies done in immortalized mouse GnRH 
neuronal cell lines (GT1-7 and GN-11) have demonstrated that kisspeptin positively 
regulates GnRH synthesis and secretion (Novaira et al. 2009, Mellon et al. 1990, Mayer 
et al. 2009).  
GnRH-R1 is expressed on anterior pituitary gonadotropes which are stimulated by 
hypothalamic GnRH to secrete LHβ and FSHβ into systemic circulation. As expected, 
Gnrh-r1 is strongly expressed in the pituitary and is significantly higher in WT than 
Gnaq
d/d
 mice. GnRH stimulation is required for Gnrhr-1gene transcription so in the 
Gnaq
d/d 
mice where there is impaired GnRH secretion as demonstrated by decreased 
gonadotropin levels (Figs. 2.22 and 2.23), there will therefore also be reduced Gnrhr-1 
mRNA expression in pituitary gonadotropes (Kaiser et al. 1994 and Bedecarrats and 
Kaiser 2007). Lhb (gene encoding for LHβ) and Fshb (gene encoding for FSHβ) are 
expressed significantly higher in WT pituitary than Gnaq
d/d
. This further supports the 
finding that GnRH secretion is impaired in Gnaq
d/d 
mice since GnRH is required for 
gonadotropin gene expression (Kaiser et al 1997 and Noel et al 2011).  
Overall, based on relative gene expression, there is no evidence to support compensatory 
up-regulation of gene expression due to Gαq/11 deletion in hypothalamic GnRH neurons. 
In Gnaq
d/d 
mice there is increased Kiss-1 expression (due to lack of negative steroid 
feedback) this stimulates increased GnRH-1 transcription since kisspeptin regulates both 
GnRH transcription and secretion (Fig. 2.24) (Novaira et al. 2009). However in the 
absence of Gαq/11, GnRH secretion is compromised, demonstrated by the significantly 
lower levels of gonadotropin gene expression and basal secretion in Gnaq
d/d 
mice (Figs. 
2.22, 2.23 and 2.24). Nonetheless, kisspeptin treatment in these mice is still able to 
stimulate significant gonadotropin and sex steroid release via a Gαq/11 independent 
pathway (Figs. 2.22 and 2.23).   
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Figure 2.24: Loss of Gnaq and Gna11 in the GnRH neuron does not affect 
expression of genes regulating reproduction in the mouse hypothalamus and 
pituitary. 
In this study 7 week old male Gnaq
d/d
 (-/-) and WT (+/+) mice were used. Hypothalami 
and pituitaries were used for quantitative RT-PCR (qPCR) measurement of relative gene 
expression. There is significantly more hypothalamic Kiss1 and GnRH-1 in Gnaq
d/d 
mice 
and significantly less expression of Gnrh-r, Lhb and Fshb in Gnaq
d/d 
pituitary. No 
significant difference in Kiss1r expression is observed. All gene expression normalized to 
housekeeping gene Actb (encodes β-actin). Inset shows representative 1% agarose gel 
with qPCR products. *P<0.01. Each bar is an average of 3 independent analyses. Error 
bars represent SEM. 
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2.3.5.3 Gnaqd/d mice do not signal through Gna14 in the absence 
of Gnaq and Gna11.  
Our Gnaq
d/d
 mouse model employed Gnrh-Cre to allow GnRH-neuron specific 
inactivation of Gαq, and Gα11. From our in vivo findings, the Gnaq
d/d
 mice are still able to 
secrete sufficient GnRH in response to kisspeptin to give rise to a small yet significant 
increase in serum gonadotropins and gonadal steroids (Figs. 2.22 and 2.23). The Gnaq
d/d
 
mice also exhibited a modest reproductive capacity where males could sometimes 
impregnate proven dams and females were still able to undergo follicle development 
(Figs. 2.20 and 2.21). This is not surprising since reproduction is critical for the survival 
of any species and multiple redundant and back-up systems are probably in place to 
maintain some level of fertility. We hypothesized that this kisspeptin-triggered GnRH 
secretion in the Gnaq
d/d
 mice was due to a Gαq/11 –independent pathway downstream of 
KISS1R. Coupled with our in vivo results showing that lack of either β-arrestin isoform 
(1 or 2) significantly impaired kisspeptin-triggered GnRH secretion (Fig. 2.4) and a 
KISS1R mutant; L148S signals to ERK1/2 (Figs. 2.5,2.6, 2.7 and 2.8), we propose that β-
arrestins are part of the Gαq/11 –independent pathway downstream of KISS1R that 
regulates GnRH secretion.  
The four members of the Gαq family of proteins are Gαq, Gα11, Gα14, Gα15/16 encoded by 
genes Gnaq, Gna11, Gna14 and Gna15 respectively (Exton, 1996 and Rhee, 2001). Gαq, 
and Gα11 are ubiquitously expressed and most receptors are able to activate either isoform 
equally hence the “Gαq/11” terminology used in the literature (Wange et al., 1991, Wu et 
al., 1992, Offermanns et al., 1994, 1999 and 2003). Murine Gα15 (human equivalent Gα16) 
is only expressed in a subset of hematopoietic cells and Gα14 expression is restricted to 
the lung, kidney and testis (Amatruda et al. 1991, Wilkie et al. 1991, Tanaka et al., 2000, 
Offermanns, 1999 and 2003). To further support our hypothesis that KISS1R can signal 
via β-arrestins (Gαq/11–independent) to trigger GnRH secretion we firstly investigated 
hypothalamic expression of other member of the Gαq family; Gα14 and Gα15. 
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A.  
B.  
 
Figure 2.25: Loss of Gnaq and Gna11 in the GnRH neuron does not affect 
expression of other Gq family of genes, specifically Gna14 and Gna15.   
In this study 7 week old male Gnaq
d/d
 (-/-) and WT (+/+) mice were used. Hypothalami 
and pituitaries were used for quantitative RT-PCR (qPCR) measurement of relative gene 
expression of Gnaq, Gna11 and Gna14. All samples were normalized to Actb (β-actin). 
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Inset shows representative 1% agarose gel with qPCR products. No significant difference 
in G-protein gene expression is observed between Gnaq
d/d
 and WT mice. Error bars 
represent SEM. Each bar is an average of 3 independent analyses. B. Representative 
images of sagittal brain sections of 8 week old male mice from the Allen Mouse Brain 
Atlas showing the localization of Gnaq, Gna14 and Gna15 by in situ hybridization (left 
panels) and having background signal filtered out so that only expression patterns are 
visible (right panels). Circled region represents the approximate localization of the 
hypothalamus. Scale bar is 2000 µm. (Image credit: Allen Mouse Brain Atlas, 2014) 
 
As expected there is no significant difference in expression between genotypes (Gnaq
d/d
 
vs. WT). Since Gαq was only deleted in GnRH neurons the hypothalamic Gnaq
d/d
 sample 
still shows strong expression of Gαq since it will be expressed normally in all other 
hypothalamic cells (Fig. 2.25A). Gnaq
d/d
 mice also were created in the background of full 
body Gα11 deletion and which is why only the WT hypothalamus and pituitary show 
Gna11 expression (Fig. 2.25A). Unlike Gnaq, both Gna14 and Gna15 are weakly 
expressed the brain with no detectable expression in the hypothalamus as demonstrated 
by quantitative real-time PCR (Fig. 2.25A) and in situ hybridization by the Allan Institute 
for Brain Science (Fig. 2.25B). This is in agreement with other published studies (Wilkie 
et al., 1991, Amatruda et al., 1991, Tanaka et al., 2000). Functional studies done by 
Wacker et al., 2008 demonstrated that when overexpressed in a heterologous system of 
HEK 293 cells, KISS1R displays Gna15-concentration dependent PIP2 hydrolysis. These 
studies were however performed in HEK 293 cells and our present study focuses on the 
hypothalamic GnRH neuron where there is no compelling evidence that Gα15 is expressed 
in the hypothalamus (Fig. 2.25B) (Wilkie et al., 1991, Amatruda et al., 1991, Tanaka et 
al., 2000). Therefore, while KISS1R may be able to signal through Gα15 this is not a 
mechanism likely to be employed in the GnRH neuron. To date, it has not been 
determined whether or not KISS1R can signal via Gα14 and therefore one of our goals 
was to investigate this, despite the evidence suggesting that GnRH neurons do not 
express Gna14 (Fig. 2.25).  
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We co-transfected HEK 293 cells with WT KISS1R and various concentrations of Gnaq 
and Gna14 then measured ERK1/2 phosphorylation after 10 minutes of 100nM KP-10 
(Fig. 2.26). We see that while KISS1R displays a concentration-dependent ERK1/2 
phosphorylation response with increasing amounts of Gnaq, this response is not seen 
with increasing concentrations of Gna14 indicating that KISS1R does not signal through 
Gna14. Overall, the results in Figs 2.25 and 2.26 strongly indicate that the Gαq/11–
independent cascade downstream from KISS1R is not via Gna14 or Gna15.  
 
Figure 2.26: KISS1R does not signal through Gα14 to trigger ERK1/2 phosphorylation. 
Representative autoradiographs and densitometric analysis showing the expression of 
phosphorylated ERK1/2 and β-actin as a loading control. A. KISS1R and Gαq co-
transfected cells show a significant increase in ERK1/2 phosphorylation with increasing 
Gαq concentrations. B. KISS1R and Gα14 co-transfected cells show no significant 
difference in ERK1/2 phosphorylation with increasing Gα14 concentrations. Data 
represents the mean of 3 independent experiments #P<0.05 pERK/ β-actin ratio 
compared to KISS1R only. Error bars represent SEM.  
168 
 
2.4 Discussion 
Since the initial discovery of the role of the KISS1/KISS1R system in regulating the 
timely onset of puberty, many studies have since confirmed the integral role of this 
system in reproductive function and fertility. Firstly genetic analysis have revealed even 
more KISS1R mutations (12 to date) in patients diagnosed with infertility and IHH 
(Cerrato et al. 2007, Wahab et al. 2011, Nimiri et al. 2011, Pinilla et al. 2012). Secondly, 
mice genetically modified to lack Kiss1 or Kiss1r expression are infertile and phenocopy 
human IHH patients (Funes et al. 2003, Seminara et al. 2003, Lapatto et al. 2007, Kirilov 
et al. 2013, Novaira et al. 2014). Thirdly, central and peripheral administration of 
kisspeptin potently stimulates GnRH and gonadotropin secretion in rodents, sheep and 
primates and kisspeptin antagonists ablate this response (d’Anglemont de Tassigny et al. 
2007, Gottsch et al. 2004, Navarro et al. 2004. Irwig et al. 2004, Han et al. 2005, Shahab 
et al. 2005, Keen et al. 2008, Ramaswamy et al. 2007, Roseweir et al. 2009, Guierro et al. 
2012, Pineda et al. 2010). Finally, kisspeptin agonists have been used to stimulate the 
HPG axis in both healthy and unhealthy male and female patients (Jayasena et al. 2010 
and Chan et al. 2011). Recently, kisspeptin has even been used to facilitate successful in 
vitro fertilization resulting in full term pregnancy and live birth of a healthy baby 
(Jayasena et al. 2014).  
In contrast to the in vivo reports above, a much smaller number of studies have provided 
substantial mechanistic insight into how KISS1R signals intracellularly to regulate 
biological functions and how receptor-based mutations affect these signaling events 
(Pampillo et al. 2009, Szereszewski et al. 2010, Ahow et al. 2014, Nimiri et al. 2011, 
Chevrier et al. 2013, Teles et al. 2008, Liu et al. 2008, Wacker et al. 2008, Bianco et al. 
2011, Babwah et al. 2012, Zajac et al. 2011, Cvetkovic et al. 2013). Based on these 
studies it is now well established that the KISS1/KISS1R system potently stimulates 
GnRH secretion in a Gαq/11-dependent manner. Previous publications have also suggested 
that KISS1R is capable of signaling to ERK1/2 independently of Gαq/11, in a β-arrestin-
dependent manner (Pampillo et al. 2009, Szereszewski et al. 2010). β-arrestin dependent 
signaling has now been established for many GPCRs including but not limited to, AT1AR, 
β2AR, PAR, V2R and NK-1 (Ahn et al. 2004, shenoy et al. 2006, Ren et al. 2005, Getsy-
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Palmer et al. 2006, Wei et al. 2003, Tohgo et al. 2002, DeFea et al. 2000, Luttrell et al. 
2001). β-arrestin has been shown to mediate insulin secretion and since ERK1/2 is critical 
step in GnRH secretion it is therefore plausible that KISS1R can signal through β-arrestin 
to promote GnRH secretion (Sonoda et al. 2008, Ravier et al. 2014, Silvestre et al. 2008, 
Castellano et al. 2006). We therefore hypothesize that KISS1R can signal through Gαq/11 
and Gαq/11 –independent mechanisms, the latter most likely involving β-arrestins, to 
mediate GnRH secretion and overall fertility.  
Many in vivo studies demonstrated that KISS1R rapidly desensitizes in the continuous 
presence of the kisspeptin agonist however the underlying mechanism was unknown  
(Seminara et al. 2006, Plant et al. 2006, Thompson et al. 2006, Ramaswamy et al. 2007, 
Messager et al. 2005). We demonstrated that GRK2 mediated KISS1R homologous 
desensitization and suggested that β-arrestin may be involved (Pampillo et al. 2009). Here 
we provide direct proof that β-arrestins mediate KISS1R homologous desensitization on a 
molecular level. Physiologically this is an important finding since kisspeptin agonists are 
proposed as a more effective therapy compared to GnRH agonists currently used for 
endometriosis, sex-steroid dependent cancers and uterine fibroids. This treatment strategy 
is based on KISS1R being more rapidly desensitized than GnRHR (Pinilla et al. 2012 and 
Millar, 2010). On a molecular level, this is also a significant and novel finding since 
some GPCRs such as GnRHR desensitize in a β-arrestin-independent manner. Also it 
supports the hypothesis that KISS1R engages in β-arrestin-dependent signaling since 
desensitization is a critical initial step in this process (Luttrell et al. 2002, Luttrell et al. 
2010). In this study we demonstrated that a loss of either β-arrestin-1 or -2 results in 
about 20-25% reduction in kisspeptin-triggered LH secretion while had no effect on 
GnRH-triggered LH secretion at the level of the pituitary (Ahow et al. 2014). This 
reduced kisspeptin-triggered LH secretion had no effect on fertility based on brood size 
and is consistent with previous reports that describe limited secretion still being sufficient 
to support fertility (Popa et al. 2013, Mayer et al. 2011, Herbison et al. 2008). It is 
possible that isoform compensation did occur to some extent where the β-arrestin isoform 
that was still expressed was able to perform most of the functions of the isoform that was 
absent. However since we still observed reduced kisspeptin-triggered LH response in the 
single β-arrestin knockout mice it is plausible that if compensation did occur it was not 
170 
 
complete. Additionally, since both β-arrestin-1 and -2 mediate LH secretion we predict 
that their combined loss would result in a much larger reduction in LH secretion, 
reflecting an even greater role for β-arrestin in promoting GnRH secretion. It is also 
possible that combined loss of both isoforms would result in a sub-fertile phenotype, but 
unlikely an infertile phenotype since KISS1R signaling through Gαq/11 would still be 
intact. However, since β-arrestin-1 and -2 double knockout mice die around birth and 
floxed Arrb mice are unavailable, we could not test this prediction (Zhang et al. 2010 and 
Zhang et al. 2011).  
Since we could not further this study in β-arrestin double knockout mice we then 
considered the significance of all Gαq/11-independent mechanisms on KISS1R signaling 
and biological response. To investigate this further we tested the hypothesis that naturally 
occurring Gαq/11-uncoupled KISS1R mutants might maintain the ability to couple and 
signal via Gαq/11-independent mechanisms. In order to be used in this study, a given 
KISS1R mutant must fulfill the following criteria. It must localize to the plasma 
membrane, bind kisspeptin and interact with signaling molecules in the G-protein cascade 
to a similar extent as WT KISS1R. In addition to fulfilling these criteria, L148S is also 
one of a few KISS1R mutants that have been functionally well-characterised in the 
literature (Wacker et al. 2008). Furthermore, based on its strong interaction with β-
arrestin (Szereszewski et al. 2010) we hypothesize that the β-arrestin pathway represents 
a major conduit for L148S signaling (Wacker et al. 2008). We demonstrated that the 
diminished yet significant kisspeptin-triggered ERK1/2 phosphorylation downstream of 
L148S was Gαq/11 –independent and confirmed that loss of β-arrestin expression 
abolished this response (Ahow et al. 2014). The finding that L148S displays Gαq/11 –
independent signaling is important because it reveals that some mutant KISS1Rs which 
are classified as loss-of-function based on InsP3 formation might in fact be capable of 
signaling and therefore need to be more extensively functionally characterised.   
Differential activation of PLCβ and InsP3 formation is not the only way in which the 
KISS1R coupled Gαq/11 –dependent response is functionally distinct from that of the 
Gαq/11 –independent pathway. While both pathways trigger ERK1/2 phosphorylation, we 
identified STAT3 phosphorylation as a Gαq/11 pathway-specific response since it is 
171 
 
abolished following L148S activation. Signal transducer and activator of transcription 3 
(STAT3), also known as acute-phase response factor, is a transcription factor that is 
activated in the cytosol and translocates to the nucleus. This has important implications 
for the development of clinical therapies and further studies are necessary to fully 
elucidate and separate these KISS1R signaling cascades.  We previously showed that 
KISS1R activated ERK1/2 translocates to the nucleus and mediates changes in gene 
expression in GT1-7 cells (Szereszewski et al. 2010). STAT3 is activated by members of 
the MAPK pathway and it therefore may be involved in KISS1R-mediated gene 
expression via the Gαq/11 pathway (Heim 2001, Takeda et al, 1997, Yokogami et al. 
2000). STAT3 phosphorylation may also be a useful indicator for future functional assays 
to determine if the KISS1R mutants being tested are truly able to activate Gαq/11-
independent pathways or if the signaling observed is due to residual activation of Gαq/11-
dependent mechanisms. 
 At this point in our study, we demonstrated that Gαq/11-independent signaling is involved 
in both kisspeptin-triggered LH secretion through β-arrestins and L148S-mediated 
ERK1/2 phosphorylation. Therefore the Gαq/11-independent pathway may also regulate 
GnRH secretion and overall fertility. To further investigate the physiological importance 
of Gαq/11-independent signaling in reproduction GnRH-neuron specific Gαq/11 double 
knockout mice (Gnaq
d/d
) were used. We hypothesized that this mouse will display a sub-
fertile and not completely infertile phenotype since the endogenous signaling machinery 
will still be intact to allow partial GnRH release through Gαq/11-independent mechanisms. 
We further hypothesized that exogenous kisspeptin stimulation in the Gnaq
d/d 
mouse will 
still be able to trigger KISS1R-dependent GnRH secretion; albeit at a diminished level. 
To generate the Gnaq
d/d 
mouse we used well established floxed and Cre-expressing mice, 
specifically, the Gnaq
fl/fl
; Gna11
-/-
 mouse (Offermans et al. 1998, Wettschureck et al. 
2001 and Kero et al. 2007) and Gnrh-Cre transgenic mouse (Yoon et al. 2005). Both 
parental strains have been extensively used to characterise the functional importance of 
other genes in the GnRH neuron and also to identify the role of Gαq/11 in various specific 
tissues (Yoon et al. 2005, Skynner et al. 1999 and Wintermantel et al. 2006, Wolfe et al. 
2008, Leshan et al. 2009, Offermans et al. 1998, Wettschureck et al. 2001, 2005, Kero et 
al. 2007 and Breen et al. 2013). Cre recombinase expression and resulting excision of 
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exon 6 from the Gnaq gene is targeted to GnRH neurons only and we showed that this 
recombination occurs as early as E18, before pubertal onset and after the normal GnRH 
neuronal migration in development.  
We used a variety of reproductive phenotypic indices in order to assess GnRH neuronal 
function and overall fertility in the Gnaq
d/d
 mice. Established markers for pubertal onset 
(vaginal opening, preputial separation and anogenital distance) were dependant on 
exposure to estrogen and testosterone during puberty in females and males respectively 
(Lapatto et al 2007, Herbison et al. 2008 and Chan et al. 2009, Caligioni 2009, Ojeda and 
Urbanski 1994 and Nelson et al. 1982, Parakarainen et al. 2005, Novaira 2014). Post 
puberty we assessed estrous cyclicity, gonadal histology and breeding success to evaluate 
the significance of Gαq/11-independent GnRH neuronal function on adult fertility. We 
found that for both male and female Gnaq
d/d
 mice puberty onset was delayed and adults 
were sub-fertile. This phenotype closely resembles that of the Kiss1
-/-
 and Kiss1r
-/- 
mice 
(Seminara et al. 2003, Funes et al. 2003, Lapatto et al. 2007, Kirilov et al. 2013 and 
Noviara et al. 2014).  While females had abnormal estrous cycles, lacked corpora lutea in 
ovaries and were completely infertile, some males maintained the ability to produce 
sperm and were able to sire litters in 60% of matings. Overall these results indicate that 
loss of Gαq/11 in the GnRH neuron does not completely abolish GnRH secretion and that 
Gαq/11-independent mechanisms are capable of maintaining partial fertility in adults.  
We then investigated if this partial fertility was due to KISS1R signaling through Gαq/11- 
independent mechanisms to trigger kisspeptin-dependent GnRH secretion. While the 
kisspeptin-triggered LH and FSH responses in Gnaq
d/d
 ovariectomized females were 
diminished by approximately 70-90% compared to littermate controls, they were still 
significantly greater than the saline-triggered response by 86% and 98% respectively. 
Gnaq
d/d
 males followed this pattern for kisspeptin-triggered LH, FSH and testosterone 
secretion. Taken together, these results indicate that in the absence of Gαq/11 in the GnRH 
neuron, kisspeptin is still able to trigger significant yet diminished levels gonadotropin 
and gonadal hormones and therefore KISS1R can maintain partial levels of fertility 
through Gαq/11- independent mechanisms in the GnRH neuron. We therefore have shown 
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that KISS1R signals via Gαq/11 independent signaling in the GnRH neuron which is a 
novel signaling mechanism by which the mouse triggers GnRH secretion. 
Although we demonstrated that our Gαq/11 double knockout is highly specific to the 
GnRH neuron one alternative explanation for the partial fertility in the Gnaq
d/d 
mice is 
direct action of kisspeptin on the pituitary. Kiss1 and Kiss1r expression have also been 
detected in the mouse pituitary (Kotani et al 2001, Ohtaki et al 2001) and some studies 
have suggested that KISS1/KISS1R signaling in the pituitary may directly regulate 
gonadotropin secretion (Kauffman et al 2007, Richard et al. 2009, Gutierrez-Pascual et al. 
2007, Chan et al. 2009/2011, Suzuki et al. 2008 and Witham et al. 2013). Two recent 
independent studies refuted this by creating GnRH-neuronal specific Kiss1r knockout 
mice which demonstrated that regulation of reproduction by KISS1R solely occurs at the 
level of the GnRH neuron and while it may play modulatory roles in the pituitary and 
other tissues, the main site of action is at the GnRH neuron (Kirilov et al 2013 and 
Novaira et al. 2014). Our results agreed with these latter studies, confirming that 
Kiss1/Kiss1r regulation of reproduction is at the level of GnRH secretion and not due to 
direct action at the level of the pituitary since a GnRH antagonist (antide) abolished the 
kisspeptin response.  
We also confirmed by real-time PCR that the partial GnRH secretion in the Gnaq
d/d 
mice 
was not due to compensatory gene expression of other genes involved in regulating 
reproduction at the level of the hypothalamus and pituitary. While expression levels were 
different between Gnaq
d/d 
mice and littermate controls, these were expected and can be 
explained by differences in the hormonal regulation and milieu along the HPG axis of the 
Gnaq
d/d 
mice. The partial function of the GnRH neuron in the Gnaq
d/d 
mice was therefore 
through Gαq/11- independent mechanisms and we wanted to investigate if it was possible 
for the other G-proteins in this family, namely Gna14 and Gna15 could be involved in 
compensatory signaling. Functional studies done by Wacker et al. (2008) demonstrated 
that KISS1R can signal through Gα15 to activate ERK1/2. However studies done by the 
Allen Institute for Brain Science show that Gα15 is not significantly expressed in the 
mouse hypothalamus and this is supported by assays on pure cultures of immortalized 
GnRH neuronal cells such as GT1-7 that show Gα15  to be weakly expressed (Mellon et 
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al. 1990). Our results corroborated those from those from the Allan Institute which show 
non-significant hypothalamic Gα14 expression. There was also no difference in expression 
levels between Gnaq
d/d 
mice and littermate controls indicating that compensation for the 
loss of Gnaq and Gna11 through Gna14 is unlikely. In the absence of known published 
studies, we conducted a functional assay which showed that unlike Gα15 KISS1R could 
not signal through Gα14 to trigger ERK1/2 phosphorylation. Taken together these results 
demonstrate that Gαq/11 independent signaling in the GnRH neuron is most likely the 
explanation for partial fertility in the Gnaq
d/d 
male mice and not compensatory signaling 
through Gα14 and Gα15. 
An important question that emerges from our findings is whether KISS1R-coupled 
Gαq/11-independent signaling is physiologically relevant in the human population? There 
is evidence among human patients to suggest that it is. Like L148S, another KISS1R 
mutant, L120P, may meet the criteria for Gαq/11-independent signaling based on its 
pharmacological and molecular characterization (Tenebaum-Rakover et al. 2007).  
Patients bearing the L120P KISS1R mutation were diagnosed with IHH but also 
displayed variable gonadotropic deficiency ranging from partial to complete. 
Interestingly, a L102P-bearing male patient who was examined from ages 12 to 21 was 
observed to undergo progressive changes in pituitary response from an early pubertal to 
an almost full pubertal pattern (Tenebaum-Rakover et al. 2007).  This led the authors to 
propose that KISS1R inactivation, as seen with L102P, does not impede pubertal onset 
but instead delays pubertal maturation of the gonadotropic axis. Based on the current 
study, we suggest that, mechanistically, gradual pubertal maturation among patients 
bearing KISS1R mutations like L102P is in part due to Gαq/11-independent, and in 
particular β-arrestin-dependent, GnRH secretion (Tenebaum-Rakover et al. 2007).  
IHH was once considered a permanent condition, but a growing number of studies over 
the last two decades have reported on the reversal of this condition among some patients. 
In their study, Sidhoum, et al. (2014), present clinical, laboratory, neuroendocrine, and 
neuroradiologic characteristics of 308 patients with IHH. Of these, 44 patients, even 
some with severe IHH, underwent reversal. Patients exhibiting reversal had a higher 
frequency of mutations affecting neurokinin B (NKB) signaling compared to patients 
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with no reversal. Perturbations in NKB activity or signaling have been implicated in 
GnRH deficiency (Topalaglu et al. 2009, Gianetti et al. 2010 and Noel et al. 2014). The 
NKB receptor, NK3R, is a Gαq/11-coupled receptor that appears to signal via β-arrestin 
(Schmidlin et al. 2003) in addition to PKC (Glidewell-Kenney et al. 2013). Thus, it is 
possible that NK3R, like Kiss1r, regulates GnRH secretion via β-arrestin and therefore 
some NK3R mutants that are uncoupled from Gαq/11 might continue to regulate GnRH 
secretion via β-arrestin (Noel et al. 2014). 
In developing novel molecular strategies to treat diseases, it is critical to develop a 
detailed mechanistic understanding of the signaling pathways that underlie normal and 
pathological responses. For example, drugs that trigger β-arrestin-coupled KISS1R 
signaling with great efficacy may prove useful in treating IHH patients who bear Gαq/11-
uncoupled KISS1R mutants that localize to the cell surface and bind Kp. Such treatment 
may even be extended to patients bearing KISS1R mutants such as R331X that do not 
localize efficiently to the cell surface (Pampillo et al. 2009) by developing and using 
other drugs that can rescue mislocalized receptors (Re et al. 2010 and Janovick et al. 
2013). The future development of agonists which potently activate the β-arrestin pathway 
to trigger KISS1R-dependent GnRH secretion is only possible by first recognizing that 
KISS1R displays Gαq/11-independent signaling.  
Given that reproductive success is paramount to the survival of any species, it is not 
surprising to find that there is more than one pathway significantly co-regulating GnRH 
secretion. Thus, reproductive success, though it might be diminished, can still be 
achieved in animals bearing certain types of inactivating mutations. The current study 
describes an important and novel discovery that KISS1R signals and triggers LH 
secretion via the β-arrestin pathway in the male mouse. We suggest that other GPCRs 
such as NK3R employ β-arrestin to regulate the reproductive endocrine axis at several 
levels and that the β-arrestin signaling pathway likely represents a major regulator of 
fertility. We propose that for some patients, Gαq/11-independent signaling could account 
for the phenomenon of IHH reversal and hope that our study will stimulate further 
investigation which may lead to new approaches in the treatment of IHH and several 
other reproductive endocrine disorders. 
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Chapter 3: Conclusion 
3.1 General Summary 
Since the discovery of the critical role of the KISS1/KISS1R system in mediating GnRH 
secretion and thus pubertal onset and fertility, our understanding in the field of 
reproductive neuroendocrinology has dramatically expanded. Studies have demonstrated 
that central and peripheral administration of kisspeptin potently stimulates gonadotropin 
release in a wide variety of mammals and has been used to advance pubertal onset in 
juvenile rats and monkeys while kisspeptin antagonists were used to supress 
gonadotropin secretion and delay puberty (Shahab et al. 2005, Keen et al. 2008, 
Guerriero et al. 2012, Han et al. 2005, Messager et al. 2005, Irwig et al. 2004, Navarro et 
al. 2004, Gottsch et al. 2004, Ramaswamy et al. 2007, Shahab et al. 2005, Plant et al. 
2006, Pineda et al 2010, Roseweir et al. 2009, Millar et al 2010). These responses are 
conserved in humans where kisspeptin administration in both male and female patients 
elicits a potent gonadotropin response (Dhillo et al. 2005, Dhillo et al. 2007, George et al. 
2011, Chan et al. 2012). Recently, Jayasena et al. (2014) successfully used a single KP-
54 injection to stimulate egg maturation for in vitro fertilization therapy with sub-fertile 
women resulting in fertilization, implantation, successful term pregnancy and twelve 
healthy live births. Acute treatment with kisspeptin has also been used to restore 
reproductive function in women with hypothalamic amenorrhea and in hypogonadal male 
patients with type II diabetes (Jayasena et al. 2009, George et al. 2013). Long-term or 
chronic administration of kisspeptin has been found to result in an initial increase in 
gonodotropin secretion and pulsatility followed by tachyphylaxis, most likely through the 
desensitization of KISS1R (Jayasena et al. 2009 and Matsui et al. 2012). This response is 
clinically useful in treating conditions which improve with lower gonadal steroid levels 
such as benign prostatic hyperplasia, endometriosis, uterine fibroids and polycystic 
ovarian syndrome (PCOS) (Pinilla et al. 2012 and Millar et al. 2013).  
While many potential therapeutic benefits of the KISS1/KISS1R system have been 
identified, limited knowledge currently exists on the molecular regulation of this system. 
The work presented in this dissertation has improved the mechanistic understanding of 
KISS1R signaling and its physiological role in regulating reproduction. Here we describe 
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that in addition to the major Gαq/11-dependent pathway, KISS1R also signals through 
novel Gαq/11-independent mechanisms to trigger GnRH secretion and we further provide 
evidence that these mechanisms involve β-arrestins. Although continuous administration 
of kisspeptin in vivo results in long-term reduced gonadotropin response (Thompson et al. 
2006, Messager et al. 2005, Jayasena et al. 2009, Matsui et al. 2012), the mechanism 
behind this tachyphylaxis was not known until we described a role for GRK2 in 
mediating the homologous desensitization of KISS1R (Pampillo et al. 2009). In that 
publication we suggested that β-arrestins may also be involved and here we confirmed 
that both β-arrestin-1 and -2 potentiate the termination of Gαq/11-dependent KISS1R 
signaling. Our group was also the first to reveal that kisspeptin stimulation lead to 
KISS1R- β-arrestin interaction and subsequent ERK1/2 phosphorylation (Pampillo et al. 
2009). Using genetically modified MEFs lacking either Gαq/11 or β-arrestin we 
demonstrated that kisspeptin-triggered ERK1/2 activation could be both Gαq/11-
independent and β-arrestin-dependent (Szereszewski et al. 2010). Here, using a Gαq/11-
uncoupled KISS1R mutant, L148S, we confirm that kisspeptin is still able to trigger an 
ERK1/2 phosphorylation response and that this response is largely mediated by β-
arrestin. Using mice lacking either β-arrestin isoform, we are the first to demonstrate the 
physiological significance of these in vitro results where a loss of β-arrestin causes a 
reduced kisspeptin-stimulated gonadotropin response in male mice (Ahow et al. 2014). 
Since mice lacking both β-arrestin isoforms are not available we decided to create Gnrh 
neuron-specific Gαq/11 double knockout mice in order to investigate the collective effect 
of Gαq/11-independent mechanisms on fertility. Our data has provided clear evidence that 
while mice lacking Gαq/11 in the Gnrh neuron are subfertile and hypogonadal they still 
maintain some degree of reproductive function which we attribute to Gαq/11-independent 
signaling in the Gnrh neuron. Furthermore, we demonstrate that Kiss1r is able to signal 
through these Gαq/11-independent mechanisms since kisspeptin treatment results in a 
modest yet significant increase in gonadotropin secretion and testosterone in these mice. 
Overall, the findings presented in this dissertation provide evidence of novel signaling 
mechanisms downstream of the KISS1/KISS1R system in the GnRH neuron which can 
be used for development of more effective therapies that involve manipulating the HPG 
axis. 
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3.2 Future Directions 
As our understanding of the KISS1/KISS1R system continues to grow and technical 
advances enable more indepth experiments, there are many significant avenues which 
remain to be investigated.  
3.2.1 More comprehensive functional assays and long-term follow 
up of patients with KISS1R mutations 
As mentioned previously, the novel discovery that KISS1R can signal independently of 
Gαq/11, leads to the realization that IHH patients bearing KISS1R mutations may not be 
completely infertile and may in fact recover some degree of fertility later in life 
(Tenebaum-Rakover et al. 2007). In vitro assays performed to evaluate the degree of 
function affected by mutations in KISS1R use InsP3 as a read-out. However as we have 
shown, while L148S is incapable of stimulating InsP3 formation and PLCβ mobilization it 
is still capable of stimulating ERK1/2 phosphorylation and since ERK1/2 
phosphorylation is a major event involved in GnRH secretion (Castellano et al. 2006), it 
is plausible to infer that some degree of GnRH secretion is maintained in patients bearing 
L148S. Therefore there is a need for more detailed functional assays using ERK1/2 
phosphorylation and other read-outs with already known Gαq/11 –uncoupled mutants such 
as L102P.  Although we have shown that GnRH secretion is sustained in mice lacking 
Gαq/11 in the GnRH neuron, long-term follow-up of patients with KISS1R mutations is 
needed to evaluate the ability of the Gαq/11-independent mechanisims to attain and 
maintain fertility in humans.  
3.2.2 Distinguish molecular events between the Gαq/11-dependent 
and Gαq/11-independent pathways downstream of KISS1R in 
the GnRH neuron 
While ERK1/2 phosphorylation can be mediated by both Gαq/11-dependent and 
independent pathways (Szereszewski et al. 2010), we identified a key signaling molecule, 
Stat3, that is solely phosphorylated by the Gαq/11-dependent cascade (Figs. 2.11 and 
2.12). We recently demonstrated that kisspeptin stimulates Lif (leukemia inhibitory 
factor) expression in the uterine epithelia which subsequently leads to activation of the 
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Lif receptor (gp130) and downstream Stat3 –mediated gene transcription necessary for 
embryo implantation in the mouse (Calder et al. 2014). Therefore it is not surprising that 
Stat3 may also play a role in modulating gene transcription downstream of the 
KISS1/KISS1R system in the hypothalamus. Further studies are necessary to elucidate 
this response but here we show that Kp-triggered Stat3 phosphorylation is Gαq/11-specific 
response since HEK 293 cells transfected with L148S fail to demonstrate this response 
(Figs. 2.11 and 2.12). This not the first instance where β-arrestin and G-protein pathways 
differentially regulate factors affecting gene expression. For AT1aR, PAR2 and NK1 
receptors, β -arrestin-MAPK signalosomes have been described to sequester ERK1/2 in 
the cytosol, most likely due to the large size of the complex, whereas ERK1/2 that has 
been phosphorylated by the G-protein pathway is capable of translocating to the nucleus 
where it triggers Elk-1 driven gene transcription (Luttrell, et al. 2001, DeFea et al. 2000, 
Luttrell et al. 2010). The stability of the β-arrestin-receptor complex however has a 
significant role to play in determining the localization and effect of downstream signaling 
molecules like ERK1/2 specifically, class A GPCRs with more stable β-arrestin 
interaction tend to demonstrate cytosolic retention of ERK1/2 while some class B 
receptors like β2AR and LPA1 have demonstrated ERK1/2 nuclear translocation (Getsy-
Palmer et al. 2005 and Shenoy et al. 2006). The overall functional role for this 
differentiated response is not fully understood but it is thought that it allows the receptor 
to direct signaling down different pathways since by retaining ERK1/2 in the cytosol 
more non-nuclear substrates are phosphorylated for example which may include 
alternative transcription factors that go to the nucleus instead of ERK1/2 (Pearson et al. 
2001, Elorza et al. 2000). By distinguishing the Gαq/11-dependent and independent 
pathways mediating GnRH secretion we would be better able to develop clinical 
treatments for specific conditions.  
3.2.3 Further elucidate the β-arrestin-mediated KISS1R signaling 
pathway 
We showed that β-arrestin mediates KISS1R homologous desensitization in the presence 
of continuous kisspeptin administration (Fig. 2.13). We also demonstrated that β-arrestin 
mediated Gnrh secretion in mice after a single bolus of KP-54 (Fig. 2.4). In order to 
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harness the therapeutic capacity of kisspeptin we must further understand more about the 
β-arrestin mediated KISS1R response. For example it may be possible for continuous 
kisspeptin treatment to be given to trigger KISS1R desensitization resulting in 
downregulation of the HPG axis (discussed in detail in Chapter 1). Alternatively, in cases 
where upregulation of the HPG axis is desirious, stimulation with synthetic β-arrestin-
biased agonists that stimulate KISS1R to preferentially signal through β-arrestin when the 
Gαq/11 pathway to stimulate gonadotropin and gonadal steroid release (discussed in detail 
in Chapter 1).  
While KISS1/KISS1R plays an important role in regulating the HPG axis, there is 
evidence that it is involved in other organ systems. Therefore improved knowledge of the 
signaling mechanisms downstream of KISS1R may also be used to treat disease 
conditions in these systems. KISS1R is expressed in the pancreas (Kotani et al. 2001) and 
kisspeptin has been shown to have stimulatory effects on insulin secretion (Sonada et al. 
2008, Silvestre et al. 2008 and Ravier et al. 2014). Although the mechanism behind this is 
not fully understood it may provide a novel therapeutic avenue for treatment of diabetes. 
KISS1 is also highly expressed in the placenta in the first trimester (Bilban et al. 2004, 
Horikoshi et al. 2003) and KISS1R has been shown to be involved in the placental 
attachment and invasion process (Taylor et al. 2013). KISS1/KISS1R may therefore be 
manipulated in novel treatments for placental insufficiency and preeclampsia. Lastly, 
initially discovered as a metastasis suppressor, (Lee et al. 1999) KISS1R continues to be 
described in studies as an inhibitor of tumor metastasis (Nash et al. 2007 and Cvetnovic 
et al. 2013). In addition to manipulating fertility in humans, the Kiss1/Kiss1r system can 
also be a valuable tool for maximising livestock breeding and propogation of endangered 
species in zoos and wildlife reserves. Overall, further understanding of the 
KISS1/KISS1R signaling system is essential for implementation of effective treatments 
in a wide variety of applications.  
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3.2.4 Investigate if kisspeptin can restore fertility in Gnaqd/d 
females 
We showed that while Gnaq
d/d
 females were completely infertile and were not able to 
ovulate as evidenced by lack of corporea lutea (CL) in the ovaries (Figs. 2.20 and 2.21) 
they were still able to respond to kisspeptin measured by increased gonadotropin release 
and were also able to sporadically enter estrus and undergo puberty eventually (Figs. 
2.18, 2.19 and 2.22). In patients with impaired Gαq/11 pathways in the GnRH neuron, 
determining the therapeutic potential of the Gαq/11- independent pathway may be very 
beneficial for rescuing their fertility. Future studies with the Gnaq
d/d
 females may involve 
combining regular superovulation protocols involving HCG and PMSG injections 
(Calder et al. 2014) with KP-54 administration. Improvement in fertility would be 
determined by detection of CL in the ovaries and/or successful breeding resulting in birth 
of full-term litters.  
3.2.5 Further confirm kisspeptin triggered response in Gnaqd/d 
mice is as a result of Gαq/11-independent pathways in GnRH 
neurons 
Both parental lines used in the creation of the Gnaq
d/d
 mice were extensively 
characterised in other publications and shown to result in effective conditional knockout 
of various genes (discussed in Chapter 2 Results 2.3.4.1 -2.3.4.2). Additionally we 
performed detailed and extensive experiments which show that Cre recombinase 
expression is restricted to the hypothalamus and is active as early as embryonic day 18 
(E18) (Fig. 2.14). We also used a ROSA26::loxP-Stop-loxP-GFP reporter mouse to 
further show that the spatial distribution of Cre recombination co-localized strongly with 
approximately 98% of the Gnrh neuronal population (Fig.2.15). However due to the lack 
of effective Gαq antibodies for immunoflouresence as well as the scattered spatial 
distribution of hypothalamic Gnrh neurons we are not able to directly measure the degree 
of Gαq loss in Gnrh neurons. To further support our data, we can directly measure the 
gonodatropin response in Gnaq
d/d
 mice where kisspeptin is administered 
intracerebroventricularly (i.c.v) and compare this response to mice pre-treated with GP2A 
(Gαq specific inhibitor). We would expect that GP2A pre-treatment would not have an 
effect on kisspeptin-triggered gonadotropin response in the Gnaq
d/d
 mice since we 
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hypothesize that this is due to Gαq/11 –independent mechanisms. Intracerebroventricular 
(i.c.v) administration (directly into the third ventricle of the brain) would be important for 
this study as it sequesters the Gαq specific inhibitor near to the Gnrh neurons and prevents 
it from affecting the pituitary where Gnrhr signals via Gαq/11 in gonadotropes to stimulate 
LH and FSH release.  
3.2.6 Elucidate other major molecules involved in the Gαq/11-
independent pathway 
We demonstrated that β-arrestin is involved in the Gαq/11-independent response in Gnrh 
neurons (Figs. 2.4 and 2.8). However, we do acknowledge that β-arrestin may not be the 
only molecules involved in the Gαq/11-independent pathway. Some studies suggest that 
some GPCRs which couple to the Gαq protein family also tend to couple with and 
activate Gα12/Gα13 proteins resulting in p115RhoGEF activation (Dagmara et al. 2005, 
Offermanns review 2003 and Lambert et al. 2008). Kotani et al. (2001) showed that in 
CHO cells, kisspeptin stimulates stress fibre formation through activating the Rho 
subfamily of G-proteins and therefore Gα12/Gα13 proteins may be another component in 
the Gαq/11-independent response in Gnrh neurons. Other studies have even shown that 
kisspeptin transactivates the epidermal growth factor receptor (EGFR) in breast cancer 
cells and thus may also contribute to the Gαq/11-independent response in the GnRH 
neuron (Zajac et al. 2011 and Cvetkovic et al. 2013).  
 
 
 
 
 
 
 
194 
 
3.3 Experimental Limitations 
3.3.1 Kiss1r triggers LH secretion via β-arrestin (Figure 2.4) 
To test the hypothesis that KISS1R stimulates GnRH secretion via the β-arrestin pathway 
we used single β-arrestin knockout mice (Fig. 2.4). While a mouse model completely 
lacking both Arrb1 (encodes for β-arrestin-1) and Arrb2 (encodes for β-arrestin-2) would 
be ideal for testing this hypothesis, full body Arrb1
-/-
;Arrb2
-/-
 dKO mice are perinatal 
lethal due to pulmonary hypoplasia (Zhang et al. 2010, Conner et al. 1997, Bohn et al. 
1998). Floxed β-arrestin mice have not been created yet thereby precluding the creation 
of Gnrh-neuron specific Arrb1
-/-
;Arrb2
-/- 
dKO mice.  
3.3.2 L148S displays Gαq/11-independent signaling (Figures 2.5 – 
2.12) 
To test the hypothesis that L148S, a Gαq/11 –uncoupled KISS1R mutant, is still able to 
signal and that this is mediated by β-arrestins we expressed L148S in HEK 293 cells. 
Previous publications showed that although HEK 293 cells are not representative of the 
GnRH neuron they do express low levels of KISS1R endogenously and as such provide a 
strong model in which to investigate molecular signaling mechanisms (Pampillo et al. 
2009). Although GnRH neuronal cell cultures are available such as the GT1-7s (used in 
Fig. 2.13) these cells are very slow to propagate with a doubling time of 36 – 48 hours 
that is further reduced under antibiotic selection in the creation of shRNA knockdown 
stable colonies (Mellon et al. 1990). Additionally, similar to other neuronal cultures, 
GT1-7s are very difficult to transfect requiring chemical reagents such as Lipofectamine 
in order to have sufficient expression levels. This makes transient expression experiments 
very expensive and not feasible to perform regularly. New hypothalamic Gnrh neuronal 
lines have been created and while the GT1-7s are well established and have been used 
extensively, these newer lines may prove to be less technically challenging for future 
experiments (Belsham et al. 2004 and Mayer et al. 2009).  
Our previous studies utilized Gαq/11 double knockout MEFs (Szereszewski et al. 2010) to 
investigate the ability of WT KISS1R to signal independently of Gαq/11. Here we used a 
different approach by expressing a Gαq/11 –uncoupled KISS1R mutant, L148S, in HEK 
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293 cells to investigate if signaling was still possible. While there is the possibility that 
L148S-dependent ERK1/2 activation (Figs. 2.5 – 2.8) may be due to undetectable levels 
of Gαq/11-dependent signalling we validated with two functional assays: InsP3 formation 
and PLC mobilization, that L148S is indeed uncoupled from the Gαq/11 pathway. We 
could have used Gαq/11 double knockout MEFs to address this issue of potential residual 
Gαq/11 signaling downstream of L148S however this this system also removes Gαq/11 from 
all other receptors and signaling pathways, some of which may be involved in the 
physiological response. Our approach was a further improvement on the previous study 
since MEFs are derived from mice and therefore not a human based model like the HEK 
293 cells and since L148S is an actual KISS1R mutation identified in humans diagnosed 
with IHH. 
3.3.3 KISS1R signals via Gαq/11 –independent mechanisms to 
trigger LH secretion and attain and maintain fertility (Figures 
2.14- 2.23) 
To investigate the role of the Gαq/11-independent pathway in pubertal onset, fertility and 
kisspeptin-triggered gonadotropin release, we used mice lacking both Gnaq and 
Gna11expression in the Gnrh neuron referred to here as the Gnaq
d/d
 mice (discussed in 
Chapter 2 Results 2.3.4 – 2.3.5). In order to circumvent the phenotypes associated with 
global loss of these genes (Chapter 1 Table 1.4), the Gnaq
d/d
 mice bear Gnrh-neuronal 
specific deletion of Gnaq in the context of a global deletion of Gna11. In addition to 
yielding viable mice, this approach renders the advantage of specifically targeting the 
Gnrh neuron and not other hypothalamic cells. Both parental lines used to create the 
Gnaq
d/d
 mice have been extensively used in the literature and reports confirm highly 
effective and specific conditional genetic recombination in each of those studies (Skynner 
et al. 1999, Yoon et al. 2005, Wintermantel et al. 2006, Kawakowsky et al. 2012, Schmid 
et al. 2013, Offermanns et al. 1997, Dagmara et al. 2005, Wettschureck et al. 2006, 
Wettschureck et al. 2007, Kero et al, 2007). Therefore we were fairly certain that we 
would observe a similar level of Gnaq ablation in the Gnrh neuron with the Gnaq
d/d
 mice.  
However, due to the lack of commercially available robust Gαq antibodies and the 
scattered distribution of the Gnrh neuronal population throughout the hypothalamus, we 
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were unable to directly demonstrate the loss of Gαq in all Gnrh neurons. To address this 
we investigated the spatial and temporal activation of Cre recombinase using RT-PCR 
and ROSA26::loxP-Stop-loxP-GFP reporter mice. We found that Cre recombinase 
expression and action were specific to the hypothalamus of the Gnaq
d/d
 mice and not 
expressed elsewhere along the HPG axis (Fig. 2.14). While we only examined the female 
HPG axis (Fig. 2.14D) we would expect that if Gnrh-Cre was expressed in the male 
pituitary or testis that fertility would be further decreased. We see the opposite however 
since male Gnaq
d/d
 mice are more fertile than females thereby providing further evidence 
for the hypothalamic specificity of Gnrh- Cre recombinase expression.  We also found 
that Cre recombinase activity occoured as early as E18 and strongly colocalized with at 
least 97% of Gnrh neurons (Fig. 2.15) thus confirming existing studies with this Gnrh-
Cre mouse strain (Skynner et al. 1999, Yoon et al. 2005 and Wintermantel et al. 2006). 
Mayer and Boehm (2011) demonstrated that only 10% of the entire Gnrh population is 
enough to sustain pubertal onset and fertility. Since the Gnaq
d/d
 mice demonstrate a 
distinct phenotype with significant delays in pubertal onset and infertility, it would be fair 
to deduce that genetic recombination and ablation of Gnaq was more than 90% effective 
in Gnrh neurons. In addition to being a highly efficient and specific system, Gnrh-Cre is 
activated very early in development so that there is sufficient time to allow for complete 
enzymatic recombination of Gnaq prior to puberty (7 -8 weeks in this case).  
Overall, while we were not able to directly demonstrate the loss of Gαq in all Gnrh 
neurons we are confident that efficient ablation of Gnaq and Gna11 occoured in the 
majority of Gnrh neurons and is therefore an ideal model for these studies.  
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3.4 Final Conclusions 
Our study is the first to report on novel Gαq/11-independent pathways downstream of 
KISS1R in the GnRH neuron and to describe the role of β-arrestin in mediating this 
pathway. We also identified β-arrestin is a molecule involved in the rapid homologous 
desensitization of KISS1R. In addition to improving our understanding of the molecular 
regulation of the KISS1/KISS1R system, these results also highlight the physiological 
importance of these signaling pathways on fertility and reproductive capacity. It is our 
hope that the work presented here will fuel further research and development of more 
effective treatment strategies for disorders involving HPG axis dysregulation.  
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Appendix 1: Time-course for KP-54 triggered LH secretion in 
β-arrestin deficient mice 
 
Appendix 1: Both Arrb1
-/-
 or Arrb2
-/-
 mice along with littermate controls 
demonstrate maximal LH release 60 min after a single KP-54 injection.  
Serum LH levels were measured by RIA. Mice were either left untreated or treated with 
100 nmol KP-54/kg body weight and blood was collected 15, 30 and 60 min later. KP-
54-triggered LH levels in all mice were significantly higher (*P < 0.001) compared to 
their respective untreated controls. For all genotypes 60 min following KP-54 
administration resulted in the most robust serum LH response. For (A) Arrb1
+/+ 
and (B) 
Arrb1
-/-
 mice and for (C) Arrb2
+/+
 and (D) Arrb2
-/-
 mice, bars represent a mean of 3-6 
mice for each time-point
6
. Only male mice were used to preclude the effects of estrous 
cycle variation on GnRH secretion in females. Error bars represent SEM.  
                                                 
6
 Because Arrb1 and Arrb2 mice were generated in different strains we evaluated the WT littermates 
individually even though genotypically they were identical 
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Appendix 2: Signaling molecules differentially regulated by 
the Gαq/11-independent pathway 
 
 
Appendix 2: Other molecules which are differentially phosphorylated by the Gαq/11-
independent pathway downstream of L148S.  
Densitometric analysis of specific signaling molecules on the Human Phospho-Kinase 
Array in Figure 2.11 (A) p38 (B) CREB and (C) RSK1/2/3
7
.   After KP-10 treatment, 
KISS1R expressing HEK 293 cells showed a significant increase in p38, CREB and 
RSK1/2/3 phosphorylation (*P < 0.05) while cells expressing L148S failed to 
demonstrate any significant response. Densitometric analysis represents the mean of 3 
independent experiments where mean pixel intensity is normalized to reference controls 
on array in Figure 2.11. Error bars represent SEM.  
 
 
 
 
                                                 
7
 Absense of activation of STAT3 in Fig. 2.11 as well as CREB and RSK1/2/3 suggest that the Gαq/11-
independent pathway downstream of L148S may not mediate changes in gene expression since these are all 
transcriptional factors.  
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Appendix 3: Animal Protocol Ethics Approval 
Appendix 3: Animal Protocol Ethics Approval Form 
 
AUP Number: 2008-017-03  
PI Name: Babwah, Andy V  
AUP Title: An In Vivo Analysis Of Kisspeptin/gpr54 (kiss1r) Signaling In Human 
Reproduction  
Approval Date: 10/15/2012  
 
Official Notice of Animal Use Subcommittee (AUS) Approval: Your new Animal Use 
Protocol (AUP) entitled "An In Vivo Analysis Of Kisspeptin/gpr54 (kiss1r) Signaling In 
Human Reproduction" has been APPROVED by the Animal Use Subcommittee of the 
University Council on Animal Care. This approval, although valid for four years, and is 
subject to annual Protocol Renewal.2008-017-03::5  
 
1. This AUP number must be indicated when ordering animals for this project.  
2. Animals for other projects may not be ordered under this AUP number.  
3. Purchases of animals other than through this system must be cleared through the 
ACVS office. Health certificates will be required.  
 
The holder of this Animal Use Protocol is responsible to ensure that all associated safety 
components (biosafety, radiation safety, general laboratory safety) comply with 
institutional safety standards and have received all necessary approvals. Please consult 
directly with your institutional safety officers.  
 
Submitted by: Copeman, Laura  
on behalf of the Animal Use Subcommittee University Council on Animal Care 
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